<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004687.pub4" GROUP_ID="DEPRESSN" ID="009803070207320644" MERGED_FROM="" MODIFIED="2014-06-06 09:11:30 +0100" MODIFIED_BY="Jessica Sharp" NOTES="&lt;p&gt;Authors have to go to Cochrane to change details of positions etc. &lt;/p&gt;" NOTES_MODIFIED="2014-05-20 09:49:48 +0100" NOTES_MODIFIED_BY="Sarah Dawson" REVIEW_NO="H05" REVMAN_SUB_VERSION="5.2.6 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="9.1">
<COVER_SHEET MODIFIED="2014-06-06 09:11:30 +0100" MODIFIED_BY="Jessica Sharp">
<TITLE MODIFIED="2013-11-20 17:07:06 +0000" MODIFIED_BY="[Empty name]">Short-term psychodynamic psychotherapies for common mental disorders</TITLE>
<CONTACT MODIFIED="2014-06-06 09:11:30 +0100" MODIFIED_BY="Jessica Sharp"><PERSON ID="13097" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Allan</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Abbass</LAST_NAME><POSITION>Director of Education</POSITION><EMAIL_1>Allan.Abbass@dal.ca</EMAIL_1><ADDRESS><DEPARTMENT>Department of Psychiatry</DEPARTMENT><ORGANISATION>Dalhousie University</ORGANISATION><ADDRESS_2>8203 - 5909 Veterans Memorial Lane</ADDRESS_2><CITY>Halifax</CITY><ZIP>B3H 2E2</ZIP><REGION>NS</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 902 473 2514</PHONE_1><PHONE_2>+1 902 2259930</PHONE_2><FAX_1>+1 902 473 4545</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2014-06-06 09:11:30 +0100" MODIFIED_BY="Jessica Sharp"><PERSON ID="13097" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Allan</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Abbass</LAST_NAME><POSITION>Director of Education</POSITION><EMAIL_1>Allan.Abbass@dal.ca</EMAIL_1><ADDRESS><DEPARTMENT>Department of Psychiatry</DEPARTMENT><ORGANISATION>Dalhousie University</ORGANISATION><ADDRESS_2>8203 - 5909 Veterans Memorial Lane</ADDRESS_2><CITY>Halifax</CITY><ZIP>B3H 2E2</ZIP><REGION>NS</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 902 473 2514</PHONE_1><PHONE_2>+1 902 2259930</PHONE_2><FAX_1>+1 902 473 4545</FAX_1></ADDRESS></PERSON><PERSON ID="11850CA282E26AA201DC7B3EB1649BD5" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Steve</FIRST_NAME><MIDDLE_INITIALS>R</MIDDLE_INITIALS><LAST_NAME>Kisely</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>s.kisely@uq.edu.au</EMAIL_1><EMAIL_2>steve.kisely@health.qld.gov.au</EMAIL_2><MOBILE_PHONE>0447 447 702</MOBILE_PHONE><ADDRESS><DEPARTMENT>School of Medicine</DEPARTMENT><ORGANISATION>The University of Queensland</ORGANISATION><ADDRESS_1>Princess Alexandra Hospital</ADDRESS_1><ADDRESS_2>Ipswich Road</ADDRESS_2><CITY>Woolloongabba</CITY><ZIP>QLD 4102</ZIP><REGION>Queensland</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 7 3176 6438</PHONE_1><FAX_1>+61 7 3176 5399</FAX_1></ADDRESS></PERSON><PERSON ID="29485538147092684176101105170106" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Joel</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Town</LAST_NAME><POSITION>Clinical Psychologist</POSITION><EMAIL_1>joel.town@dal.ca</EMAIL_1><URL>http://psychiatry.medicine.dal.ca/people/faculty/town.htm</URL><MOBILE_PHONE>+44 (0)7817 253638</MOBILE_PHONE><ADDRESS><DEPARTMENT>Centre for Emotions &amp; Health</DEPARTMENT><ORGANISATION>Dalhousie University</ORGANISATION><ADDRESS_1>5909 Veterans' Memorial Lane</ADDRESS_1><CITY>Halifax</CITY><ZIP>B3H 2E2</ZIP><COUNTRY CODE="CA">Canada</COUNTRY></ADDRESS></PERSON><PERSON ID="50A05EC282E26AA2017F61BB25C13EA8" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Falk</FIRST_NAME><LAST_NAME>Leichsenring</LAST_NAME><EMAIL_1>falk.leichsenring@psycho.med.uni-giessen.de</EMAIL_1><URL>www.uniklinikum-giessen.de</URL><ADDRESS><DEPARTMENT>Klinik für Psychosomatik und Psychotherapie</DEPARTMENT><ORGANISATION>University of Giessen</ORGANISATION><ADDRESS_1>Ludwigstr. 76</ADDRESS_1><CITY>Giessen</CITY><ZIP>35392</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 641 9945660</PHONE_1><FAX_1>+49 641 9945664</FAX_1></ADDRESS></PERSON><PERSON ID="50A55FD382E26AA2017F61BBD13AF04B" ROLE="AUTHOR"><FIRST_NAME>Ellen</FIRST_NAME><LAST_NAME>Driessen</LAST_NAME><POSITION>PhD candidate</POSITION><EMAIL_1>e.driessen@vu.nl</EMAIL_1><ADDRESS><DEPARTMENT>Faculty of Psychology and Education, Department of Clinical Psychology</DEPARTMENT><ORGANISATION>VU University Amsterdam</ORGANISATION><ADDRESS_1>Van der Boechorststraat 1</ADDRESS_1><ADDRESS_2>Transitorium 2B-57</ADDRESS_2><CITY>Amsterdam</CITY><ZIP>1081 BT</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31 20 598 8973</PHONE_1></ADDRESS></PERSON><PERSON ID="50A7630682E26AA2017F61BB64B12E0F" ROLE="AUTHOR"><FIRST_NAME>Saskia</FIRST_NAME><LAST_NAME>De Maat</LAST_NAME><POSITION>Psychotherapist, Training Candidate NVPA</POSITION><EMAIL_1>saskia.demaat@gmail.com</EMAIL_1><EMAIL_2>saskia.demaat@planet.nl</EMAIL_2><ADDRESS><ORGANISATION>Dutch Psychoanalytic Institute (NPI)</ORGANISATION><ADDRESS_1>Olympiaplein 4</ADDRESS_1><CITY>Amsterdam</CITY><ZIP>1076 AB</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>0031(0)205703838</PHONE_1></ADDRESS></PERSON><PERSON ID="50A9601E82E26AA2017F61BBDA00B1D2" ROLE="AUTHOR"><FIRST_NAME>Andrew</FIRST_NAME><LAST_NAME>Gerber</LAST_NAME><POSITION>Assistant Professor of Clinical Psychiatry</POSITION><URL>http://childpsych.columbia.edu/brainimaging/CV_gerber.html</URL><MOBILE_PHONE>917 921-4537</MOBILE_PHONE><ADDRESS><DEPARTMENT>Psychiatry</DEPARTMENT><ORGANISATION>New York State Psychiatric Institute</ORGANISATION><ADDRESS_1>1051 Riverside Drive, Unit 74</ADDRESS_1><CITY>New York</CITY><ZIP>10032</ZIP><REGION>New York</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>212 543-5104</PHONE_1><FAX_1>917 522-9586</FAX_1></ADDRESS></PERSON><PERSON ID="4FF9FB9B82E26AA2017F61BB290A0C39" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Jack</FIRST_NAME><LAST_NAME>Dekker</LAST_NAME><EMAIL_1>jack.dekker@arkin.nl</EMAIL_1><URL>www.arkin.nl</URL><ADDRESS><DEPARTMENT>Research Department</DEPARTMENT><ORGANISATION>Arkin Mental Health Institute</ORGANISATION><ADDRESS_1>Klaprozenweg 111</ADDRESS_1><CITY>Amsterdam</CITY><ZIP>1033 NN</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY></ADDRESS></PERSON><PERSON ID="z1301251413262757031162189942043" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Sven</FIRST_NAME><LAST_NAME>Rabung</LAST_NAME><EMAIL_1>srabung@uke.de</EMAIL_1><EMAIL_2>sven.rabung@aau.at</EMAIL_2><MOBILE_PHONE>+43 680 4424495</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Psychology</DEPARTMENT><ORGANISATION>Alpen-Adria-Universität Klagenfurt</ORGANISATION><ADDRESS_1>Universitätsstr. 65-67</ADDRESS_1><CITY>Klagenfurt</CITY><ZIP>9020</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43 463 2700 1635</PHONE_1></ADDRESS></PERSON><PERSON ID="0E07551E82E26AA200CF038461C18305" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Svitlana</FIRST_NAME><LAST_NAME>Rusalovska</LAST_NAME><POSITION>Psychiatry Resident</POSITION><EMAIL_1>svitlana.rusalovska@cdha.nshealth.ca</EMAIL_1><ADDRESS><ORGANISATION>Dalhousie University</ORGANISATION><CITY>Halifax</CITY><REGION>Nova Scotia</REGION><COUNTRY CODE="CA">Canada</COUNTRY></ADDRESS></PERSON><PERSON ID="76231682459954658758120504101350" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Elizabeth</FIRST_NAME><LAST_NAME>Crowe</LAST_NAME><POSITION>Research Officer/Public health Physician</POSITION><EMAIL_1>bethcrowe@doctors.org.uk</EMAIL_1><EMAIL_2>bethcrowe@gmail.com</EMAIL_2><ADDRESS><DEPARTMENT>School of Population Health</DEPARTMENT><ORGANISATION>University of Queensland</ORGANISATION><ADDRESS_1>Herston Road</ADDRESS_1><CITY>Brisbane</CITY><ZIP>4006</ZIP><REGION>Queensland</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 7 33464640</PHONE_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2014-06-06 09:11:30 +0100" MODIFIED_BY="Jessica Sharp">
<UP_TO_DATE>
<DATE DAY="23" MONTH="7" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="21" MONTH="2" YEAR="2014"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="2" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2004"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2006"/>
<LAST_CITATION_ISSUE ISSUE="6" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2014-04-04 09:14:35 +0100" MODIFIED_BY="Chris Champion">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-04-04 09:14:07 +0100" MODIFIED_BY="Chris Champion">
<DATE DAY="4" MONTH="4" YEAR="2014"/>
<DESCRIPTION>
<P>Review updated</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-04-04 09:14:35 +0100" MODIFIED_BY="Chris Champion">
<DATE DAY="4" MONTH="4" YEAR="2014"/>
<DESCRIPTION>
<P>Review updated with newer methodology and new studies incorporated</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2009-09-11 06:34:28 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-09-11 06:05:48 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="6" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="21" MONTH="8" YEAR="2006"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-09-11 06:34:28 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="9" MONTH="11" YEAR="2005"/>
<DESCRIPTION>
<P>A minor update was submitted for publication in November 2005</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2012-01-30 12:15:38 +0000" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2012-01-30 12:15:38 +0000" MODIFIED_BY="[Empty name]">
<SOURCE>
<NAME>Department of Psychiatry, Dalhousie University</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2012-01-30 12:15:38 +0000" MODIFIED_BY="[Empty name]">
<NAME>Nova Scotia Department of Health</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Cochrane Canada</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-05-16 11:36:17 +0100" MODIFIED_BY="Anne Lawson">
<SUMMARY MODIFIED="2014-05-16 11:29:52 +0100" MODIFIED_BY="Anne Lawson">
<TITLE MODIFIED="2013-12-04 11:08:02 +0000" MODIFIED_BY="Jessica Sharp">Short-term psychodynamic psychotherapies for common mental disorders</TITLE>
<SUMMARY_BODY MODIFIED="2014-05-16 11:29:52 +0100" MODIFIED_BY="Anne Lawson">
<P>
<B>Background</B>
</P>
<P>Common mental disorders include anxiety disorders, depressive disorders, stress-related physical conditions, certain behaviour disorders and personality disorders. People with these disorders tend to have problems handling difficult emotions and often respond with physical and psychic symptoms or avoidant behavioural patterns. Such patterns and emotional responses are theoretically treatable by short-term psychodynamic psychotherapies (STPP) because these therapies aim to improve long- and short-term problems with emotion processing, behaviour and communication/relationships with others. STPP is thought to work by making people aware of emotions, thoughts and problems with communication/relationships that are related to past and recent trauma. This in turn helps to correct problems with emotions and relationships with others.</P>
<P>This review sought to find out whether STPP is more effective than wait-list control (where people receive therapy after a delay during which people in the 'active' group receive the therapy), treatment as usual and minimal treatment (partial treatments not expected to provide a robust effect).</P>
<P>
<B>Study characteristics</B>
</P>
<P>We searched scientific databases to find all published and unpublished studies of STPP compared with wait-list control, treatment as usual or minimal treatment up to July 2012. We searched for studies in adults over 17 years of age with common mental disorders being treated in an outpatient setting. We excluded people with psychotic disorders.</P>
<P>
<B>Key results</B>
</P>
<P>We included 33 studies involving 2173 people. When the results of the studies were combined and analysed, we found that there was a significantly greater improvement in the groups of people who received STPP versus the control groups, both in the short-term (less than three months after treatment) and medium-term (three to six months after treatment). These benefits generally appeared to increase in the long-term. However, some results did not remain statistically significant in the long-term and, in addition, the studies varied in terms of their design, meaning that these conclusions are tentative and need confirmation with further research. The finding that a short-term psychological therapy treatment may be broadly applicable and effective is of importance in the atmosphere of current global healthcare and economic restrictions.</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>The studies were of variable quality.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-05-08 12:55:58 +0100" MODIFIED_BY="Anne Lawson">
<ABS_BACKGROUND MODIFIED="2014-05-01 17:57:54 +0100" MODIFIED_BY="Anne Lawson">
<P>Since the mid-1970s, short-term psychodynamic psychotherapies (STPP) for a broad range of psychological and somatic disorders have been developed and studied. Early published meta-analyses of STPP, using different methods and samples, have yielded conflicting results, although some meta-analyses have consistently supported an empirical basis for STPP. This is an update of a review that was last updated in 2006.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2014-05-01 16:37:03 +0100" MODIFIED_BY="Anne Lawson">
<P>To evaluate the efficacy of STPP for adults with common mental disorders compared with wait-list controls, treatments as usual and minimal contact controls in randomised controlled trials (RCTs). To specify the differential effects of STPP for people with different disorders (e.g. depressive disorders, anxiety disorders, somatoform disorders, mixed disorders and personality disorder) and treatment characteristics (e.g. manualised versus non-manualised therapies).</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2014-05-08 12:55:58 +0100" MODIFIED_BY="Anne Lawson">
<P>The Cochrane Depression, Anxiety and Neurosis Group's Specialised Register (CCDANCTR) was searched to February 2014, this register includes relevant randomised controlled trials from The Cochrane Library (all years), EMBASE (1974-), MEDLINE (1950-) and PsycINFO (1967-). We also conducted searches on CENTRAL, MEDLINE, EMBASE, CINAHL, PsycINFO, DARE and Biological Abstracts (all years to July 2012) and all relevant studies (identified to 2012) were fully incorporated in this review update. We checked references from papers retrieved. We contacted a large group of psychodynamic researchers in an attempt to find new studies.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2014-05-01 16:38:44 +0100" MODIFIED_BY="Anne Lawson">
<P>We included all RCTs of adults with common mental disorders, in which a brief psychodynamic therapy lasting 40 or fewer hours in total was provided in individual format.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2014-05-01 16:42:03 +0100" MODIFIED_BY="Anne Lawson">
<P>Eight review authors working in pairs evaluated studies. We selected studies only if pairs of review authors agreed that the studies met inclusion criteria. We consulted a third review author if two review authors could not reach consensus. Two review authors collected data and entered it into Review Manager software. Two review authors assessed and scored risk of bias. We assessed publication bias using a funnel plot. Two review authors conducted and reviewed subgroup analyses.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-05-07 17:00:32 +0100" MODIFIED_BY="Anne Lawson">
<P>We included 33 studies of STPP involving 2173 randomised participants with common mental disorders. Studies were of diverse conditions in which problems with emotional regulation were purported to play a causative role albeit through a range of symptom presentations. These studies evaluated STPP for this review's primary outcomes (general, somatic, anxiety and depressive symptom reduction), as well as interpersonal problems and social adjustment. Except for somatic measures in the short-term, all outcome categories suggested significantly greater improvement in the treatment versus the control groups in the short-term and medium-term. Effect sizes increased in long-term follow-up, but some of these effects did not reach statistical significance. A relatively small number of studies (N &lt; 20) contributed data for the outcome categories. There was also significant heterogeneity between studies in most categories, possibly due to observed differences between manualised versus non-manualised treatments, short versus longer treatments, studies with observer-rated versus self report outcomes, and studies employing different treatment models.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2014-05-01 16:43:59 +0100" MODIFIED_BY="Anne Lawson">
<P>There has been further study of STPP and it continues to show promise, with modest to large gains for a wide variety of people. However, given the limited data, loss of significance in some measures at long-term follow-up and heterogeneity between studies, these findings should be interpreted with caution. Furthermore, variability in treatment delivery and treatment quality may limit the reliability of estimates of effect for STPP. Larger studies of higher quality and with specific diagnoses are warranted.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-05-16 11:30:41 +0100" MODIFIED_BY="Anne Lawson">
<BACKGROUND MODIFIED="2014-05-16 11:06:55 +0100" MODIFIED_BY="Anne Lawson">
<CONDITION MODIFIED="2014-05-01 17:57:12 +0100" MODIFIED_BY="Anne Lawson">
<P>Common mental disorders (CMD) are the range of non-psychotic symptom and behaviour disorders frequently seen in primary care and psychiatry services. They include depressive disorders, anxiety disorders, somatoform disorders and other conditions often mixed with interpersonal or personality disorders. These are extremely common conditions, with 12-month prevalences of 6.9% for depression, 14.0% for anxiety disorders and 6.3% for somatoform disorders in one European review (<LINK REF="REF-Wittchen-2011" TYPE="REFERENCE">Wittchen 2011</LINK>). Collectively, they produce great expense to society and personal suffering for those people afflicted (<LINK REF="REF-Lazar-2010" TYPE="REFERENCE">Lazar 2010</LINK>). Treatment guidelines for these conditions commonly cite the use of psychological therapy alongside medication as front-line treatment options. Psychotherapies have established effectiveness in some of these conditions. Medications such as antidepressants are frequently used and, although there is some controversy about the magnitude of their effectiveness in real world samples, these appear to be marginally superior to (non-active) placebo controls in short-term randomised controlled trials (RCTs) for many of these conditions.</P>
<P>People with such a broad range of CMDs present to physicians, hospitals and mental health services. Common treatment options in these settings include psychotherapy (e.g. psychodynamic psychotherapy, cognitive behavioural therapies), medications and, in certain situations such as severe depression, procedures such as electroconvulsive therapy.</P>
</CONDITION>
<INTERVENTION MODIFIED="2014-05-16 11:06:55 +0100" MODIFIED_BY="Anne Lawson">
<P>Short-term psychodynamic psychotherapy (STPP) has been developed since the mid-1970s by a number of proponents including James Mann (<LINK REF="REF-Mann-1973" TYPE="REFERENCE">Mann 1973</LINK>), David Malan (<LINK REF="REF-Malan-1979" TYPE="REFERENCE">Malan 1979</LINK>), Habib Davanloo (<LINK REF="REF-Davanloo-2000" TYPE="REFERENCE">Davanloo 2000</LINK>), Peter Sifneos (<LINK REF="REF-Sifneos-1972" TYPE="REFERENCE">Sifneos 1972</LINK>), Hans Strupp and Jeffrey Binder (<LINK REF="REF-Strupp-1984" TYPE="REFERENCE">Strupp 1984</LINK>), and Lester Luborsky (<LINK REF="REF-Luborsky-1984" TYPE="REFERENCE">Luborsky 1984</LINK>), as brief alternatives to the prior long-term psychodynamic therapy models. These treatments are brief talking therapies developed to work with unconscious impulses, feelings and processes that can underpin or perpetuate CMDs. Such unconscious impulses, feelings and processes often relate to losses or traumatising events in the past. Such adverse events are known risk factors for self destructive behaviours, multiple CMDs and multiple somatic disorders (<LINK REF="REF-Felitti-1998" TYPE="REFERENCE">Felitti 1998</LINK>). Thus, psychodynamic psychotherapy, with its focus on resolving old trauma and its damaging effects on relationships, is used to treat multiple conditions including CMD (<LINK REF="REF-Leichsenring-2014" TYPE="REFERENCE">Leichsenring 2014</LINK>; <LINK REF="REF-Shedler-2010" TYPE="REFERENCE">Shedler 2010</LINK>).</P>
<P>Psychodynamic psychotherapy has common factors outlined by Blagys and Hilsenroth including: focus on affect and expression of emotion, exploration of attempts to avoid distressing thoughts and feelings, identification of recurring themes and patterns, discussion of past experience, focus on interpersonal relations, focus on the therapy relationship and exploration of wishes and fantasies (<LINK REF="REF-Blagys-2000" TYPE="REFERENCE">Blagys 2000</LINK>). These features can reliably distinguish psychodynamic therapy from other models such as cognitive therapy (<LINK REF="REF-Blagys-2000" TYPE="REFERENCE">Blagys 2000</LINK>).</P>
<P>In addition to these factors, elements that distinguish STPP from long-term psychodynamic treatments include the use of selection criteria, time restriction, selection of and adherence to a therapeutic focus, efforts to prevent regression, high degrees of therapist activity and active focus on the transference (therapeutic) relationship as a template to learn about and activate emotional-relational processes. Some models use a strict time limited format (e.g. <LINK REF="REF-Mann-1973" TYPE="REFERENCE">Mann 1973</LINK>), while others do not (<LINK REF="REF-Davanloo-2000" TYPE="REFERENCE">Davanloo 2000</LINK>), but the within-study mean number of sessions is typically 12 to 24 with a range of four to 40 weekly sessions. The sessions are face-to-face and generally 45 to 60 minutes weekly. Many STPP methods use the triangle of conflict (the link between feelings, anxiety and defence) and the triangle of person (the link between past, therapist and current people) as key linkages to examine in the therapeutic process (<LINK REF="REF-Davanloo-1980" TYPE="REFERENCE">Davanloo 1980;</LINK> <LINK REF="REF-Malan-1979" TYPE="REFERENCE">Malan 1979</LINK>).</P>
<P>STPP treatment efforts include interventions falling along a continuum between 'supportive' (such as reassurance and encouragement) and 'expressive' elements (such as challenge to defences and elicitation of emotions) (<LINK REF="REF-Luborsky-1984" TYPE="REFERENCE">Luborsky 1984</LINK>). They may also be more or less focused on emotional mobilisation and experiencing versus insight into processes. Some models include a process to build anxiety tolerance through graded exposure to unconscious anxiety, feelings and impulses (<LINK REF="REF-Davanloo-2000" TYPE="REFERENCE">Davanloo 2000</LINK>). Hence, models of STPP can be used with people who may otherwise be unable to tolerate an emotion-focused treatment. This includes people with active major depression or somatisation and people who use projective defences and dissociation. Hence, these models (e.g. <LINK REF="REF-Davanloo-2000" TYPE="REFERENCE">Davanloo 2000</LINK>; <LINK REF="REF-Luborsky-1984" TYPE="REFERENCE">Luborsky 1984</LINK>; <LINK REF="REF-McCullough-2003" TYPE="REFERENCE">McCullough 2003</LINK>) can be used with a broad range of people with personality disorder including borderline personality disorder (<LINK REF="REF-Town-2011" TYPE="REFERENCE">Town 2011</LINK>), and a range of depressive (<LINK REF="REF-Abbass-2010" TYPE="REFERENCE">Abbass 2010</LINK>; <LINK REF="REF-Driessen-2010" TYPE="REFERENCE">Driessen 2010</LINK>), and somatic disorders (<LINK REF="REF-Abbass-2009" TYPE="REFERENCE">Abbass 2009</LINK>).</P>
<P>In the early phase of STPP development, case-based research showed that a range of people could be successfully treated by these brief therapies, and that the gains were maintained at follow-up (<LINK REF="REF-Davanloo-1980" TYPE="REFERENCE">Davanloo 1980</LINK>; <LINK REF="REF-Malan-1979" TYPE="REFERENCE">Malan 1979</LINK>; <LINK REF="REF-Mann-1973" TYPE="REFERENCE">Mann 1973</LINK>; <LINK REF="REF-Sifneos-1972" TYPE="REFERENCE">Sifneos 1972</LINK>). Since the 1980s, other STPP models have, and continue to be, developed. Some are more focused on various aspects of these above-noted common processes. For example, one well-studied model, psychodynamic interpersonal therapy (PIT), which was developed based on the Hobson model (<LINK REF="REF-Hobson-1985" TYPE="REFERENCE">Hobson 1985</LINK>), emphasises interpersonal problems and the use of the therapy relationship as a means of understanding and changing these problematic patterns. A second model, intensive short-term dynamic psychotherapy, is an emotion-focused model developed by Davanloo (<LINK REF="REF-Davanloo-2000" TYPE="REFERENCE">Davanloo 2000</LINK>) and Malan (<LINK REF="REF-Malan-1986" TYPE="REFERENCE">Malan 1986</LINK>) with the expressed purpose of treating complex and resistant populations. Twenty-one studies of this model were reviewed revealing large within- and between-group (cases versus controls) effects across a broad range of populations (<LINK REF="REF-Abbass-2012" TYPE="REFERENCE">Abbass 2012</LINK>) and specifically for personality and somatic disorders (<LINK REF="REF-Town-2013" TYPE="REFERENCE">Town 2013</LINK>). Luborsky's technique (<LINK REF="REF-Luborsky-1984" TYPE="REFERENCE">Luborsky 1984</LINK>), supportive-expressive therapy, operationalises and focuses on conflict through the examination of core conflictual relationship themes. Affect phobia therapy (<LINK REF="REF-McCullough-2003" TYPE="REFERENCE">McCullough 2003</LINK>), influenced by Davanloo's model, focuses on exposure to feared affect warded off by defence mechanisms that are associated with symptoms and personality disorder (<LINK REF="STD-Svartberg-2004" TYPE="STUDY">Svartberg 2004</LINK>). Milrod and colleagues have developed and studied panic-focused psychodynamic psychotherapy (<LINK REF="STD-Milrod-2007" TYPE="STUDY">Milrod 2007</LINK>), and <LINK REF="STD-Monsen-2000" TYPE="STUDY">Monsen 2000</LINK> developed psychodynamic body therapy. Other new STPP models include dynamic interpersonal therapy (<LINK REF="REF-Lemma-2010" TYPE="REFERENCE">Lemma 2010</LINK>), a time-limited treatment for anxiety and depression.</P>
</INTERVENTION>
<THEORY MODIFIED="2014-05-07 17:45:58 +0100" MODIFIED_BY="Anne Lawson">
<P>STPP is a form of psychodynamic therapy and, thus, its mechanisms of action parallel that of psychodynamic therapy overall (<LINK REF="REF-Blagys-2000" TYPE="REFERENCE">Blagys 2000</LINK>; <LINK REF="REF-Shedler-2010" TYPE="REFERENCE">Shedler 2010</LINK>). These mechanisms include facilitation of a therapeutic alliance, building emotional capacities, building self awareness, emotional work to heal past wounds and an interpersonally corrective experience.</P>
<P>In terms of key processes, STPP is purported to work by engaging the person to recognise and relinquish intrapsychic and interpersonal patterns that interrupt the processing and working through of anxiety-laden past and current experiences. The therapy relationship is used as vehicle to promote change. It is seen to provide both a window to access unprocessed emotions related to past relationships, and as an in vivo interpersonal context in which to learn how to respond adaptively to these unprocessed emotions (<LINK REF="REF-Shedler-2010" TYPE="REFERENCE">Shedler 2010</LINK>). Helping a person see the connections between past/current and therapeutic relationships plus feelings/impulses/anxiety and defences brings insight on how emotions activate unconscious reactions and how the past and present are intertwined in the unconscious mind. Healing may take place through the emergence of new understanding about the impact of these often previously implicit processes associated with emotional trauma. The extent to which this involves emotional as well as intellectual neural structures may point to the nature and relative degree of therapeutic change (<LINK REF="REF-Diener-2007" TYPE="REFERENCE">Diener 2007</LINK>; <LINK REF="REF-Ulvenes-2012" TYPE="REFERENCE">Ulvenes 2012</LINK>). Long-lasting and sustained improvement in quality of life and interpersonal relationships, as well as symptom reduction, are presumed to be associated with the healthy adaptation of previously negative internal representations of the self and other. Common results from this work include improved awareness of emotions, awareness of and changes in interpersonal patterns, and improved capacity to tolerate both interactions and emotions. So overall, combinations of building insight, interpersonal corrective experiences with the therapist and emotional processing appear key treatment factors.</P>
<P>The STPP therapist uses a range of interventions to facilitate the therapeutic alliance. In STPP, the therapeutic alliance is mobilised through, in addition to other elements, efforts to help the person face difficult emotions, clarification of observed repeated defensive patterns and challenge to emotional avoidance in the therapeutic relationship (<LINK REF="REF-Davanloo-1980" TYPE="REFERENCE">Davanloo 1980</LINK>; <LINK REF="REF-Luborsky-1984" TYPE="REFERENCE">Luborsky 1984</LINK>). These efforts activate conscious and unconscious drives in the person to be aware of and address hitherto avoided emotions: these healing forces are what comprise the therapeutic alliance contributions of the person. Recapitulation and interpretation of what is discovered is employed to help cement learning and foster a stronger therapeutic alliance (<LINK REF="REF-Davanloo-2000" TYPE="REFERENCE">Davanloo 2000</LINK>; <LINK REF="REF-Messer-1995" TYPE="REFERENCE">Messer 1995</LINK>). This alliance appears to be a strong contributor to outcomes across many forms of psychotherapy.</P>
<P>Some STPP models are more supportive than confrontative of defences. Some are more reliant on developing insight into repeated patterns (<LINK REF="REF-Luborsky-1984" TYPE="REFERENCE">Luborsky 1984</LINK>), while others rely more on defence handling and emotional mobilisation (e.g. <LINK REF="REF-Davanloo-2000" TYPE="REFERENCE">Davanloo 2000</LINK>; <LINK REF="REF-McCullough-2003" TYPE="REFERENCE">McCullough 2003</LINK>). Most models and therapists are likely to use combinations of supportive/confrontative techniques and interpretation/emotion mobilisation in line with patient in-session response and presentation (<LINK REF="REF-Luborsky-1984" TYPE="REFERENCE">Luborsky 1984</LINK>; <LINK REF="REF-Messer-1995" TYPE="REFERENCE">Messer 1995</LINK>).</P>
<P>As noted, the treatment course is relatively brief averaging 12 to 24 sessions, although some treatment courses will extend up to 40 sessions when working with people with more severe emotional dysregulation, limited anxiety tolerance and depression. Working through of emotions and conflict takes place over a series of sessions followed by a phase of termination. At termination, emotions related to past losses are generally activated and worked through (<LINK REF="REF-Mann-1973" TYPE="REFERENCE">Mann 1973</LINK>; <LINK REF="REF-Messer-1995" TYPE="REFERENCE">Messer 1995</LINK>).</P>
<P>STPP may be provided in combination with medication such as antidepressants, especially where first-line psychotherapy or medication alone were not adequately effective (<LINK REF="REF-Malhi-2009" TYPE="REFERENCE">Malhi 2009</LINK>). Some reviews have suggested that combination treatments are more effective than either medication or psychotherapy alone, for example in the treatment of chronic depression (<LINK REF="REF-Malhi-2009" TYPE="REFERENCE">Malhi 2009</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2014-05-15 12:31:31 +0100" MODIFIED_BY="Anne Lawson">
<P>When we published this original review (<LINK REF="REF-Abbass-2006" TYPE="REFERENCE">Abbass 2006</LINK>), we estimated that there were over 50 studies of STPP published in the English language literature and that the mix of results from early meta-analyses made a call for a formal review of this evidence base using Cochrane methodology. Since then, many more studies have been published along with a series of meta-analyses (e.g. <LINK REF="REF-Abbass-2009" TYPE="REFERENCE">Abbass 2009</LINK>; <LINK REF="REF-Abbass-2010" TYPE="REFERENCE">Abbass 2010</LINK>; <LINK REF="REF-Abbass-2011" TYPE="REFERENCE">Abbass 2011</LINK>; <LINK REF="REF-Driessen-2010" TYPE="REFERENCE">Driessen 2010</LINK>; <LINK REF="REF-Town-2011" TYPE="REFERENCE">Town 2011</LINK>; <LINK REF="REF-Town-2012" TYPE="REFERENCE">Town 2012</LINK>). Conservatively, there are now over 100 published trials of STPP reviewed in over 12 meta-analyses. These individual studies are of a broad range of psychological and medical conditions and with a range of controls and research methodologies. Furthermore, recent research shows that psychodynamic therapy is frequently used in clinical practice (<LINK REF="REF-Cook-2010" TYPE="REFERENCE">Cook 2010</LINK>; <LINK REF="REF-Norcross-2013" TYPE="REFERENCE">Norcross 2013</LINK>). Hence, it is important to update this Cochrane review to clarify the current state of evidence of STPP for CMDs.</P>
<P>While early meta-analyses have yielded differing results due to differences in methodology (<LINK REF="REF-Anderson-1995" TYPE="REFERENCE">Anderson 1995</LINK>; <LINK REF="REF-Crits_x002d_Christoph-1992" TYPE="REFERENCE">Crits-Christoph 1992;</LINK> <LINK REF="REF-Svartberg-1991" TYPE="REFERENCE">Svartberg 1991</LINK>), more recent reviews have generally reported large effects sustained or increasing over time within group while studying RCTs and non-RCTs. Heterogeneity has been high in many studies and not all results were maintained in subgroup analyses suggesting a cautious interpretation is required. None of these reviews employed a methodology similar to ours including the entire cluster of CMDs versus all non-formal psychotherapy or wait-list controls.</P>
<P>Thus, we present this updated Cochrane review of these treatment approaches compared with non-treatment and minimal treatment controls for people with CMDs.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2014-05-06 21:49:58 +0100" MODIFIED_BY="Anne Lawson">
<P>To evaluate the efficacy of STPP for adults with CMDs compared with wait-list controls, treatments as usual and minimal contact controls in RCTs. To specify the differential effects of STPP for people with different disorders (e.g. depressive disorders, anxiety disorders, somatoform disorders, mixed disorders and personality disorder) and treatment characteristics (e.g. manualised versus non-manualised therapies).</P>
</OBJECTIVES>
<METHODS MODIFIED="2014-05-15 12:38:31 +0100" MODIFIED_BY="Anne Lawson">
<SELECTION_CRITERIA MODIFIED="2014-05-15 12:38:31 +0100" MODIFIED_BY="Anne Lawson">
<CRIT_STUDIES MODIFIED="2014-05-06 08:30:02 +0100" MODIFIED_BY="Anne Lawson">
<P>RCTs of STPP treatments. Cluster randomised trials and cross-over randomised trials were eligible.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2014-05-06 08:32:34 +0100" MODIFIED_BY="Anne Lawson">
<SUBSECTION>
<HEADING LEVEL="4">Participant characteristics</HEADING>
<P>Adults (i.e. over 17 years old).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Diagnosis</HEADING>
<P>We reviewed the following CMDs (among others), anxiety disorders, depressive disorders, somatoform disorders, certain behaviour disorders (such as eating disorder, self injurious behaviour) and interpersonal or personality problems mixed with symptom disorders.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Co-morbidities</HEADING>
<P>We accepted studies with medical or psychiatric co-morbidity, including personality disorder.</P>
<P>We excluded studies of people with psychotic disorders.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Setting</HEADING>
<P>We limited the population to outpatients.</P>
</SUBSECTION>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2014-05-15 12:38:31 +0100" MODIFIED_BY="Anne Lawson">
<SUBSECTION>
<HEADING LEVEL="4">Experimental intervention</HEADING>
<P>We defined STPP as:</P>
<OL>
<LI>at least one treatment group as psychodynamic in nature and treatment lasted 40 weeks or less on average. </LI>
<LI>treatment was 40 or fewer sessions, as this is the definition used in previous meta-analyses;</LI>
<LI>the treatment technique was derived from the work of one or more developers of STPPs such as Malan (<LINK REF="REF-Malan-1979" TYPE="REFERENCE">Malan 1979</LINK>), Davanloo (<LINK REF="REF-Davanloo-1980" TYPE="REFERENCE">Davanloo 1980</LINK>), or Luborsky (<LINK REF="REF-Luborsky-1984" TYPE="REFERENCE">Luborsky 1984</LINK>), or was specifically developed and described for a brief psychodynamic approach;</LI>
<LI>the treatment under investigation was given in an individual format; and</LI>
<LI>the treatment had standard length sessions of 45 to 60 minutes.</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Control interventions</HEADING>
<P>We included studies in which controls were those conditions other than robust, bona fide psychological therapy treatments for the condition studied. These included:</P>
<UL>
<LI>wait-list controls;</LI>
<LI>minimal treatment controls that had been designed as psychological 'placebo treatments'. For example these may have included short supportive conversations each month, the provision of psycho-education, or partial treatments not expected to provide a robust psychotherapy effect;</LI>
<LI>treatments as usual including, for example, medical treatment as usual and psychiatric care as usual; and</LI>
<LI>studies in which non-psychotherapeutic treatments (such as medications or medical care as usual) were provided equally in both arms.</LI>
</UL>
</SUBSECTION>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2014-05-15 12:32:04 +0100" MODIFIED_BY="Anne Lawson">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2014-05-08 09:57:45 +0100" MODIFIED_BY="Anne Lawson">
<P>1. General symptoms as defined by standardised psychiatric instruments or criteria (e.g. Symptom Checklist 90; <LINK REF="REF-Derogatis-1994" TYPE="REFERENCE">Derogatis 1994</LINK>).</P>
<P>2. Somatic symptoms (e.g. McGill Pain Questionnaire; <LINK REF="REF-Melzack-1975" TYPE="REFERENCE">Melzack 1975</LINK>).</P>
<P>3. Anxiety (e.g. Hamilton Anxiety Rating Scale; <LINK REF="REF-Hamilton-1959" TYPE="REFERENCE">Hamilton 1959</LINK>).</P>
<P>4. Depression (e.g. Beck Depression Inventory (BDI); <LINK REF="REF-Beck-1961" TYPE="REFERENCE">Beck 1961</LINK>).</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2014-05-15 12:32:04 +0100" MODIFIED_BY="Anne Lawson">
<P>5. Social adjustment (e.g. the Social Adjustment Scale; <LINK REF="REF-Weissman-1978" TYPE="REFERENCE">Weissman 1978</LINK>).</P>
<P>6. Quality of life (e.g. EuroQol; <LINK REF="REF-EuroQol-1990" TYPE="REFERENCE">EuroQol 1990</LINK>).</P>
<P>7. Behavioural measures (e.g. attempts at self harm).</P>
<P>8. Interpersonal problem measures (e.g. Inventory of Interpersonal Problems; <LINK REF="REF-Horowitz-1988" TYPE="REFERENCE">Horowitz 1988</LINK>).</P>
<P>9. Patient satisfaction as measured by standardised instruments.</P>
<P>10. Health service use (e.g. hospital admission, outpatient contacts, visits to primary care).</P>
<P>11. Cost measures (e.g. medication cost changes).</P>
<P>12. Death.</P>
<P>13. Dropout rates.</P>
<P>14. Occupational functioning.</P>
<SUBSECTION>
<HEADING LEVEL="4">Hierarchy of outcome measures</HEADING>
<P>When more than one scale was used to measure similar elements or the same element (e.g. depression), we used the following approach:</P>
<OL>
<LI>blind observer rated measures were used over self reported measures;</LI>
<LI>well-known, validated measures were used ahead of lesser known, not well-validated measures;</LI>
<LI>measures covering the scope of a condition were used ahead of measures covering only part of a condition (e.g. BDI versus Beck Hopelessness Scale: hopelessness is only one part of depression and is covered in the BDI so the BDI is used);</LI>
<LI>the measure designated as the a priori primary outcome measure was used over what was an a priori designated secondary outcome measure.</LI>
</OL>
<P>We solved cases of any disagreement between evaluators through consensus or eliciting the opinion of a third rater.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Timing of outcome assessment</HEADING>
<P>Where sufficient data were available, we studied treatment outcomes in three time frames:</P>
<UL>
<LI>short-term: less than three months after treatment was concluded;</LI>
<LI>medium-term: three to nine months after treatment was concluded;</LI>
<LI>long-term: nine or more months after treatment is completed.</LI>
</UL>
<P>When there were multiple measurement points inside one time frame, we used data from the longest follow-up assessment.</P>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2014-05-08 12:16:20 +0100" MODIFIED_BY="Anne Lawson">
<P>
<B>The Cochrane, Depression, Anxiety and Neurosis Review Group's Specialised Register (CCDANCTR)</B> </P>
<P>The Cochrane Depression, Anxiety and Neurosis Group (CCDAN) maintain two clinical trials registers at their editorial base in Bristol, UK, a references register and a studies based register. The CCDANCTR-References Register contains over 34,000 reports of randomized controlled trials in depression, anxiety and neurosis. Approximately 60% of these references have been tagged to individual, coded trials. The coded trials are held in the CCDANCTR-Studies Register and records are linked between the two registers through the use of unique Study ID tags. Coding of trials is based on the EU-Psi coding manual. Please contact the CCDAN Trials Search Coordinator for further details. Reports of trials for inclusion in the Group's registers are collated from routine (weekly), generic searches of MEDLINE (1950-), EMBASE (1974-) and PsycINFO (1967-); quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL) and review specific searches of additional databases. Reports of trials are also sourced from international trials registers c/o the World Health Organisation&#8217;s trials portal (<A HREF="http://apps.who.int/trialsearch/">ICTRP</A>), <A HREF="http://www.clinicaltrials.gov/">ClinicalTrials.gov</A>, drug companies, the hand-searching of key journals, conference proceedings and other (non-Cochrane) systematic reviews and meta-analyses. </P>
<P>Details of <A HREF="http://ccdan.cochrane.org/search-strategies-identification-studies">CCDAN's generic search strategies</A> can be found on the Group&#8216;s website.<B>
<BR/>
</B>
</P>
<ELECTRONIC_SEARCHES MODIFIED="2014-05-08 12:16:20 +0100" MODIFIED_BY="Anne Lawson">
<P>
<B>1. The Cochrane, Depression, Anxiety and Neurosis Review Group's Specialised Register (CCDANCTR)</B>
</P>
<P>The CCDANCTR was searched by the Group's Trials Search Co-ordinator (TSC) to February 2010 using a sensitive list of terms for psychodynamic psychotherapies (intervention only). An update search was conducted in February 2014 using a more precision maximazing search strategy (intervention + comparator). A companion search of PsycINFO was also conducted at this time.</P>
<P>CCDANCTR (Studies and References Register, update search 2014-02-21):<BR/>#1 (psychoanalytic or psychodynamic* or psycho-dynamic* or (*dynamic* and (brief or *psycho* or *therap*)) or "time limited psychotherap*" or mann's or davanloo* or hobson* or STPP or ISTDP):<I>ti,ab,kw,ky,emt,mh,mc</I>
<BR/>#2 ("treatment as usual" or tau:ab or "usual care" or "care as usual" or waitlist* or "wait* list*" or wait-list* or "minim* contact*")<BR/>#3 (enhanced or routine or standard or traditional or usual) NEAR2 (*care or treatment or *therap*)<BR/>#4 (delay* or &#8220;no treatment&#8221; or &#8220;no *therap*&#8221;) NEAR (control or group or treatment*)<BR/>#5 (peer or &#8220;self help*&#8221; or &#8220;mutual help*&#8221; or (support* NEAR2 (&#8220;help&#8221; or group or *therap* or listening)) or relaxation)<BR/>#6 (&#8220;combined modality&#8221; or (combin* NEAR2 (therapy or treatment)))<BR/>#7 (#1 and (#2 or #3 or #4 or #5 or #6))</P>
<P>OVID PsycINFO (update search 2014-02-21):<BR/>1. PSYCHODYNAMICS/<BR/>2. PSYCHODYNAMIC PSYCHOTHERAPY/<BR/>3. (psychodynamic* and (therapy or psychotherapy)).ti,ab.<BR/>4. ((brief adj3 dynamic) and (therapy or psychotherapy)).ti,ab.<BR/>5. (dynamic* adj3 (therapy or psychotherapy)).ti,ab.<BR/>6. or/1-5<BR/>7. (randomized or randomised).ti,ab,sh.<BR/>8. (random* adj3 (administ* or allocat* or assign* or class* or control* or determine* or divide* or distribut* or expose* or fashion or number* or place* or recruit* or subsitut* or treat*)).ab.<BR/>9. or/7-8<BR/>10. 6 and 9<BR/>PsycINFO records were screened and added to the CCDANCTR as appropriate.</P>
<P>CCDANCTR (Studies and References Register, initial search, all years to 2010-02-03):<BR/>Studies Register: Intervention = (Psychodynamic or Dynamic or Psychoanalytic or Analytic) and Age Group = (Adult or Aged)<BR/>References Register: Free-Text = Psychodynamic or Dynamic or Psychoanalytic or Analytic</P>
<P>
<B>2.Other electronic searches</B>
<BR/>To ensure all eligible studies and review articles were identified, we conducted our own searches on the following electronic databases (2012-07-23): The Cochrane Central Register of Controlled Trials (CENTRAL); MEDLINE (1966-); EMBASE (1980-), CINAHL (1982-), PsycINFO (1887- ), the Database of Abstracts of Reviews of Effectiveness (DARE) and Biological Abstracts (January 1980-). The search strategy included terms for common mental health disorders and brief/time limited psychodynamic psychotherapies, see CENTRAL search (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>).</P>
<P>For MEDLINE, we expanded the search to include ANALYTIC, PSYCHOANALYTIC, DYNAMIC or PSYCHODYNAMIC, as the National Library of Medicine has defined brief psychotherapy as being not more than 20 sessions for indexing purposes since 1973. This ensured we did not miss therapies of up to 40 sessions.</P>
<P>No restrictions on date, language or publication status were applied to the searches. All relevant foreign language papers were translated.<BR/>
</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2014-05-02 12:07:57 +0100" MODIFIED_BY="Anne Lawson">
<SUBSECTION>
<HEADING LEVEL="4">Reference lists</HEADING>
<P>We checked the reference lists of all retrieved and potentially relevant papers, as well as relevant systematic reviews and literature reviews to identify other potentially relevant articles. We retrieved and assessed these articles for possible inclusion in the review.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Personal communications</HEADING>
<P>We wrote to the lead author of relevant studies to ascertain if they knew of any additional related published or unpublished data that may have been relevant to the review. We contacted two list serves containing psychodynamic researchers to ask about recent studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Handsearching</HEADING>
<P>We scrutinised abstracts from national and international psychiatry and psychology conferences to identify unpublished studies. These included meetings organised by national and international medical colleges, speciality societies and professional organisations. We contacted the authors of these studies to obtain further details about the studies and to enquire if they knew of any other unpublished or published relevant work.</P>
</SUBSECTION>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2014-05-08 10:02:24 +0100" MODIFIED_BY="Anne Lawson">
<STUDY_SELECTION MODIFIED="2014-05-06 22:27:03 +0100" MODIFIED_BY="Anne Lawson">
<P>Pairs of review authors independently selected suitable studies for inclusion in this review as detailed below. Where the two review authors disagreed about the inclusion of a study, we resolved disagreements by consensus, and consulted a third author if they could not reach consensus. Where resolution was not possible, we contacted the investigator to obtain more information and clarification.</P>
<P>We assessed the titles and abstracts of studies identified by searching electronic databases to determine whether each article met the eligibility criteria. In order to limit bias, we printed out a list of all titles and abstracts excluding the investigators' names, institutions and journal title. If the title and abstract contained sufficient information to determine that an article did not meet the inclusion criteria, we rejected that article. We documented all rejected papers and the reasons for rejection.</P>
<P>We retrieved the full papers of all remaining titles and abstracts deemed relevant. In addition, we reviewed all other potentially relevant articles identified by the various search strategies (reference checking, personal communications, etc.). We translated all papers in languages other than English or someone competent in that language reviewed them.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-05-06 22:27:43 +0100" MODIFIED_BY="Anne Lawson">
<P>Two review authors independently reviewed all articles, each of whom completed a form for each study and made a judgement on the quality using the 'Risk of bias' tools defined below. We documented the reasons for exclusion. Where the same study had more than one article written about the outcomes, we treated all articles as one study and presented the results only once.</P>
<SUBSECTION>
<HEADING LEVEL="4">Data extraction</HEADING>
<P>We extracted data from the papers and recorded them on forms to elicit the following information:</P>
<OL>
<LI>general (published/unpublished, title, authors, source, contact address, country, language of publication, year of publication, duplicate publications);</LI>
<LI>interventions (frequency, timing, individual versus group, up to 20 sessions versus 20 to 40 sessions, manual driven versus non-manualised therapies), comparison interventions, concurrent medications;</LI>
<LI>participant characteristics - sampling, exclusion criteria, number of participants, age, sex, ethnicity, marital status, educational status, duration of symptoms, number of complications, similarity of groups at baseline (including any co-morbidity), withdrawals/losses to follow-up (reasons/descriptions);</LI>
<LI>primary diagnosis (e.g. depression, anxiety or somatoform disorders). These were determined based on the reported diagnoses being treated in the paper independent of which diagnostic criteria were being used (e.g. Feighner Criteria or Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) for major depression were both considered as depression);</LI>
<LI>type of medical co-morbidity if present;</LI>
<LI>type of psychiatric co-morbidity - clinical diagnosis or symptomatology assessed by questionnaire;</LI>
<LI>type of outcome - self report or observer-rated;</LI>
<LI>type of assessment tool used to assess psychiatric co-morbidity (e.g. BDI, Zung Depression Scale, Hospital Anxiety and Depression Scale, Structured interview, DSM-IV criteria;</LI>
<LI>cut-off used on psychiatric scale, percentage of people defined as psychiatric cases on this basis; mean (standard deviation (SD)) symptom score;</LI>
<LI>timing of follow-up: short-term (less than three months), medium-term (three to nine months) and long-term (more than nine months);</LI>
<LI>assessment of different domains of bias according to the 'Risk of bias' tool defined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2008b" TYPE="REFERENCE">Higgins 2008b</LINK>).</LI>
</OL>
<P>We reported a summary of data extracted from included studies.</P>
<SUBSECTION>
<HEADING LEVEL="5">Main planned comparisons</HEADING>
<UL>
<LI>STPP versus wait-list/treatment as usual/minimal treatment.</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2014-05-02 12:23:00 +0100" MODIFIED_BY="Anne Lawson">
<P>For the current update of this review, we have updated the methods to include assessment for 'Risk of bias' based on the revised version of the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(Section 8.5.1; <LINK REF="REF-Higgins-2008b" TYPE="REFERENCE">Higgins 2008b</LINK>). For each included study, two review authors assessed the degree to which:</P>
<UL>
<LI>the allocation sequence was adequately generated (random sequence generation);</LI>
<LI>the allocation was adequately concealed (allocation concealment);</LI>
<LI>knowledge of the allocated interventions was adequately prevented during the study (blinding);</LI>
<LI>incomplete outcome data were adequately addressed;</LI>
<LI>reports of the study were free of suggestion of selective outcome reporting; and</LI>
<LI>the study was apparently free of other problems that could put it at high risk of bias.</LI>
</UL>
<P>We allocated each domain one of three possible categories for each of the included studies: low risk of bias, high risk of bias and unclear risk of bias (where the risk of bias was uncertain or unknown).</P>
<P>We resolved any disagreements by discussion or by involving a third review author.</P>
<P>In future reviews, we will adapt the 'Risk of bias' tool to incorporate features such as the use of adherence ratings, the use of manuals, therapist experience, handling of participants lost to follow-up and researcher allegiance to enable measurement of psychotherapy quality.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2014-05-02 12:25:33 +0100" MODIFIED_BY="Anne Lawson">
<P>Many rating scales are available to measure outcomes in psychological trials. These scales vary in the quality of their validation and reliability. Therefore, if a rating scale's validation had not been published in a peer-reviewed journal, then the data were not included in this review. In addition, the rating scale should have been either self report or completed by an independent observer or relative. Trials that used the same instrument to measure specific outcomes were used in direct comparisons where possible. We reported the mean and SD. Where SDs were not reported in the paper, we attempted to obtain them from the authors or to calculate them using others measures of variation that were reported, such as the confidence intervals (CI). Where possible, we meta-analysed data from different scales, rating the same effect using the standardised mean difference (SMD). We considered SMDs of 0.2 as small, 0.5 as moderate and 0.8 and greater as large (<LINK REF="REF-Cohen-1988" TYPE="REFERENCE">Cohen 1988</LINK>).</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2014-05-07 17:12:05 +0100" MODIFIED_BY="Anne Lawson">
<SUBSECTION>
<HEADING LEVEL="3">Cross-over trials</HEADING>
<P>Due to the risk of carry-over effects in cross-over trials, we used only data from the first phase of the study.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Cluster-randomised trials</HEADING>
<P>Should any cluster randomised trials be identified in future updates of this review, we will include them as long as proper adjustment for the intra-cluster correlation can be undertaken as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<A HREF="http://archie.cochrane.org/sections/documents/view?document=637899072120134263&amp;format=REVMAN#REF-Higgins-2009">Higgins 2009</A>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Studies with multiple treatment groups</HEADING>
<P>Where studies had additional treatment arms that were not relevant to this review, we did not consider those additional data. If a study had more than two treatment arms that met the inclusion criteria (e.g. two brief psychodynamic psychotherapy models and a psychological placebo arm), then the data from the psychological placebo arm were split equally between to produce two (or more) pair wise comparisons.</P>
</SUBSECTION>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2014-05-06 22:28:32 +0100" MODIFIED_BY="Anne Lawson">
<P>Where it was not possible to analyse data quantitatively as reported in published studies, we contacted the first author to obtain the additional data required. We used data from intention-to-treat (ITT) analyses where possible. We listed issues of attrition bias in the 'Risk of Bias' tables.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2014-05-02 12:52:56 +0100" MODIFIED_BY="Anne Lawson">
<P>We assessed heterogeneity on the basis of the recommendations of the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(I<SUP>2</SUP> values of 0% to 40%: might not be important; 30% to 60%: may represent moderate heterogeneity; 50% to 90%: may represent substantial heterogeneity; 75% to 100%: considerable heterogeneity). In addition to the I<I>
<SUP>2</SUP>
</I> value (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>), we presented the Chi<SUP>2</SUP> and its P value and considered the direction and magnitude of the treatment effects. In a meta-analysis with few studies, the Chi<SUP>2</SUP> test is underpowered to detect heterogeneity should it exist, thus, we used a P value of 0.10 as a threshold of statistical significance. Hence, we consider P value &lt; 0.10 and I<SUP>2</SUP> of 50% or more to reflect significant heterogeneity.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2014-05-02 12:51:57 +0100" MODIFIED_BY="Anne Lawson">
<P>We used data from all identified and selected trials to draw a funnel plot (size of study versus effect size) (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>), to attempt to detect the possibility of publication bias. However, it should be noted that there may be other reasons for asymmetry in funnel plots, such as heterogeneity and small-study effects.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2014-05-08 10:02:24 +0100" MODIFIED_BY="Anne Lawson">
<P>If studies were available that were sufficiently similar and of sufficient quality, we pooled those that could be grouped together and used the statistical techniques of meta-analysis using Review Manager 5 software (<LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>). We used a fixed-effect model when there was little statistical heterogeneity (both P value &gt; 0.10 and I<SUP>2</SUP> of 50% or greater). In cases where there was significant heterogeneity (both P value &lt; 0.10 and I<SUP>2</SUP> of 50% or greater), we used a random-effects model. Thus, we relied on the results of these two measures to decide which model to report. The rationale for this decision was that, even though there were expectations of variation between studies (due to samples, treatment approaches and controls), within each subgroup (e.g. social adjustment, short-term follow-up) there was a possibility of low heterogeneity due to the measures, timing and groups using those measures (e.g. mostly studies of people with depression measuring depression). In cases where these measures of heterogeneity were not significant and we used a fixed-effect model, we also examined the effects using a random-effects model to determine if this decision had any bearing on outcomes.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2014-05-02 12:56:55 +0100" MODIFIED_BY="Anne Lawson">
<P>In order to investigate sources of heterogeneity, we performed subgroup analyses as follows:</P>
<OL>
<LI>studies using minimal treatment or wait-list controls as opposed to treatment as usual as a comparator;</LI>
<LI>studies of therapy of up to 20 sessions versus over 20 sessions in duration;</LI>
<LI>studies of specific STPP methods when there were adequate numbers (five or more) of such studies; and</LI>
<LI>studies of different diagnostic groups including depressive disorders, anxiety disorders, somatoform disorders, mixed disorders and personality disorder.</LI>
</OL>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2014-05-02 12:57:30 +0100" MODIFIED_BY="Anne Lawson">
<P>We performed sensitivity analyses examining treatment effects of the following groups of studies in comparison with those of the entire group of studies:</P>
<OL>
<LI>manualised therapies only;</LI>
<LI>studies giving observer-rated outcome;</LI>
<LI>studies with medications provided on both study arms.</LI>
</OL>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-05-16 11:01:40 +0100" MODIFIED_BY="Anne Lawson">
<STUDY_DESCRIPTION MODIFIED="2014-05-16 11:01:40 +0100" MODIFIED_BY="Anne Lawson">
<SEARCH_RESULTS MODIFIED="2014-05-08 12:25:36 +0100" MODIFIED_BY="Anne Lawson">
<P>We carried out update searches to 23 July 2012. These broad searches identified more than 6800 references. It is likely many of these overlapped with the large set of studies reviewed for this original review (<LINK REF="REF-Abbass-2006" TYPE="REFERENCE">Abbass 2006</LINK>). We excluded all but 18 from assessment of title and abstract. Fifteen remained after de-duplication. We retrieved full papers for these 15 records. After inspection of the full-text papers, we excluded five records. The remaining 10 references were added to those from the earlier version of this review and they contributed to the analysis (<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>).</P>
<P>In this updated version of the review, <LINK REF="STD-Dare-2001" TYPE="STUDY">Dare 2001</LINK> was moved from the excluded studies to the included studies, in accordance with Cochrane's MECIR standards (<LINK REF="REF-Chandler-2013" TYPE="REFERENCE">Chandler 2013</LINK>), which states that eligible studies be included irrespective of whether measured outcome data has been reported in a 'useable' way.</P>
<P>The study selection process is also detailed in the PRISMA flow diagram (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
<P>A late-stage literature search was conducted by the Cochrane, Depression, Anxiety and Neurosis Group<B> </B>(February 2014) and publications to be considered for inclusion in the next update of this review are listed (for the reader's benefits) in the <LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK> .</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2014-05-07 17:00:57 +0100" MODIFIED_BY="Anne Lawson">
<P>See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</P>
<SUBSECTION>
<HEADING LEVEL="4">Design</HEADING>
<P>All 33 studies included were RCTs. We found several cross-over trials but no cluster randomised trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Sample sizes</HEADING>
<P>The mean number of randomised participants was 65.3 with nearly all samples containing between 30 and 80 participants.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Setting</HEADING>
<P>All studies were conducted in outpatient settings. Studies were conducted in several countries primarily in Europe and North America.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>All studies were of adult samples. Six studies included only female participants (<LINK REF="STD-Alstrom-1984b" TYPE="STUDY">Alstrom 1984b</LINK>; <LINK REF="STD-Baldoni-1995" TYPE="STUDY">Baldoni 1995</LINK>; <LINK REF="STD-Carrington-1979" TYPE="STUDY">Carrington 1979</LINK>; <LINK REF="STD-Cooper-2003" TYPE="STUDY">Cooper 2003</LINK>; <LINK REF="STD-Marmar-1988" TYPE="STUDY">Marmar 1988</LINK>; <LINK REF="STD-Vitriol-2009" TYPE="STUDY">Vitriol 2009</LINK>), and almost all of the studies had a majority of females. Primary problems were diverse and included somatoform disorders (eight studies), mixed conditions (eight studies), anxiety disorders (seven studies), depressive disorders (five studies), personality disorders (three studies), self induced poisoning (one study) and eating disorders (one study). The somatoform disorders included multisomatoform disorder, irritable bowel syndrome (three studies), chronic pain, urethral syndrome, pelvic pain, chronic dyspepsia and atopic dermatitis. Anxiety disorders included obsessive-compulsive disorder, generalised anxiety disorder, hypochondriasis, agoraphobia, social phobia, panic disorder and post-traumatic stress disorder.</P>
<P>Over one-third of these studies included challenging-to-treat populations. Three studies included people with co-morbid personality disorders among their samples or as the main study sample (<LINK REF="STD-Abbass-2008" TYPE="STUDY">Abbass 2008</LINK>; <LINK REF="STD-Emmelkamp-2006" TYPE="STUDY">Emmelkamp 2006;</LINK> <LINK REF="STD-Winston-1994" TYPE="STUDY">Winston 1994</LINK>). One study included people with deliberate self poisoning (<LINK REF="STD-Guthrie-2001" TYPE="STUDY">Guthrie 2001</LINK>). Several studies were of 'treatment resistant' (<LINK REF="STD-Guthrie-1993" TYPE="STUDY">Guthrie 1993</LINK>), 'high utilizers' (<LINK REF="STD-Guthrie-1999" TYPE="STUDY">Guthrie 1999</LINK>), 'chronic' (<LINK REF="STD-Hamilton-2000" TYPE="STUDY">Hamilton 2000</LINK>), or 'severe' (<LINK REF="STD-Creed-2003" TYPE="STUDY">Creed 2003</LINK>; <LINK REF="STD-Sattel-2012" TYPE="STUDY">Sattel 2012</LINK>; <LINK REF="STD-Vitriol-2009" TYPE="STUDY">Vitriol 2009</LINK>) populations, while two included participants who were not candidates for a traditional psychoanalytic treatment (<LINK REF="STD-Alstrom-1984a" TYPE="STUDY">Alstrom 1984a;</LINK> <LINK REF="STD-Alstrom-1984b" TYPE="STUDY">Alstrom 1984b</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions</HEADING>
<P>A range of brief psychodynamic-based psychotherapy methods were represented in these studies. Eleven cited Davanloo/Malan's model (<LINK REF="REF-Davanloo-1980" TYPE="REFERENCE">Davanloo 1980;</LINK> <LINK REF="REF-Malan-1979" TYPE="REFERENCE">Malan 1979</LINK>), while six cited PIT derived from <LINK REF="REF-Hobson-1985" TYPE="REFERENCE">Hobson 1985</LINK>. These courses of therapy averaged 15.0 psychodynamic therapy sessions (SD 8.9, range 4 to 40). They were described as employing common factors of brief dynamic therapies such as focus on unconscious operations and emotions, and their link to symptoms or behavioural problems. All but one study described the use of some brief therapy framework, while two studies had a general psychoanalytic model of short duration (<LINK REF="STD-Cooper-2003" TYPE="STUDY">Cooper 2003</LINK>; <LINK REF="STD-Sloane-1975" TYPE="STUDY">Sloane 1975</LINK>). Fourteen of these studies described using experienced therapists, but it was often unclear whether the therapists were experienced in the specific brief therapy approach versus other psychotherapy models. Fifteen studies referred to specific manuals while others referenced models including those of <LINK REF="REF-Davanloo-1980" TYPE="REFERENCE">Davanloo 1980</LINK>; <LINK REF="REF-Malan-1979" TYPE="REFERENCE">Malan 1979;</LINK> <LINK REF="REF-Mann-1973" TYPE="REFERENCE">Mann 1973;</LINK> and <LINK REF="REF-Strupp-1984" TYPE="REFERENCE">Strupp 1984</LINK>. Because we did not exclude studies with medication use on both treatment arms, we included five such studies (<LINK REF="STD-Burnand-2002" TYPE="STUDY">Burnand 2002;</LINK> <LINK REF="STD-de-Jonghe-2001" TYPE="STUDY">de Jonghe 2001;</LINK> <LINK REF="STD-Maina-2010" TYPE="STUDY">Maina 2010;</LINK> <LINK REF="STD-Vitriol-2009" TYPE="STUDY">Vitriol 2009</LINK>; <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK>). These five studies included people with depression, panic disorder and mixed disorders: participants were provided medications including clomipramine (two studies), other antidepressants (two studies) and psychotropic agents (one study) according to an algorithm from antidepressants to antipsychotics.</P>
<P>A range of controls was employed in these studies. Eighteen studies had treatment as usual, which included medications, medical management and, in some cases, psychotherapeutic support that did not constitute a robust treatment effort. Ten studies had wait-list controls, often with cross-over designs where participants received STPP after the wait list. Five studies had minimal psychological interventions used as controls. Overall, treatment as usual control situations provided less face-to-face therapist contact time than the STPP groups, although these were considered standard treatment approaches with presumed effectiveness. Fewer treatment benefits, due in part to less intense therapeutic exposures, would be expected in the wait list and minimal treatment controls versus controls with more robust treatments as usual including medication in many cases: for this reason, we conducted a sensitivity analysis excluding studies with treatment as usual controls.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcomes</HEADING>
<P>Nineteen studies reported on general psychiatric symptoms, 18 studies used measures of depression, 18 studies used measures of anxiety, eight studies used somatic symptom measures, six studies used interpersonal problem measures and nine studies used measures of social adjustment. Other measures were used only a few times or were not comparable enough to combine in this review.</P>
<P>Follow-up periods varied from immediately post treatment up to four years (<LINK REF="STD-Baldoni-1995" TYPE="STUDY">Baldoni 1995</LINK>).</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2014-05-16 11:01:40 +0100" MODIFIED_BY="Anne Lawson">
<P>We listed 22 studies in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table. Most studies examined in detail and ultimately excluded were studies that had other formal treatment controls. We excluded a study of ulcers that was included in the previous version of this review as it was conducted prior to the discovery of <I>Helicobacter pylori</I> and specific treatment of this (<LINK REF="STD-Sjodin-1986" TYPE="STUDY">Sjodin 1986</LINK>): thus, the care of ulcer disease has undergone major changes since this discovery. Other studies were not randomised trials.</P>
<SUBSECTION>
<HEADING LEVEL="3">Studies awaiting classification</HEADING>
<P>There are 11 studies awaiting classification (see <LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK> table). Three of these studies are of depression, three studies are of somatic symptom disorders and two studies are of anxiety disorders. Four of the studies are large with over 150 participants. Due to these large numbers and sets of studies inside of specific diagnostic categories, it is possible these studies may influence meta-analytic outcomes.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">New studies found at this update</HEADING>
<P>We included 10 new trials in this update (<LINK REF="STD-Bressi-2010" TYPE="STUDY">Bressi 2010</LINK>; <LINK REF="STD-Burnand-2002" TYPE="STUDY">Burnand 2002</LINK>; <LINK REF="STD-Carrington-1979" TYPE="STUDY">Carrington 1979</LINK>; <LINK REF="STD-Emmelkamp-2006" TYPE="STUDY">Emmelkamp 2006</LINK>; <LINK REF="STD-Levy-Berg-2009" TYPE="STUDY">Levy Berg 2009</LINK>; <LINK REF="STD-Maina-2010" TYPE="STUDY">Maina 2010</LINK>; <LINK REF="STD-Milrod-2007" TYPE="STUDY">Milrod 2007</LINK>; <LINK REF="STD-Sattel-2012" TYPE="STUDY">Sattel 2012</LINK>; <LINK REF="STD-S_x00f8_rensen-2010" TYPE="STUDY">Sørensen 2010</LINK>; <LINK REF="STD-Vitriol-2009" TYPE="STUDY">Vitriol 2009</LINK>). <LINK REF="STD-Dare-2001" TYPE="STUDY">Dare 2001</LINK> was moved from the excluded studies to the included studies, in accordance with The Cochrane Collaboration's methodological stipulation that studies that meet the inclusion criteria should be included in the review irrespective of whether they reported data in a useable way (<LINK REF="REF-Chandler-2013" TYPE="REFERENCE">Chandler 2013</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Ongoing studies</HEADING>
<P>We have identified three ongoing studies (see <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>). One of these is an RCT of intensive short-term dynamic psychotherapy versus medical care as usual for treatment-refractory depression (<LINK REF="STD-NCT01141426" TYPE="STUDY">NCT01141426</LINK>). One is an RCT of intensive short-term dynamic psychotherapy versus care as usual for medically unexplained symptoms in the emergency department (<LINK REF="STD-NCT02076867" TYPE="STUDY">NCT02076867</LINK>). One is an RCT of dynamic interpersonal therapy versus an enhanced wait list condition for major depression (<LINK REF="STD-ISRCTN38209986" TYPE="STUDY">ISRCTN38209986</LINK>).</P>
</SUBSECTION>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2014-05-15 12:35:29 +0100" MODIFIED_BY="Anne Lawson">
<P>For details of the risk of bias judgements for each study, see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. Graphical representations of the overall risk of bias in included studies are presented in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.</P>
<ALLOCATION MODIFIED="2014-05-02 13:32:16 +0100" MODIFIED_BY="Anne Lawson">
<P>We judged only three of the 33 included studies to be at high risk of selection bias. However, for the majority of studies (19 out of 33 for selection bias (random sequence generation) and 23 out of 33 for selection bias (allocation concealment)), there was inadequate information to make a satisfactory risk of bias judgement.</P>
</ALLOCATION>
<BLINDING MODIFIED="2014-05-02 13:33:19 +0100" MODIFIED_BY="Anne Lawson">
<P>With self reported measures, blinding of the observer was less important. We judged the majority of studies (24 out of 33) to be of low risk of bias. For observer-rated measures, we reported six studies as being at high risk of detection bias because raters were not blinded to treatment allocation group.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2014-05-02 13:34:24 +0100" MODIFIED_BY="Anne Lawson">
<P>For the majority of studies (23 out of 33), we judged attrition bias to be at low risk of bias. We judged eight studies to be at high risk of bias and there was insufficient information to make an assessment for two studies. Studies classified as at high risk of attrition bias did not account for evident attrition in analyses.</P>
<P>To limit the influences of attrition bias, we only included studies with less than 20% drop-outs but in the next iteration of this review, this will not be the case. Examination of the effects of the methods of handling of lost cases will be performed through risk of bias assessment and subgroup analyses.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2014-05-15 12:35:29 +0100" MODIFIED_BY="Anne Lawson">
<P>In six studies, we deemed there to be high risk of reporting bias. Without details of the study protocol, we deemed there to be insufficient information regarding reporting bias and therefore, we judged assessment of reporting bias to be unclear for the remaining studies.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2014-05-07 17:12:20 +0100" MODIFIED_BY="Anne Lawson">
<P>For all studies, we judged risk of other sources of bias to be unclear due to insufficient information. One study employed a restricted STPP model where some key treatment ingredients were withheld for purposes of the study (<LINK REF="STD-S_x00f8_rensen-2010" TYPE="STUDY">Sørensen 2010</LINK>).</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-05-15 12:46:25 +0100" MODIFIED_BY="Anne Lawson">
<P>We were able to combine results from studies for general psychiatric symptoms as well as anxiety disorders, depressive disorders and somatic symptoms. In each case, we have grouped findings under the following diagnostic groups: depression, anxiety, somatoform and mixed disorders. We highlighted any differences between groups in the section on subgroup analyses.</P>
<P>A few studies (e.g. <LINK REF="STD-Baldoni-1995" TYPE="STUDY">Baldoni 1995;</LINK> <LINK REF="STD-Creed-2003" TYPE="STUDY">Creed 2003;</LINK> <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK> in general outcome measures) provided data at long-term follow-up but not at short-term follow-up in some outcome categories. Attrition data was lacking from or varied in definition in most papers so we reported only papers with self described dropout rates where they did statistical analyses and reported on it: we are considering a plan to extract/seek this data formally and report it in the next review.</P>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 1. Short-term psychodynamic psychotherapy versus wait-list/treatment as usual/minimal treatment</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>There was significant heterogeneity (P values &lt; 0.10, I<SUP>2</SUP> = 50% or greater) in 10 of the 16 analyses. Therefore, we reported results derived from the random-effects model for these comparisons. We reported results derived from the fixed-effect model for the remaining analyses where measures of heterogeneity were not significant. These are illustrated in the <LINK TAG="ANALYSES_AND_DATA" TYPE="SECTION">Data and analyses</LINK> table and figures. Given the frequency of significant heterogeneity in these analyses, in each study where a fixed-effect model was reported, we also examined results using a random-effects model: in each of the six cases, the differences were nil to negligible and there were no changes in statistical significance.</P>
<SUBSECTION>
<HEADING LEVEL="5">1.1 General symptoms as defined by standardised psychiatric instruments or criteria</HEADING>
<P>We were able to incorporate 19 studies that reported measures of general psychiatric symptoms. We used the random-effects model for short- and long-term follow-up, as there was significant heterogeneity and used the fixed-effect model for medium-term comparisons. These measures showed small to large differences in favour of STPP treatment.</P>
<P>The differences reached significance in the short-term (SMD -0.71, 95% CI -1.00 to -0.41; 19 studies, 1424 participants) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>) and medium-term (SMD -0.27, 95% CI -0.46 to -0.08; 5 studies, 437 participants) (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). In the case of long-term follow-up, the effect sizes increased but marginally did not reach significance (SMD -1.51, 95% CI -3.14 to 0.12, P value = 0.07; 4 studies, 344 participants) (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.2 Somatic symptoms</HEADING>
<P>We were able to incorporate eight studies that reported measures of somatic symptoms. We used the random-effects model for short-, medium- and long-term follow-up, as there was significant heterogeneity. These measures showed moderate to large differences in favour of STPP treatment.</P>
<P>The difference between treatment and control groups marginally did not reach statistical significance in the short-term (SMD -0.63, 95% CI -1.29 to 0.04, P value = 0.07; 8 studies, 744 participants) (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). The effects were significant in the medium-term (SMD -1.39, 95% CI -2.75 to -0.02; 4 studies, 359 participants) (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>) but did not reach significance in long-term follow-up (SMD -2.21, 95% CI -5.49 to 1.07; 3 studies, 280 participants) (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.3 Anxiety</HEADING>
<P>We were able to incorporate 18 studies that reported measures of anxiety symptoms. We used the random-effects model for short-, medium- and long-term follow-up, as there was significant heterogeneity. These measures showed modest to large differences in favour of STPP treatment.</P>
<P>The differences were statistically significant in the short-term (SMD -0.64, 95% CI -1.02 to -0.26; 18 studies, 1102 participants) (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>) and medium-term (SMD -0.46, 95% CI -0.77 to -0.16; 7 studies, 506 participants) (<LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>). In the long-term follow-up, these effects increased but marginally did not reach significance (SMD -1.10, 95% CI -2.24 to 0.04, P value = 0.06; 5 studies, 293 participants) (<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.4 Depression</HEADING>
<P>We were able to incorporate 18 studies that reported measures of depression symptoms. We used the random-effects model for medium- and long-term follow-up, as there was significant heterogeneity and used the fixed-effect model for short-term comparisons.</P>
<P>Measures of depression showed small to medium and significant treatment effects relative to controls in the short-term (SMD -0.50, 95% CI -0.61 to -0.39; 18 studies, 1415 participants) (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>) and the medium-term (SMD -0.34, 95% CI -0.60 to -0.09; 7 studies, 601 participants) (<LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>). The effects increased but did not reach significance in long-term follow-up (SMD -1.00, 95% CI -2.22 to 0.21; 5 studies, 321 participants) (<LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<P>In our protocol, we stated that we would consider secondary outcome measures including social adjustment, quality of life, behavioural measures, interpersonal problem measures and participant satisfaction as measured by standardised instruments. However, studies reported very different measures in insufficient detail for quantitative integration of data in most cases. In all cases, we used the fixed-effect model, as tests for heterogeneity were non-significant.</P>
<SUBSECTION>
<HEADING LEVEL="5">1.5 Social adjustment</HEADING>
<P>Ten studies reported on social adjustment and showed significant and moderate effects in short-term follow-up using the fixed-effect model (SMD -0.51, 95% CI -0.66 to -0.36; 9 studies, 720 participants) (<LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>), which increased in long-term follow-up (SMD -0.58, 95% CI -0.86 to -0.29; 3 studies, 199 participants) (<LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.6 Quality of life</HEADING>
<P>
<LINK REF="STD-Guthrie-1999" TYPE="STUDY">Guthrie 1999</LINK>, using the EuroQol 5D, did not find significant differences at termination but did find significantly higher quality of life ratings in the STPP group in follow-up. <LINK REF="STD-Creed-2003" TYPE="STUDY">Creed 2003</LINK> found significant and persistent improvements on the 36-item Short Form (SF-36) physical scores relative to controls, but found significant superiority of STPP only in the short-term on mental symptom subscales relative to controls. <LINK REF="STD-Levy-Berg-2009" TYPE="STUDY">Levy Berg 2009</LINK> found greater improvement on the World Health Organization (WHO) Well Being Index in people receiving STPP with generalised anxiety disorder. <LINK REF="STD-de-Jonghe-2001" TYPE="STUDY">de Jonghe 2001</LINK> reported greater gains on a measure of depression-related quality of life in people who received combined STPP plus antidepressants versus antidepressant medication alone in the ITT sample.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.7 Behavioural measures</HEADING>
<P>In a unique and high-quality study, <LINK REF="STD-Guthrie-2001" TYPE="STUDY">Guthrie 2001</LINK> found treated participants had a reduction in suicidal ideation and self harm episodes relative to treatment as usual in people who had self induced poisoning. <LINK REF="STD-Dare-2001" TYPE="STUDY">Dare 2001</LINK> found STPP to produce superior weight gains and recovery rates compared with controls in a group of adults with anorexia nervosa.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.8 Interpersonal problem measures</HEADING>
<P>Six studies reported outcomes on measures of interpersonal problems. Using the fixed-effect model, significant effects were seen in the short-term follow-up (SMD -0.42, 95% CI -0.67 to -0.17; 6 studies, 265 participants) (<LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>), which increased in the long-term follow-up (SMD -0.49, 95% CI -0.92 to -0.05; 3 studies, 85 participants) (<LINK REF="CMP-001.16" TYPE="ANALYSIS">Analysis 1.16</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.9 Participant satisfaction</HEADING>
<P>
<LINK REF="STD-Guthrie-2001" TYPE="STUDY">Guthrie 2001</LINK> reported positive participant satisfaction measures after the six-session treatment for deliberate self poisoning.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.10 Health service use</HEADING>
<P>
<LINK REF="STD-Hamilton-2000" TYPE="STUDY">Hamilton 2000</LINK> reported within-group reduction in hospital, medication and service use but no differences between treatment and control groups. <LINK REF="STD-Burnand-2002" TYPE="STUDY">Burnand 2002</LINK> reported significantly fewer hospital admissions and days in people with depression provided STPP versus the treatment as usual control. <LINK REF="STD-Vitriol-2009" TYPE="STUDY">Vitriol 2009</LINK> reported that severely depressed women with trauma histories treated with STPP had fewer hospital days (6 versus 21.3) but did not note if this was statistically different. Psychiatry use was greater in the STPP group (7 versus 2.5) as was psychologist use (5.7 versus 4.5 visits) in six-month follow-up. <LINK REF="STD-Guthrie-2001" TYPE="STUDY">Guthrie 2001</LINK> reported no differences in healthcare use versus controls in follow-up except treated participants with deliberate self poisoning saw psychiatric nurses more often. <LINK REF="STD-Sattel-2012" TYPE="STUDY">Sattel 2012</LINK> reported significantly less medication and psychotherapy use versus controls in follow-up after STPP versus enhanced medical care for people with multisomatoform disorder: there were no differences in medical visits between the groups at any time point.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.11 Cost measures</HEADING>
<P>
<LINK REF="STD-Creed-2003" TYPE="STUDY">Creed 2003</LINK> found STPP was more cost effective than treatment as usual over the first year of treatment in people with irritable bowel syndrome, while paroxetine was not significantly more cost effective than control. <LINK REF="STD-Guthrie-1999" TYPE="STUDY">Guthrie 1999</LINK> found STPP to reduce several cost measures significantly compared with treatment as usual in a mixed sample of high service-utilising participants. <LINK REF="STD-Hamilton-2000" TYPE="STUDY">Hamilton 2000</LINK> did not find significant cost savings relative to the control treatment but did note significant cost savings compared with the period before treatment. <LINK REF="STD-Burnand-2002" TYPE="STUDY">Burnand 2002</LINK> found significant cost savings beyond treatment costs of USD 2311 due to reduced hospital and disability costs: this is greater than controls but statistical analysis of the difference was not provided.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.12 Mortality</HEADING>
<P>No data were available for mortality.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.13 Dropout rates</HEADING>
<P>Two studies reported statistical analysis of differential dropout rates. <LINK REF="STD-de-Jonghe-2001" TYPE="STUDY">de Jonghe 2001</LINK> specifically compared dropout rates between STPP added to treatment with medications versus medications alone. They found a 10% dropout rate using STPP plus medication versus 40% for medication alone. <LINK REF="STD-Milrod-2007" TYPE="STUDY">Milrod 2007</LINK> reported 7% drop-out in the STPP group compared with 34% in treatment as usual, which was significantly different.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.14 Occupational functioning</HEADING>
<P>
<LINK REF="STD-Monsen-2000" TYPE="STUDY">Monsen 2000</LINK> found those treated with STPP had significantly more job advancements and <LINK REF="STD-Creed-2003" TYPE="STUDY">Creed 2003</LINK> found STPP-treated participants had significantly less work disability compared with the paroxetine-treated group. <LINK REF="STD-Abbass-2008" TYPE="STUDY">Abbass 2008</LINK> reported significantly more works hours and higher employment rates after STPP treatment versus the control condition in people with anxiety disorders. Alstrom found significantly superior improvement in work capacity relative to controls in the agoraphobic group (<LINK REF="STD-Alstrom-1984b" TYPE="STUDY">Alstrom 1984b</LINK>), but not in the socially phobic group (<LINK REF="STD-Alstrom-1984a" TYPE="STUDY">Alstrom 1984a</LINK>). <LINK REF="STD-Burnand-2002" TYPE="STUDY">Burnand 2002</LINK> reported significantly improved occupational functioning with fewer lost days due to disability.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Heterogeneity analysis</HEADING>
<P>Tests for heterogeneity were statistically significant at the P value 0.10 or less and an I<SUP>2</SUP> statistic of 50% or greater in 10 of the 16 cases. Heterogeneity was not significant for some subgroup analyses of the symptom most specific to the condition under consideration (e.g. medium-term comparisons of depressive symptoms in depressive disorders). It was not significant in measures of social adjustment and interpersonal problems.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sensitivity and subgroup analyses</HEADING>
<P>Because of the small number of trials in each analysis, these results are limited and should be interpreted with caution. Given the degree of heterogeneity expected in these analyses, we only present results using the random-effects model. See <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> and <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">Sensitivity analyses</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">a) Manualised therapies</HEADING>
<P>When restricting analyses to studies using manualised treatments, there were smaller effects in most outcome categories compared with studies of the overall set of studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">b) Studies that gave observer-rated outcomes</HEADING>
<P>The effect sizes were larger compared with those of the overall review studies in most outcome categories when analyses were restricted to studies that included observer ratings.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">c) Studies that used medications on both treatment arms</HEADING>
<P>When analyses were restricted to studies with medication on both treatment arms, effect sizes were generally smaller than the effects of the overall set of studies.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Subgroup analyses</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">a) Therapy of up to 20 sessions</HEADING>
<P>When analyses were restricted to studies that averaged 20 or fewer sessions, measures of general symptoms in medium-term, social adjustment and interpersonal problems were smaller compared with studies where treatment was over 20 sessions.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">b) Studies that used minimal treatment or wait-list controls as opposed to treatment as usual controls</HEADING>
<P>Anxiety effect sizes were smaller when analyses were restricted to studies with minimal contact or wait-list controls. Otherwise, there were no differences in degrees of significance or effect sizes compared with studies using treatment as usual controls.</P>
<P>
<B>c) Effects of short-term psychodynamic psychotherapy treatment models</B>
</P>
<P>As a post hoc analysis, we examined outcomes by STPP treatment approach where five or more studies were available.</P>
<P>When analyses were restricted to models derived from Hobson or PIT (six studies), effects across all outcomes were smaller than studies using the Malan/Davanloo short-term dynamic psychotherapy model (11 studies) with the exceptions of general symptoms at medium-term and somatic symptom at medium-term follow-up. The effects of Hobson/PIT studies were negligible to small in all the other categories. In contrast, the effects of analyses restricted to Malan/Davanlo studies were large in all but general symptoms at medium-term follow-up.</P>
<P>
<B>d) Differences in outcomes between different diagnostic groups</B>
</P>
<P>People diagnosed with somatoform disorders had the greatest effects sizes in most outcome categories except general symptoms at medium-term and somatic symptoms at medium-term follow-up. People diagnosed with depression tended to have the lowest effects on measures of anxiety and depression. See <LINK TAG="ANALYSES_AND_DATA" TYPE="SECTION">Data and analyses</LINK>.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessing publication bias: funnel plot analysis</HEADING>
<P>We explored funnel plots as an indication of publications bias. The largest number of studies available was in each of the short-term outcome measures. Each of these had funnel plots that had some features of an inverted funnel (somatic) or had studies with similar standard errors (anxiety, depression), leaving a flat but dispersed distribution. Other categories had too few studies to allow an interpretation. Thus, we could not draw definitive conclusions about publication bias using this method.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-05-15 12:46:44 +0100" MODIFIED_BY="Anne Lawson">
<SUMMARY_OF_RESULTS MODIFIED="2014-05-02 15:06:53 +0100" MODIFIED_BY="Anne Lawson">
<P>This meta-analysis of 33 RCTs of STPP comprised of 2173 participants found it to have modest to large effects relative to controls across a broad range of CMDs. With the exception of somatic measures in the short-term, these effects were also statistically significant in short- and medium-term follow-ups while not reaching significance in long-term follow-up in some outcome categories. Benefits were observed across a broad range of outcome measures including general measures and somatic symptoms, as well as depression, anxiety, interpersonal and social adjustment. Individual studies also reported reduced self injury and weight gain in anorexia nervosa, suggesting behavioural as well as symptomatic gains. Studies also reported occupational gains and cost benefits. Combined, these findings provide converging evidence of treatment benefits. In each of somatic symptoms, depressive symptoms, anxiety, general symptoms, social adjustment and interpersonal problems, the treatment effect sizes were greater in long-term follow-up than in short-term follow-up suggesting accrued gains over time though some of this effect may have been from different studies reporting at different time intervals (i.e. short- versus long-term follow-up periods).</P>
<P>Study quality was variable in these studies, which spanned 1975 to 2012. Although STPP method (e.g. Hobson versus Malan/Davanloo) appeared to impact outcomes, it is yet to be determined if these effects are better accounted for by common (e.g. therapist training, adherence, allegiance effects) or specific (e.g. emotional experiencing, intellectual insight) factors. Heterogeneity and loss of significance of some measures in follow-up suggest these results be interpreted with caution.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2014-05-15 12:46:44 +0100" MODIFIED_BY="Anne Lawson">
<P>This review found preliminary evidence that STPP may be effective for a broad range of CMDs as are seen in mental health and medical clinics. Common specific psychiatric conditions including major depression, somatic symptom disorders, eating disorders, anxiety disorders and personality disorders were treated in these studies.</P>
<P>Several studies included treatment resistant, severe and character-disordered participants, which are challenging-to-treat patient groups. Treatment effects in these groups may be lower than what may be expected in samples without such resistance or complexity. Thus, these studies may underestimate the effects of this brief treatment. This is an important finding since these patient groups are common in clinical populations where half or more do not reach remission with first-line psychotropic medication or talking therapies. These problems are costly to the system as they induce prolonged disability from work and excess hospital and medical service use, so, brief and relatively low-cost treatment options are necessary and welcome.</P>
<P>The number of studies in many analyses was relatively small making comparisons across diagnostic groups and other subgroup analyses difficult. The diversity of the samples and treatment methods likely contributed to heterogeneity, which influences our ability to interpret these groups of studies. However, this diversity is also a strength of this literature implying the range of methods in STPP may be broadly applied in clinical populations.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2014-05-08 10:06:00 +0100" MODIFIED_BY="Anne Lawson">
<SUBSECTION>
<HEADING LEVEL="5">Study quality</HEADING>
<P>The studies were of variable quality. Manuals and adherence measures were not employed in each study calling into question the quality of psychotherapy provided. Therapist experience was in question in many studies, raising the chance that the therapy was not provided in an optimal fashion. It was apparent in one study that the STPP provided was restricted to withhold key interventions likely weakening its effects and underestimating its benefits.</P>
<P>As noted, some studies had high internal risk of bias in the categories described and many had insufficient information to rate using The Cochrane Collaboration's 'Risk of bias' tool. In future reviews, we will adapt the 'Risk of bias' tool to incorporate features such as the use of adherence ratings, the use of observer ratings, the use of manuals, therapist experience and researcher allegiance to enable measurement of psychotherapy quality. In this study, subgroup analyses pointed towards reduced effects when restricting to studies using manuals and increased effects in studies using observer ratings.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Diagnostic criteria</HEADING>
<P>The lack of specific diagnostic criteria in a few studies and the use of mixed samples may limit the clinician's ability to determine suitability of STPP for individual patients in his or her practice. This is less of an issue in studies performed in the past 20 years versus before.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Treatment methods</HEADING>
<P>Although common psychotherapy factors are the core of the treatment (<LINK REF="REF-Blagys-2000" TYPE="REFERENCE">Blagys 2000</LINK>), many therapy directions are possible. In subgroup analyses, we saw a signal of differential effects between two commonly used models. The methods were both STPP models but one (Malan/Davanloo) was primarily focused on emotional experiencing, a factor that relates to outcome in some STPP meta-analyses (<LINK REF="REF-Abbass-2009" TYPE="REFERENCE">Abbass 2009</LINK>; <LINK REF="REF-Diener-2007" TYPE="REFERENCE">Diener 2007</LINK>). However, such differences may be from many causes, such as variation in levels of therapist experience, participant samples and research methods rather than from methods inherent in the models.</P>
<P>A further issue is that the quality of the STPP provided (e.g. therapist experience, use of manual, use of adherence ratings) varied between studies raising the probability that STPP may have been provided suboptimally in some of the included studies. Therefore, the efficacy of STPP may have been underestimated in this meta-analysis. Indeed, <LINK REF="REF-Leichsenring-2004" TYPE="REFERENCE">Leichsenring 2004</LINK> found greater effect sizes with his sample of STPP studies that were selected for quality of, and validation of, treatment provided. However, given the option of excluding studies of questionable therapy technique, we decided to include all studies meeting our basic criteria. Our decision was to be cautious to avoid a possible selection bias where information was lacking or vague regarding these parameters.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Study heterogeneity</HEADING>
<P>The significant heterogeneity in 10 of the 16 analyses was a concern and suggests our findings must be treated with caution in these cases. Because of this, we have reported results of the random-effects model in these cases and verified the effects using the random-effects model in other cases. The above-noted methodological and treatment variability account for some of the observed heterogeneity of outcomes. Differences in the control conditions (i.e. treatment as usual versus wait list versus minimal treatment) may have brought more or less treatment effects in these studies leading to inter-study variability as illustrated by our subgroup analyses. Another factor that probably contributed was the collection of diverse patient populations with a broad range of physical and psychological symptoms including depression, anxiety, personality problems and diverse somatic conditions.</P>
<P>Arguably, studies included in this review should include people with clear and specific diagnoses while excluding other confounding diagnoses. However, these studies reflect the heterogeneity and complexity of people with multiple problems including symptom, somatic and personality disorders who present to all healthcare settings. Thus, this body of studies may tell us more about the real-world utility of STPP, than would a highly selected sample of participants who often do not exist in public and private psychotherapy clinics.</P>
</SUBSECTION>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2014-05-15 12:45:34 +0100" MODIFIED_BY="Anne Lawson">
<P>We have performed this review in ways to reduce the chances of bias where possible. First, if anything, we have leaned towards being over-inclusive of studies so as not to exclude any RCT study of any STPP model. This led us to include STPP studies with medications on both arms, studies of ill-defined STPP models, studies of poor quality and older studies when the method was not well developed. Thus, one possible source of bias was possible over-inclusiveness due to the breadth of our inclusion criteria. Second, we collectively, in pairs, selected studies. Third, we extended the team to include expert review authors with no affiliation to any variety of psychotherapy, and colleagues who research in long-term dynamic psychotherapy. Finally, analyses were performed or verified by a review author with no affiliation to psychotherapy.</P>
<P>As noted, we have reported results of the random-effects model in cases with significant heterogeneity and verified the effects using the random-effects model when we did not find statistical heterogeneity. As noted, there are several likely sources of heterogeneity, and this will not be likely to change between now and the next time we update this review. Hence, we are going to reconsider an approach to best examine these studies before the next update.</P>
<P>Other possible sources of bias include the inclusion of studies with medication on both arms, which may have lowered the effects of STPP relative to those studies without medication on both arms (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>). This and other subgroup analyses showing outcome differences highlight hypothetical outcome factors that can be tested in future research. A few studies (e.g. <LINK REF="STD-Baldoni-1995" TYPE="STUDY">Baldoni 1995</LINK>; <LINK REF="STD-Creed-2003" TYPE="STUDY">Creed 2003</LINK>; <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK>) in general outcome measures provided data at long-term follow-up but not at short-term follow-up in some outcome categories: this could increase or decrease relative long-term outcome effects versus short-term outcome effects. As a result of this and limited numbers of medium-term follow-up data, we are considering collapsing short and medium term into one group when we next update this review.</P>
<P>The original protocol called for exclusion of studies with over 20% attrition, introducing a possible bias. In the next update of the review, this criteria will no longer be in effect; rather we will rate techniques of handling attrition and evaluate the effects of this using the 'Risk of bias' tool.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2014-05-15 12:42:42 +0100" MODIFIED_BY="Anne Lawson">
<SUBSECTION>
<HEADING LEVEL="3">Comparison to other meta-analyses</HEADING>
<P>Overall, this review is in line with other meta-analyses and reviews of STPP since 2007 that have reported moderate to large and sustained or increased gains across diverse clinical populations. These reviews tended to focus on specific diagnostic groups. Some included non-randomised controlled trials and some provided combined pre-versus-post analyses, post-versus-post analyses and subgroup analyses including only RCTs. Overall these studies, with various limitations, found moderate to large and sustained effects within categories of depression (<LINK REF="REF-Driessen-2010" TYPE="REFERENCE">Driessen 2010</LINK>), somatic disorders (<LINK REF="REF-Abbass-2009" TYPE="REFERENCE">Abbass 2009</LINK>), personality disorders (<LINK REF="REF-Town-2011" TYPE="REFERENCE">Town 2011</LINK>), and combined personality disorder-depression (<LINK REF="REF-Abbass-2011" TYPE="REFERENCE">Abbass 2011</LINK>). The common limitations were heterogeneity, small samples in some subgroup analyses and wide ranges of study quality. In 2012, the largest published psychodynamic psychotherapy meta-analysis to date likewise found significantly increased gains in follow-up compared with immediately post treatment in a group of 46 studies of psychodynamic therapies, most all of which were STPP models (<LINK REF="REF-Town-2012" TYPE="REFERENCE">Town 2012</LINK>). Our findings also parallel the most recent review of psychodynamic therapies in specific disorders (<LINK REF="REF-Leichsenring-2014" TYPE="REFERENCE">Leichsenring 2014</LINK>).</P>
<P>Lazar and colleagues published a review of all psychological therapy cost-effectiveness studies in a 2010 book and noted growing evidence for cost effectiveness of the treatment overall (<LINK REF="REF-Lazar-2010" TYPE="REFERENCE">Lazar 2010</LINK>). The results of our review support the concept of an inexpensive talking approach that could potentially provide cost reduction in diverse populations.</P>
</SUBSECTION>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2014-05-16 11:30:41 +0100" MODIFIED_BY="Anne Lawson">
<IMPLICATIONS_PRACTICE MODIFIED="2014-05-16 11:30:41 +0100" MODIFIED_BY="Anne Lawson">
<P>We have attempted to draw modest conclusions, based on the available evidence and to highlight areas requiring further study rather than draw conclusions that may not be based on evidence of high quality. Short-term psychodynamic psychotherapies (STPP) may be effective for a very broad range of common mental disorders (CMD), with evidence of modest to large treatment effect sizes that increase in long-term follow-up. This finding supports STPP as a candidate treatment for the majority of non-psychotic and non-organic psychotherapeutic presentations. However, given the limited data, loss of significance in some measures at long-term follow-up and heterogeneity between studies, these findings should be interpreted with caution.</P>
<P>Although cost comparisons were not made in this review, it should be noted that these therapies are relatively short and much less expensive than long-term psychotherapy models. The observed reduction in symptoms may contribute to observed reductions in healthcare use, costs and improved occupational functioning noted in individual studies. STPP may represent an economical approach to problems as complex as chronic pain, personality disorder, panic disorder, self induced poisoning and other challenging-to-treat conditions. They are also less expensive than even one year of some psychotropic medications, depending on who is delivering the therapy and the setting (public versus private pay). While all people with CMD do not respond to STPP or any other short therapy, it is prudent to consider such relatively low-risk talking approaches before medications, treatment combinations or more invasive procedures such as electroconvulsive therapy are employed (e.g. <LINK REF="REF-Malhi-2009" TYPE="REFERENCE">Malhi 2009</LINK>).</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2014-05-15 12:47:30 +0100" MODIFIED_BY="Anne Lawson">
<P>Future research in these approaches should aim to improve study quality using specific treatment manuals, videotaped adherence rating (as in <LINK REF="STD-Abbass-2008" TYPE="STUDY">Abbass 2008;</LINK> <LINK REF="STD-Milrod-2007" TYPE="STUDY">Milrod 2007</LINK>; and <LINK REF="STD-Winston-1994" TYPE="STUDY">Winston 1994</LINK>), cost-benefit measures and treatment-specific, experienced therapists. More studies would also tend to reduce the heterogeneity observed here. More future studies should also focus on specific diagnostic categories to allow clinicians evidence with which to consider these treatments for specific populations. Studies should also examine specific treatment factors, such as emotional focus, and their contributions to outcomes across therapy models. There are signs of more studies in this since 2006 and overall study quality and diagnostic specificity appear to have improved.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-08-14 23:47:40 +0100" MODIFIED_BY="[Empty name]">
<P>This review team acknowledges the support of the Nova Scotia Department of Health and the Dalhousie University Department of Psychiatry. The original review was supported by a grant from Cochrane, Canada.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2014-05-16 11:36:17 +0100" MODIFIED_BY="Anne Lawson">
<P>Allan A Abbass: academic focus on a variant of short-term psychodynamic psychotherapies (STPP), and was the lead author on one of the included studies. He acknowledges a psychotherapeutic bias in his clinical work and teaching in favour of some of these methods. However, he is aware of the need to review the literature, and improve upon the research done in this field. To balance this view, colleagues without such a bias participated in this review.</P>
<P>Elizabeth Crowe: none known.</P>
<P>Saskia De Maat: works and teaches in a psychoanalytical oriented workplace (doing therapies) and teaches on the subject of psychoanalysis and psychoanalytic psychotherapy.</P>
<P>Jack Dekker: none known.</P>
<P>Ellen Driessen: none known.</P>
<P>Andrew Gerber: none known.</P>
<P>Steve R Kisely: none known.</P>
<P>Falk Leichsenring: none known.</P>
<P>Sven Rabung: none known.</P>
<P>Svitlana Rusalovska: none known.</P>
<P>Joel M Town: none known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2014-05-06 22:41:27 +0100" MODIFIED_BY="Anne Lawson">
<P>Abbass is the guarantor of this review.<BR/>Abbass originally conceived the review.<BR/>Abbass, Kisely and Hancock designed the review.<BR/>Rusalovska collected data for the review.<BR/>Kisely and Hancock developed the search strategy.<BR/>Rusalovska and Abbass undertook searches.<BR/>All review authors screened and retrieved papers against inclusion criteria.<BR/>Abbass and Town appraised quality of papers.<BR/>Town and Abbass abstracted data from papers.<BR/>Abbass and Rusalovska wrote to authors of papers for additional information.<BR/>Kisely, Town and Abbass entered data into Review Manager 5.<BR/>Kisely, Town and Abbass analysed and interpreted data.<BR/>All review authors provided a methodological perspective.<BR/>Abbass, Leichsenring and Town provided a clinical perspective.<BR/>All review authors contributed towards writing the review.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2014-05-06 09:15:05 +0100" MODIFIED_BY="Anne Lawson">
<P>As the protocol was written in 2004, the methods have been updated to those of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> of 2008 (<LINK REF="REF-Higgins-2008a" TYPE="REFERENCE">Higgins 2008a</LINK>). We added several new international researchers from Germany, the Netherlands, Australia and the USA strengthening the team of this review. We have also included 'occupational function' as a relevant cost-related issue in common mental disorders outcome.</P>
<P>In following phrase was deleted from the methods: "Where no further usable data was provided, studies were not included in the meta-analysis, and were listed as excluded due to missing data." This is in accordance with Cochrane's methodological stipulation that studies that meet the inclusion criteria should be included in the review irrespective of whether measured they report data in a useable way (<LINK REF="REF-Chandler-2013" TYPE="REFERENCE">Chandler 2013</LINK>).</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2014-05-16 11:06:24 +0100" MODIFIED_BY="Anne Lawson">
<STUDIES MODIFIED="2014-05-15 16:33:48 +0100" MODIFIED_BY="Anne Lawson">
<INCLUDED_STUDIES MODIFIED="2014-05-15 13:11:17 +0100" MODIFIED_BY="Anne Lawson">
<STUDY DATA_SOURCE="PUB" ID="STD-Abbass-2008" MODIFIED="2014-05-01 19:01:06 +0100" MODIFIED_BY="Anne Lawson" NAME="Abbass 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-05-01 19:01:06 +0100" MODIFIED_BY="Anne Lawson" NOTES="&lt;p&gt;Abbass A, Sheldon A, Gyra J, Kalpin A Intensive Short-term Dynamic Psychotherapy of DSM IV Personality Disorders: A Randomized Controlled Trial. New data, unpublished.&lt;/p&gt;" NOTES_MODIFIED="2014-05-01 19:01:06 +0100" NOTES_MODIFIED_BY="Anne Lawson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Abbass A, Sheldon A, Gyra J, Kalpin A</AU>
<TI>Intensive short-term dynamic psychotherapy of patients with DSM IV personality disorders: a randomized controlled trial</TI>
<SO>Journal of Nervous and Mental Disease</SO>
<YR>2008</YR>
<VL>196</VL>
<NO>3</NO>
<PG>211-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alstrom-1984a" NAME="Alstrom 1984a" YEAR="1984">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alstrom JE, Nordlund CL, Persson G, Harding M, Ljungqvist C</AU>
<TI>Effects of four treatment methods on social phobic patients not suitable for insight-oriented psychotherapy</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1984</YR>
<VL>70</VL>
<PG>97-110</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alstrom-1984b" MODIFIED="2014-05-07 17:34:33 +0100" MODIFIED_BY="Anne Lawson" NAME="Alstrom 1984b" YEAR="1984">
<REFERENCE MODIFIED="2014-05-07 17:34:33 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alstrom JE, Nordlund, G, Persson G, Harding M, Lundquist C</AU>
<TI>Effects of four treatment methods on agoraphobic women not suitable for insight-oriented psychotherapy</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1984</YR>
<VL>70</VL>
<PG>1-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Baldoni-1995" MODIFIED="2014-05-01 19:01:49 +0100" MODIFIED_BY="Anne Lawson" NAME="Baldoni 1995" YEAR="1995">
<REFERENCE MODIFIED="2014-05-01 19:01:49 +0100" MODIFIED_BY="Anne Lawson" NOTES="&lt;p&gt;Authors also provided further data in form of means, standard deviations.&lt;/p&gt;" NOTES_MODIFIED="2014-05-01 19:01:49 +0100" NOTES_MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baldoni F, Baldaro G, Trombin G</AU>
<TI>Psychotherapeutic perspectives in urethral syndrome</TI>
<SO>Stress Medicine</SO>
<YR>1995</YR>
<VL>11</VL>
<PG>79-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bressi-2010" MODIFIED="2014-05-15 13:11:17 +0100" MODIFIED_BY="Anne Lawson" NAME="Bressi 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-05-15 13:10:38 +0100" MODIFIED_BY="Jessica Sharp" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bressi C, Porcellana M, Marinaccio PM, Nocito EP, Magri L</AU>
<TI>Short-term psychodynamic psychotherapy versus treatment as usual for depressive and anxiety disorders. A randomized clinical trial of efficacy</TI>
<SO>Journal of Nervous Mental Disease</SO>
<YR>2010</YR>
<VL>198</VL>
<NO>9</NO>
<PG>647-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brom-1989" NAME="Brom 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brom D, Kleber RJ, Defares PB</AU>
<TI>Brief psychotherapy for posttraumatic stress disorders</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1989</YR>
<VL>57</VL>
<NO>5</NO>
<PG>607-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burnand-2002" MODIFIED="2014-05-15 13:08:36 +0100" MODIFIED_BY="Anne Lawson" NAME="Burnand 2002" YEAR="2002">
<REFERENCE MODIFIED="2014-05-15 13:08:35 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Drop-out rate?&lt;/p&gt;" NOTES_MODIFIED="2014-05-15 13:08:35 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Burnand Y, Andreoli A, Kolatte E, Venturini A, Rosset N</AU>
<TI>Psychodynamic psychotherapy and clomipramine in the treatment of major depression</TI>
<SO>Psychiatric Services</SO>
<YR>2002</YR>
<VL>53</VL>
<NO>5</NO>
<PG>585-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-06 20:51:33 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cailhol L, Rodgers R, Burnand Y, Brunet A, Damsa C, Andreoli A</AU>
<TI>Therapeutic alliance in short-term supportive and psychodynamic psychotherapies: a necessary but not sufficient condition for outcome?</TI>
<SO>Psychiatry Research</SO>
<YR>2009</YR>
<VL>170</VL>
<NO>2-3</NO>
<PG>229-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-01-22 19:49:11 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carrington-1979" MODIFIED="2014-05-01 19:20:23 +0100" MODIFIED_BY="Anne Lawson" NAME="Carrington 1979" YEAR="1979">
<REFERENCE MODIFIED="2014-05-01 19:20:23 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carrington CH</AU>
<TI>A comparison of cognitive and analytically oriented brief treatment approaches to depression in black women</TI>
<SO>Dissertation Abstracts International</SO>
<YR>1979</YR>
<VL>40</VL>
<NO>6B</NO>
<PG>UMI No. 7926513</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-05-01 19:04:45 +0100" MODIFIED_BY="Anne Lawson"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cooper-2003" NAME="Cooper 2003" YEAR="2003">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cooper PJ, Murray L, Wilson A, Romaniuk H</AU>
<TI>Controlled trial of the short- and long-term effect of psychological treatment of post-partum depression: 1. Impact on maternal mood</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2003</YR>
<VL>182</VL>
<PG>412-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cooper PJ, Murray L, Wilson A, Romaniuk H</AU>
<TI>Controlled trial of the short- and long-term effect of psychological treatment of post-partum depression: 2. Impact on the mother-child relationship and child outcome</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2003</YR>
<VL>182</VL>
<PG>420-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Creed-2003" MODIFIED="2014-05-01 19:05:29 +0100" MODIFIED_BY="Anne Lawson" NAME="Creed 2003" YEAR="2003">
<REFERENCE MODIFIED="2014-05-01 19:05:13 +0100" MODIFIED_BY="Anne Lawson" NOTES="&lt;p&gt;Further data acquired from authors for use in reanalysis.&lt;/p&gt;" NOTES_MODIFIED="2014-05-01 19:05:13 +0100" NOTES_MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Creed F, Fernandes L, Guthrie E, Palmer S, Ratcliffed J, Read N, et al</AU>
<TI>The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome</TI>
<SO>Gastroenterology</SO>
<YR>2003</YR>
<VL>124</VL>
<PG>303-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-01 19:05:29 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hyphantis T, Guthrie E, Tomenson B, Creed F</AU>
<TI>Psychodynamic interpersonal therapy and improvement in interpersonal difficulties in people with severe irritable bowel syndrome</TI>
<SO>Pain</SO>
<YR>2009</YR>
<VL>145</VL>
<NO>1-2</NO>
<PG>196-203</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dare-2001" MODIFIED="2014-04-11 11:58:04 +0100" MODIFIED_BY="Jessica Sharp" NAME="Dare 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-04-11 11:58:04 +0100" MODIFIED_BY="Jessica Sharp" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dare C, Eisler I, Russell G, Treasure J, Dodge L</AU>
<TI>Psychological therapies for adults with anorexia nervosa: randomised controlled trial of out-patient treatments</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2001</YR>
<VL>178</VL>
<PG>216-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Jonghe-2001" MODIFIED="2014-05-01 19:06:55 +0100" MODIFIED_BY="Anne Lawson" NAME="de Jonghe 2001" YEAR="2004">
<REFERENCE MODIFIED="2014-05-01 19:05:51 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gijsbers Van Wijk CMT, Dekker J, Peen J, De Jonghe F</AU>
<TI>Depression in men and women: sex differences in treatment outcomes of pharmacotherapy and combined therapy</TI>
<SO>Tijdschrift Voor Psychiatrie</SO>
<YR>2002</YR>
<VL>44</VL>
<NO>5</NO>
<PG>301-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-01 19:06:02 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van Henricus L, Schoevers RA, Kool S, Hendriksen M, Peen J, Dekker J</AU>
<TI>Does early response predict outcome in psychotherapy and combined therapy for major depression?</TI>
<SO>Journal of Affective Disorders</SO>
<YR>2008</YR>
<VL>105</VL>
<NO>1-3</NO>
<PG>261-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-01 19:06:55 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>de Jonghe F, Kool S, van Aalst J, Dekker J, Peen J</AU>
<TI>Combining psychotherapy and antidepressants in the treatment of depression</TI>
<SO>Journal of Affective Disorders</SO>
<YR>2001</YR>
<VL>64</VL>
<PG>217-29</PG>
<IDENTIFIERS MODIFIED="2014-05-01 19:06:55 +0100" MODIFIED_BY="Anne Lawson">
<IDENTIFIER MODIFIED="2014-05-01 19:06:55 +0100" MODIFIED_BY="Anne Lawson" TYPE="OTHER" VALUE="Molenaar PJ, Dekker J, Van R, Hendriksen M, Vink A, Schoevers RA. Does adding psychotherapy to pharmacotherapy improve social functioning in the treatment of outpatient depression? Depression and Anxiety 2007;24:553-62."/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Emmelkamp-2006" MODIFIED="2014-05-01 19:07:13 +0100" MODIFIED_BY="Anne Lawson" NAME="Emmelkamp 2006" YEAR="2006">
<REFERENCE MODIFIED="2014-05-01 19:07:13 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Emmelkamp P, Benner A, Kuipers A, Feiertag G, Koster H, van Apeldoorn F</AU>
<TI>Comparison of brief dynamic and cognitive-behavioural therapies in avoidant personality disorder</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2006</YR>
<VL>189</VL>
<PG>60-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Guthrie-1993" MODIFIED="2014-05-01 19:07:45 +0100" MODIFIED_BY="Anne Lawson" NAME="Guthrie 1993" YEAR="1993">
<REFERENCE MODIFIED="2014-05-01 19:07:30 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guthrie E, Creed F, Dawson D, Tomenson B</AU>
<TI>A controlled trial of psychological treatment for the irritable bowel syndrome</TI>
<SO>Gastroenterology</SO>
<YR>1991</YR>
<VL>100</VL>
<PG>450-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-01 19:07:45 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Guthrie E, Creed F, Dawson D, Tomenson B</AU>
<TI>A randomised controlled trial of psychotherapy in patients with refractory irritable bowel syndrome</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1993</YR>
<VL>163</VL>
<PG>315-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guthrie-1999" MODIFIED="2014-05-01 19:07:55 +0100" MODIFIED_BY="Anne Lawson" NAME="Guthrie 1999" YEAR="1999">
<REFERENCE MODIFIED="2014-05-01 19:07:55 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guthrie E, Moorey J, Margison F, Barker H, Palmer S, McGrath G, et al</AU>
<TI>Cost-effectiveness of brief psychodynamic-interpersonal therapy in high utilizers of psychiatric services</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1999</YR>
<VL>56</VL>
<PG>519-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guthrie-2001" MODIFIED="2014-05-15 13:08:50 +0100" MODIFIED_BY="Anne Lawson" NAME="Guthrie 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-05-15 13:08:50 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Guthrie E, Kapur N, Mackway-Jones K, Chew-Graham C, Moorey J, Mendel E, et al</AU>
<TI>Predictors of outcome following brief psychodynamic-interpersonal therapy for deliberate self-poisoning</TI>
<SO>Australian and New Zealand Journal of Psychiatry</SO>
<YR>2003</YR>
<VL>37</VL>
<PG>532-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-01 19:08:22 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guthrie E, Kapur N, Mackway-Jones K, Chew-Graham C, Moorey J, Mendel E, et al</AU>
<TI>Randomised controlled trial of brief psychological intervention after deliberate self poisoning</TI>
<SO>BMJ</SO>
<YR>2001</YR>
<VL>323</VL>
<NO>7305</NO>
<PG>135-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hamilton-2000" MODIFIED="2014-05-01 19:08:37 +0100" MODIFIED_BY="Anne Lawson" NAME="Hamilton 2000" YEAR="2000">
<REFERENCE MODIFIED="2014-05-01 19:08:37 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hamilton J, Guthrie E, Creed F, Thompson D, Tomenson B, Bennett R, et al</AU>
<TI>A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia</TI>
<SO>Gastroenterology</SO>
<YR>2000</YR>
<VL>119</VL>
<PG>661-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Levy-Berg-2009" MODIFIED="2014-05-01 19:08:51 +0100" MODIFIED_BY="Anne Lawson" NAME="Levy Berg 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-05-01 19:08:51 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Levy Berg A, Sandell R, Sandahl C</AU>
<TI>Affect-focused body psychotherapy in patients with generalized anxiety disorder: evaluation of an integrative method</TI>
<SO>Journal of Psychotherapy Integration</SO>
<YR>2009</YR>
<VL>19</VL>
<NO>1</NO>
<PG>67-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Linnet-2001" MODIFIED="2009-09-11 07:10:27 +0100" MODIFIED_BY="[Empty name]" NAME="Linnet 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-09-11 07:10:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Linnet J, Jemec GB</AU>
<TI>Anxiety level and severity of skin condition predicts outcome of psychotherapy in atopic dermatitis patients</TI>
<SO>International Journal of Dermatology</SO>
<YR>2001</YR>
<VL>40</VL>
<PG>632-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maina-2005" NAME="Maina 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maina G, Forner F, Bogetto F</AU>
<TI>Randomized controlled trial comparing brief dynamic and supportive therapy with waiting list condition in minor depressive disorders</TI>
<SO>Psychotherapy and Psychosomatics</SO>
<YR>2005</YR>
<VL>74</VL>
<PG>43-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maina-2010" MODIFIED="2014-05-08 12:45:19 +0100" MODIFIED_BY="Anne Lawson" NAME="Maina 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-05-08 12:45:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maina G, Rosso G, Bogetto F</AU>
<TI>Brief Dynamic Therapy Combined With Pharmacotherapy in the Treatment of Major Depressive Disorder: Long-Term Results</TI>
<SO>Journal of Affective Disorders</SO>
<YR>2009</YR>
<VL>114</VL>
<NO>1-3</NO>
<PG>200-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-01 19:10:37 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maina G, Rosso G, Rigardetto S, Chiadò Piat S, Bogetto F</AU>
<TI>No effect of adding brief dynamic therapy to pharmacotherapy in the treatment of obsessive-compulsive disorder with concurrent major depression</TI>
<SO>Psychotherapy and Psychosomatics</SO>
<YR>2010</YR>
<VL>79</VL>
<NO>5</NO>
<PG>295-302</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marmar-1988" NAME="Marmar 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marmar CR, Horowitz MJ, Weiss DS, Wilner NR, Kaltreider NB</AU>
<TI>A controlled trial of brief psychotherapy and mutual-help group treatment of conjugal bereavement</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1988</YR>
<VL>145</VL>
<NO>2</NO>
<PG>203-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Milrod-2007" MODIFIED="2014-05-08 12:45:49 +0100" MODIFIED_BY="Anne Lawson" NAME="Milrod 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-05-01 19:11:09 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Busch FN, Milrod BL, Sandberg LS</AU>
<TI>A study demonstrating efficacy of a psychoanalytic psychotherapy for panic disorder: implications for psychoanalytic research, theory, and practice</TI>
<SO>Journal of the American Psychoanalytic Association</SO>
<YR>2009</YR>
<VL>57</VL>
<NO>1</NO>
<PG>131-48</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-01 19:11:21 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="OTHER">
<AU>Graf EP</AU>
<TI>The relationship of reflective functioning and severity of agoraphobia in the outcome of a psychoanalytic psychotherapy for panic disorder</TI>
<SO>Dissertation Abstracts International: Section B: the Sciences and Engineering Dissertation Abstracts International</SO>
<YR>2010</YR>
<VL>70</VL>
<NO>10-B</NO>
<PG>6550</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-01 19:11:53 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Klass ET, Milrod BL, Leon AC, Kay SJ, Schwalberg M, Li C, et al</AU>
<TI>Does interpersonal loss preceding panic disorder onset moderate response to psychotherapy? An exploratory study</TI>
<SO>Journal of Clinical Psychiatry Diseases of the Nervous System</SO>
<YR>2009</YR>
<VL>70</VL>
<NO>3</NO>
<PG>406-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-01 19:12:22 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leon AC, Busch F, Rudden M, Schwalberg M, Clarkin J, Aronson A, et al</AU>
<TI>A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder: erratum</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2007</YR>
<VL>164</VL>
<NO>7</NO>
<PG>1123</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-01 19:12:45 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Milrod B, Leon AC, Busch F, Rudden M, Schwalberg M, Clarkin J, et al</AU>
<TI>A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2007</YR>
<VL>164</VL>
<NO>2</NO>
<PG>265-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-05-08 12:45:49 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-05-08 12:45:49 +0100" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00128388"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Monsen-2000" MODIFIED="2014-05-01 19:12:56 +0100" MODIFIED_BY="Anne Lawson" NAME="Monsen 2000" YEAR="2000">
<REFERENCE MODIFIED="2014-05-01 19:12:56 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Monsen K, Monsen JT</AU>
<TI>Chronic pain and psychodynamic body therapy: a controlled outcome study</TI>
<SO>Psychotherapy: Theory, Research, Practice, Training</SO>
<YR>2000</YR>
<VL>37</VL>
<NO>3</NO>
<PG>257-69</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Piper-1990" NAME="Piper 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Piper WE, Azim HF, McCallum M, Joyce AS</AU>
<TI>Patient suitability and outcome in short-term individual psychotherapy</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1990</YR>
<VL>58</VL>
<NO>4</NO>
<PG>475-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sattel-2012" MODIFIED="2014-05-01 19:13:50 +0100" MODIFIED_BY="Anne Lawson" NAME="Sattel 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-05-01 19:13:50 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sattel H, Lahmann C, Gundel H, Guthrie E, Kruse J, Noll-Hussong M, et al</AU>
<TI>Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2012</YR>
<VL>100</VL>
<PG>60-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shefler-1995" NAME="Shefler 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shefler G, Dasberg H, Ben-Shakhar G</AU>
<TI>A randomized controlled outcome and follow-up study of Mann's time-limited psychotherapy</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1995</YR>
<VL>63</VL>
<NO>4</NO>
<PG>585-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sloane-1975" NAME="Sloane 1975" YEAR="1975">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sloane RB, Staples FR, Cristol AH, Yorkston NJ, Whipple K</AU>
<TI>Short-term analytically oriented psychotherapy versus behavior therapy</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1975</YR>
<VL>132</VL>
<NO>4</NO>
<PG>373-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Svedlund-1983" NAME="Svedlund 1983" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Svedlund J, Sjodin I, Ottoson JO, Dotevall G</AU>
<TI>Controlled study of psychotherapy in irritable bowel syndrome</TI>
<SO>Lancet</SO>
<YR>1983</YR>
<VL>2</VL>
<NO>8350</NO>
<PG>589-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-S_x00f8_rensen-2010" MODIFIED="2014-05-15 13:09:08 +0100" MODIFIED_BY="Anne Lawson" NAME="Sørensen 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-05-15 13:09:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sørensen P, Birket-Smith M, Wattar U, Buemann I, Salkovskis P</AU>
<TI>A randomized clinical trial of cognitive behavioural therapy versus short-term psychodynamic psychotherapy versus no intervention for patients with hypochondriasis</TI>
<SO>Psychological Medicine</SO>
<YR>2010</YR>
<VL>41</VL>
<NO>2</NO>
<PG>431-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-01 19:17:37 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Sørensen P, Birket-Smith M, Wattar U, Buemann I, Salkovskis P</AU>
<SO>A randomised controlled study of cognitive behavioural therapy for hypochondriasis. Proceedings of the 32nd Congress of the British Association for Behavioural and Cognitive Psychotherapies (jointly with the European Association of Behavioural and Cognitive Therapies); 2004 Sept 8-11; Manchester, UK</SO>
<YR>2004</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vitriol-2009" MODIFIED="2014-05-01 19:18:23 +0100" MODIFIED_BY="Anne Lawson" NAME="Vitriol 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-05-01 19:18:23 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vitriol VG, Ballesteros ST, Florenzano RU, Weil KP, Benadof DF</AU>
<TI>Evaluation of an outpatient intervention for women with severe depression and a history of childhood trauma</TI>
<SO>Psychiatric Services</SO>
<YR>2009</YR>
<VL>60</VL>
<NO>7</NO>
<PG>936-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wiborg-1996" MODIFIED="2013-02-19 12:58:59 +0000" MODIFIED_BY="[Empty name]" NAME="Wiborg 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-02-19 12:58:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wiborg IM, Dahl AA</AU>
<TI>Does brief dynamic psychotherapy reduce the relapse rate of panic disorder?</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1996</YR>
<VL>53</VL>
<PG>689-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Winston-1994" NAME="Winston 1994" YEAR="1994">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Winston A, Laikin M, Pollack J, Samstag LW, McCullough L, Muran JC</AU>
<TI>Short-term psychotherapy of personality disorders</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1994</YR>
<VL>151</VL>
<NO>2</NO>
<PG>190-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Winston A, Pollack J, McCullough L, Flegenheimer W, Kestenbaum E, Trujillo M</AU>
<TI>Brief psychotherapy of personality disorders</TI>
<SO>Journal of Nervous and Mental Disorders</SO>
<YR>1991</YR>
<VL>179</VL>
<PG>188-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2014-05-01 20:22:54 +0100" MODIFIED_BY="Anne Lawson">
<STUDY DATA_SOURCE="PUB" ID="STD-Brodaty-1983" NAME="Brodaty 1983" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brodaty H, Andrews G</AU>
<TI>Brief psychotherapy in family practice</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1983</YR>
<VL>143</VL>
<PG>11-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Budman-1988" MODIFIED="2014-05-01 19:18:53 +0100" MODIFIED_BY="Anne Lawson" NAME="Budman 1988" YEAR="1988">
<REFERENCE MODIFIED="2014-05-01 19:18:53 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Budman SH, Demby A, Redondo JP, Hannan M, Feldstein M, Ring J, et al</AU>
<TI>Comparative outcome in time-limited individual and group psychotherapy</TI>
<SO>International Journal of Group Psychotherapy</SO>
<YR>1988</YR>
<VL>38</VL>
<NO>1</NO>
<PG>63-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fairburn-1986" NAME="Fairburn 1986" YEAR="1986">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fairburn CG, Kirk J, O'Connor M, Cooper PJ</AU>
<TI>A comparison of two psychological treatments for bulimia nervosa</TI>
<SO>Behavioral Research and Therapy</SO>
<YR>1986</YR>
<VL>24</VL>
<NO>6</NO>
<PG>629-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gallagher-1982" NAME="Gallagher 1982" YEAR="1982">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gallagher DE, Thompson LW</AU>
<TI>Treatment of major depressive disorder in older adult outpatients with brief psychotherapies</TI>
<SO>Psychotherapy: Theory, Research and Practice</SO>
<YR>1982</YR>
<VL>19</VL>
<NO>4</NO>
<PG>482-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gallagher_x002d_Thompson-1994" MODIFIED="2014-05-01 19:19:29 +0100" MODIFIED_BY="Anne Lawson" NAME="Gallagher-Thompson 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gallagher-Thompson D, Steffen A</AU>
<TI>Comparative effects of cognitive-behavioral and brief psychodynamic psychotherapies for depressed family caregivers</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1994</YR>
<VL>62</VL>
<NO>3</NO>
<PG>543-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gilbert-1982" MODIFIED="2014-05-01 19:19:42 +0100" MODIFIED_BY="Anne Lawson" NAME="Gilbert 1982" YEAR="1982">
<REFERENCE MODIFIED="2014-05-01 19:19:42 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gilbert AR</AU>
<TI>Psychotherapy and clinical depression: an evaluation of cognitive-behavioral and psychoanalytic modes of therapeutic intervention</TI>
<SO>Dissertation Abstracts International</SO>
<YR>1982</YR>
<VL>43</VL>
<NO>4B</NO>
<PG>UMI No. 8220795</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hall-1987" MODIFIED="2014-05-01 19:20:34 +0100" MODIFIED_BY="Anne Lawson" NAME="Hall 1987" YEAR="1987">
<REFERENCE MODIFIED="2014-05-01 19:20:34 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hall A, Crisp AH</AU>
<TI>Brief psychotherapy in the treatment of anorexia nervosa: outcome at one year</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1987</YR>
<VL>151</VL>
<PG>185-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hardy-1995" MODIFIED="2014-05-01 19:20:47 +0100" MODIFIED_BY="Anne Lawson" NAME="Hardy 1995" YEAR="1995">
<REFERENCE MODIFIED="2014-05-01 19:20:47 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hardy GE, Barkham M, Shapiro DA, Stiles WB, Rees A, Reynolds S</AU>
<TI>Impact of cluster C personality disorders on outcomes of contrasting brief psychotherapies for depression</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1995</YR>
<VL>63</VL>
<NO>6</NO>
<PG>997-1004</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hellerstein-1998" MODIFIED="2013-02-19 12:59:57 +0000" MODIFIED_BY="[Empty name]" NAME="Hellerstein 1998" YEAR="1998">
<REFERENCE MODIFIED="2013-02-19 12:59:57 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hellerstein DJ, Rosenthal RN, Pinsker H, Wallner Samstag L, Muran JC, Winston A</AU>
<TI>A randomized prospective study comparing supportive and dynamic therapies</TI>
<SO>Journal of Psychotherapy Practice and Research</SO>
<YR>1998</YR>
<VL>7</VL>
<PG>261-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Knekt-2004" MODIFIED="2014-05-01 19:22:30 +0100" MODIFIED_BY="Anne Lawson" NAME="Knekt 2004" YEAR="2004">
<REFERENCE MODIFIED="2014-05-01 19:22:30 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="OTHER">
<AU>Knekt P, Lindfors O</AU>
<TI>A randomized trial of the effect of four forms of psychotherapy on depressive and anxiety disorders. Design, methods, and results on the effectiveness of short-term psychodynamic psychotherapy and solution-focused therapy during a one-year follow-up</TI>
<TO>Sataunnaistettu kiininen koe neljan psykoterapiamuodon vaikuttavuudesta masennustiloihin ja ahdistuneisuushairioihin</TO>
<SO>Studies in Social Security and Health</SO>
<YR>2004</YR>
<VL>77</VL>
<NO>112</NO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maina-2009" MODIFIED="2014-05-01 20:16:15 +0100" MODIFIED_BY="Anne Lawson" NAME="Maina 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-05-01 20:16:15 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maina G, Rosso G, Bogetto F</AU>
<TI>Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results</TI>
<SO>Journal of Affective Disorders</SO>
<YR>2009</YR>
<VL>114</VL>
<PG>200-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McLean-1979" NAME="McLean 1979" YEAR="1979">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McLean PD, Hakstian AR</AU>
<TI>Clinical depression: comparative efficacy of outpatient treatments</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1979</YR>
<VL>47</VL>
<NO>5</NO>
<PG>818-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Morris-1975" MODIFIED="2014-05-01 20:19:25 +0100" MODIFIED_BY="Anne Lawson" NAME="Morris 1975" YEAR="1975">
<REFERENCE MODIFIED="2014-05-01 20:19:25 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="BOOK">
<AU>Morris NE</AU>
<SO>A Group Self-Instruction Method for the Treatment of Depressed Outpatients [doctoral thesis]</SO>
<YR>1975</YR>
<PB>University of Toronto</PB>
<CY>Toronto, Canada</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nanzer-2012" MODIFIED="2014-04-04 16:24:32 +0100" MODIFIED_BY="[Empty name]" NAME="Nanzer 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-04-04 16:24:32 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nanzer N, Rossignol AS, Righetti-Veltema M, Knauer D, Manzano J, Espasa FP</AU>
<TI>Effects of a brief psychoanalytic intervention for perinatal depression</TI>
<SO>Archives of Women's Mental Health</SO>
<YR>2012</YR>
<VL>15</VL>
<NO>4</NO>
<PG>259-68</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Piper-1998" NAME="Piper 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Piper WE, Joyce AS, McCallum M, Azim HF</AU>
<TI>Interpretive and supportive forms of psychotherapy and patient personality variables</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1998</YR>
<VL>66</VL>
<NO>3</NO>
<PG>558-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shapiro-1987" MODIFIED="2014-05-01 20:20:22 +0100" MODIFIED_BY="Anne Lawson" NAME="Shapiro 1987" YEAR="1987">
<REFERENCE MODIFIED="2014-05-01 20:20:22 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shapiro DA, Firth J</AU>
<TI>Prescriptive v. exploratory psychotherapy: outcomes of the Sheffield Psychotherapy Project</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1987</YR>
<VL>151</VL>
<PG>790-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shapiro-1995" NAME="Shapiro 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shapiro DA, Rees A, Barkham M, Hardy G</AU>
<TI>Effects of treatment duration and severity of depression on the maintenance of gains after cognitive-behavioral and psychodynamic-interpersonal psychotherapy</TI>
<SO>Journal of Counselling and Clinical Psychology</SO>
<YR>1995</YR>
<VL>63</VL>
<NO>3</NO>
<PG>378-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simpson-2003" NAME="Simpson 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Simpson S, Corney R, Fitzgerald P, Beecham J</AU>
<TI>A randomized controlled trial to evaluate the effectiveness and cost-effectiveness of psychodynamic counselling for general practice patients with chronic depression</TI>
<SO>Psychological Medicine</SO>
<YR>2003</YR>
<VL>33</VL>
<PG>229-39</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Sjodin-1986" MODIFIED="2012-11-24 20:09:28 +0000" MODIFIED_BY="[Empty name]" NAME="Sjodin 1986" YEAR="1986">
<REFERENCE MODIFIED="2012-11-24 20:09:28 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sjodin I, Svedlund J, Ottoson JO, Dotevall G</AU>
<TI>Controlled study of psychotherapy in chronic peptic ulcer disease</TI>
<SO>Psychosomatics</SO>
<YR>1986</YR>
<VL>27</VL>
<NO>3</NO>
<PG>187-200</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Svartberg-2004" MODIFIED="2014-05-01 20:22:54 +0100" MODIFIED_BY="Anne Lawson" NAME="Svartberg 2004" YEAR="2004">
<REFERENCE MODIFIED="2014-05-01 20:22:54 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Svartberg M, Stiles TC, Seltzer MH</AU>
<TI>Randomized, controlled trial of the effectiveness of short-term dynamic psychotherapy and cognitive therapy for cluster C personality disorders</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2004</YR>
<VL>161</VL>
<NO>5</NO>
<PG>810-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thompson-1987" NAME="Thompson 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thompson LW, Gallagher D, Breckenridge JS</AU>
<TI>Comparative effectiveness of psychotherapies for depressed elders</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1987</YR>
<VL>55</VL>
<NO>3</NO>
<PG>385-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vinnars-2005" MODIFIED="2013-02-19 13:01:08 +0000" MODIFIED_BY="[Empty name]" NAME="Vinnars 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-02-19 13:01:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vinnars B, Barber J, Noren K, Gallop R, Weinryb R</AU>
<TI>Manualized supportive-expressive therapy versus nonmanualized community-delivered psychodynamic therapy for patients with personality disorders: bridging efficacy and effectiveness</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2005</YR>
<VL>162</VL>
<NO>10</NO>
<PG>1933-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2014-05-15 12:34:43 +0100" MODIFIED_BY="Anne Lawson">
<STUDY DATA_SOURCE="PUB" ID="STD-Barber-2012" MODIFIED="2014-05-08 12:30:04 +0100" MODIFIED_BY="[Empty name]" NAME="Barber 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-03-24 13:39:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barber JP, Barrett MS, Gallop R, Rynn MA, Rickels K</AU>
<TI>Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2012</YR>
<VL>73</VL>
<NO>1</NO>
<PG>66-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-05-08 12:30:04 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-05-08 12:30:04 +0100" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00043550"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Beutel-2014" MODIFIED="2014-05-08 12:33:44 +0100" MODIFIED_BY="[Empty name]" NAME="Beutel 2014" YEAR="2014">
<REFERENCE MODIFIED="2014-03-24 13:09:17 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Beutel ME, Weißflog G, Leuteritz K, Wiltink J, Haselbacher A, Ruckes C, et al</AU>
<TI>Efficacy of short-term psychodynamic psychotherapy (STPP) with depressed breast cancer patients: results of a randomized controlled multicenter trial</TI>
<SO>Annals of Oncology</SO>
<YR>2014</YR>
<VL>25</VL>
<NO>2</NO>
<PG>378-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-08 12:33:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haselbacher A, Barthel Y, Brahler E, Imruck B, Kuhnt S, Zwerenz R, et al</AU>
<TI>Psychodynamic short-term therapy for cancer patients suffering from depression A treatment manual on the basis of Luborsky's supportive-expressive therapy</TI>
<SO>Psychotherapeut Praxis der Psychotherapie Und Psychosomatik</SO>
<YR>2010</YR>
<VL>55</VL>
<NO>4</NO>
<PG>321-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-08 12:32:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leuteritz K, Brahler E, Weisflog G, Barthel Y, Kuhnt S, Zwerenz R, et al</AU>
<TI>Efficacy and predictors of outcome of short-term psychodynamic psychotherapy (STPP) in depressed breast cancer patients: A randomised controlled trial</TI>
<SO>Journal of Psychosomatic Research</SO>
<YR>2013</YR>
<VL>74</VL>
<NO>6</NO>
<PG>552</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bressi-2011" MODIFIED="2014-05-01 20:29:01 +0100" MODIFIED_BY="Anne Lawson" NAME="Bressi 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-05-01 20:29:01 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bressi C, Ciabatti M, Nocito EP, Catenacci E, Porcellana M, Invernizzi G, et al</AU>
<TI>A preliminary longitudinal study on the importance of early intervention in panic disorder</TI>
<SO>Journal of Psychosomatic Research</SO>
<YR>2010</YR>
<VL>68</VL>
<NO>6</NO>
<PG>610</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Faramarzi-2013" MODIFIED="2014-03-24 13:05:35 +0000" MODIFIED_BY="[Empty name]" NAME="Faramarzi 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-03-24 13:05:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Faramarzi M, Azadfallah P, Book HE, Tabatabaei KR, Taheri H, Shokri-shirvani J</AU>
<TI>A randomized controlled trial of brief psychoanalytic psychotherapy in patients with functional dyspepsia</TI>
<SO>Asian Journal of Psychiatry</SO>
<YR>2013</YR>
<VL>6</VL>
<NO>3</NO>
<PG>228-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gibbons-2012" MODIFIED="2014-03-24 13:05:44 +0000" MODIFIED_BY="[Empty name]" NAME="Gibbons 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-03-24 13:05:44 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gibbons MB, Thompson SM, Scott K, Schauble LA, Mooney T, Thompson D, et al</AU>
<TI>Supportive-expressive dynamic psychotherapy in the community mental health system: a pilot effectiveness trial for the treatment of depression</TI>
<SO>Psychotherapy (Chicago, Ill.)</SO>
<YR>2012</YR>
<VL>49</VL>
<NO>3</NO>
<PG>303-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kompoliti-2014" MODIFIED="2014-05-01 20:30:09 +0100" MODIFIED_BY="Anne Lawson" NAME="Kompoliti 2014" YEAR="2014">
<REFERENCE MODIFIED="2014-05-01 20:30:09 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kompoliti K, Wilson B, Stebbins G, Bernard B, Hinson V</AU>
<TI>Immediate vs. delayed treatment of psychogenic movement disorders with short term psychodynamic psychotherapy: randomized clinical trial</TI>
<SO>Parkinsonism and Related Disorders</SO>
<YR>2014</YR>
<VL>20</VL>
<NO>1</NO>
<PG>60-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leichsenring-2013" MODIFIED="2014-05-15 12:34:43 +0100" MODIFIED_BY="Anne Lawson" NAME="Leichsenring 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-05-08 12:36:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leichsenring F, Hoyer J, Beutel M, Herpertz S, Hiller W, Irle E, et al.</AU>
<TI>The social phobia psychotherapy research network - The first multicenter randomized controlled trial of psychotherapy for social phobia: Rationale, methods and patient characteristics</TI>
<SO>Psychotherapy and Psychosomatics Acta Psychotherapeutica</SO>
<YR>2009</YR>
<VL>78</VL>
<NO>1</NO>
<PG>35-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-15 12:34:43 +0100" MODIFIED_BY="Jessica Sharp" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leichsenring F, Salzer S, Beutel ME, Herpertz S, Hiller W, Hoyer J, et al</AU>
<TI>Long-term outcome of psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder</TI>
<SO>American Journal of Psychiatry</SO>
<YR>(In press)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-06 20:27:31 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leichsenring F, Salzer S, Beutel ME, Herpertz S, Hiller W, Hoyer J, et al</AU>
<TI>Psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder: a multicenter randomized controlled trial [SOPHO-NET]</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2013</YR>
<VL>170</VL>
<NO>7</NO>
<PG>759-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-08 12:38:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leichsenring F, Salzer S, Beutel ME, von Consbruch K, Herpertz S, Hiller W, et al</AU>
<TI>SOPHO-NET -- A research network on psychotherapy for social phobia</TI>
<SO>Psychotherapie, Psychosomatik, Medizinische Psychologie</SO>
<YR>2009</YR>
<VL>59</VL>
<NO>3-4</NO>
<PG>117-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-08 12:40:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ritter V, Leichsenring F, Strauss BM, Stangier U.</AU>
<TI>Changes in implicit and explicit self-esteem following cognitive and psychodynamic therapy in social anxiety disorder</TI>
<SO>Psychotherapy Research</SO>
<YR>2013</YR>
<VL>23</VL>
<NO>5</NO>
<PG>547-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-05-08 12:29:21 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-05-08 12:29:15 +0100" MODIFIED_BY="[Empty name]" TYPE="ISRCTN" VALUE="53517394 "/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reneses-2013" MODIFIED="2014-05-06 20:28:06 +0100" MODIFIED_BY="Anne Lawson" NAME="Reneses 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-05-06 20:28:06 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reneses B, Galin M, Serrano R, Figuera D, Salcedo G, Del Moral AF, et al</AU>
<TI>A new time limited psychotherapy for BPD: preliminary results of a randomized and controlled trial</TI>
<TO>Una nueva psicoterapia breve para trastornoslímite de la personalidad. Resultados preliminaresde un ensayo controlado y aleatorizado</TO>
<SO>Actas Españolas de Psiquiatría</SO>
<YR>2013</YR>
<VL>41</VL>
<NO>3</NO>
<PG>139-48</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scheidt-2013" MODIFIED="2014-03-24 13:53:00 +0000" MODIFIED_BY="[Empty name]" NAME="Scheidt 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-03-24 13:52:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Scheidt CE, Waller E, Endorf K, Schmidt S, Konig R, Zeeck A, et al</AU>
<TI>Is brief psychodynamic psychotherapy in primary fibromyalgia syndrome with concurrent depression an effective treatment? A randomized controlled trial</TI>
<SO>General Hospital Psychiatry</SO>
<YR>2013</YR>
<VL>35</VL>
<NO>2</NO>
<PG>160-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shaw-2001" MODIFIED="2014-05-01 20:34:01 +0100" MODIFIED_BY="Anne Lawson" NAME="Shaw 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-05-01 20:34:01 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shaw CM, Margison FR, Guthrie EA, Tomenson B</AU>
<TI>Psychodynamic interpersonal therapy by inexperienced therapists in a naturalistic setting: a pilot study</TI>
<SO>European Journal of Psychotherapy, Counselling and Health European Journal of Psychotherapy and Counselling</SO>
<YR>2001</YR>
<VL>4</VL>
<NO>1</NO>
<PG>87-101</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zipfel-2014" MODIFIED="2014-05-08 12:41:10 +0100" MODIFIED_BY="Anne Lawson" NAME="Zipfel 2014" YEAR="2014">
<REFERENCE MODIFIED="2014-05-01 20:36:39 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wild B, Friederich H-C, Gross G, Teufel M, Herzog W, Giel KE, et al</AU>
<TI>The ANTOP study: focal psychodynamic psychotherapy, cognitive-behavioural therapy, and treatment-as-usual in outpatients with anorexia nervosa - a randomized controlled trial</TI>
<SO>Trials</SO>
<YR>2009</YR>
<VL>10</VL>
<PG>23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-01 20:34:32 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Zipfel S, Wild B, Groß G, Friederich HC, Teufel M, Schellberg D, et al</AU>
<TI>Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in outpatients with anorexia nervosa (ANTOP study): randomised controlled trial</TI>
<SO>Lancet</SO>
<YR>2014</YR>
<VL>383</VL>
<NO>9912</NO>
<PG>127-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-05-08 12:41:10 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-05-08 12:41:10 +0100" MODIFIED_BY="[Empty name]" TYPE="ISRCTN" VALUE="72809357"/>
</IDENTIFIERS>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2014-05-15 16:33:48 +0100" MODIFIED_BY="Anne Lawson">
<STUDY DATA_SOURCE="PUB" ID="STD-ISRCTN38209986" MODIFIED="2014-05-15 13:29:23 +0100" MODIFIED_BY="Jessica Sharp" NAME="ISRCTN38209986" YEAR="">
<REFERENCE MODIFIED="2014-05-15 13:28:57 +0100" MODIFIED_BY="Jessica Sharp" PRIMARY="NO" TYPE="OTHER">
<AU>ISRCTN38209986</AU>
<TI>Psychodynamic Psychotherapy in Primary Care: A Randomised Study to evaluate the effectiveness of Dynamic Interpersonal Therapy (DIT)</TI>
<SO>http://www.controlled-trials.com/ISRCTN38209986</SO>
<YR>(accessed 15 May 2014)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-05-15 13:29:18 +0100" MODIFIED_BY="Jessica Sharp"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01141426" MODIFIED="2014-05-08 12:42:18 +0100" MODIFIED_BY="Anne Lawson" NAME="NCT01141426" YEAR="2013">
<REFERENCE MODIFIED="2014-05-08 12:42:18 +0100" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01141426</AU>
<TI>Halifax Treatment Refractory Depression Trial: A Randomized Controlled Trial of Intensive Short-Term Dynamic Psychotherapy (ISTDP) Compared to Secondary Care Treatment as Usual</TI>
<SO>clinicaltrials.gov/ct2/show/NCT01141426</SO>
<YR>(accessed 6 May 2014)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02076867" MODIFIED="2014-05-15 13:26:33 +0100" MODIFIED_BY="Jessica Sharp" NAME="NCT02076867" YEAR="2014">
<REFERENCE MODIFIED="2014-05-15 13:26:31 +0100" MODIFIED_BY="Jessica Sharp" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02076867</AU>
<TI>Halifax Somatic Symptom Disorder Trial: A Randomized Parallel Group Cross-Over Study of Intensive Short-Term Dynamic Psychotherapy Compared to Medical Treatment as Usual for Somatic Symptoms in the Emergency Department</TI>
<SO>http://clinicaltrials.gov/ct2/show/NCT02076867</SO>
<YR>(accessed 15 May 2014)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2014-05-16 11:06:24 +0100" MODIFIED_BY="Anne Lawson">
<ADDITIONAL_REFERENCES MODIFIED="2014-05-16 11:06:24 +0100" MODIFIED_BY="Anne Lawson">
<REFERENCE ID="REF-Abbass-2006" MODIFIED="2014-05-01 20:41:28 +0100" MODIFIED_BY="Anne Lawson" NAME="Abbass 2006" TYPE="COCHRANE_REVIEW">
<AU>Abbass AA, Henderson J, Kisely S, Hancock JT</AU>
<TI>Short-term psychodynamic psychotherapies for common mental disorders</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2014-05-01 20:41:28 +0100" MODIFIED_BY="Anne Lawson">
<IDENTIFIER MODIFIED="2014-05-01 20:41:28 +0100" MODIFIED_BY="Anne Lawson" TYPE="DOI" VALUE="10.1002/14651858.CD004687.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Abbass-2009" MODIFIED="2014-05-01 20:42:15 +0100" MODIFIED_BY="Anne Lawson" NAME="Abbass 2009" TYPE="JOURNAL_ARTICLE">
<AU>Abbass A, Kisely S, Kroenke K</AU>
<TI>Short-term psychodynamic psychotherapy for somatic symptom disorders: a systematic review and meta-analysis</TI>
<SO>Psychotherapy and Psychosomatics</SO>
<YR>2009</YR>
<VL>78</VL>
<PG>265-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Abbass-2010" MODIFIED="2014-05-01 20:42:37 +0100" MODIFIED_BY="Anne Lawson" NAME="Abbass 2010" TYPE="JOURNAL_ARTICLE">
<AU>Abbass A, Driessen E</AU>
<TI>The efficacy of short-term psychodynamic psychotherapy for depression: a summary of recent findings</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>2010</YR>
<VL>121</VL>
<PG>398-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Abbass-2011" MODIFIED="2013-03-11 13:05:33 +0000" MODIFIED_BY="[Empty name]" NAME="Abbass 2011" TYPE="JOURNAL_ARTICLE">
<AU>Abbass A, Driessen E, Town J</AU>
<TI>The efficacy of short-term psychodynamic psychotherapy for depressive disorders with comorbid personality disorder</TI>
<SO>Psychiatry</SO>
<YR>2011</YR>
<VL>74</VL>
<PG>58-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Abbass-2012" MODIFIED="2014-05-01 20:43:30 +0100" MODIFIED_BY="Anne Lawson" NAME="Abbass 2012" TYPE="JOURNAL_ARTICLE">
<AU>Abbass A, Town J, Driessen E</AU>
<TI>Intensive short-term dynamic psychotherapy: a systematic review and meta-analysis of outcome research</TI>
<SO>Harvard Review of Psychiatry</SO>
<YR>2012</YR>
<VL>20</VL>
<PG>97-108</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Anderson-1995" MODIFIED="2014-05-01 20:43:43 +0100" MODIFIED_BY="Anne Lawson" NAME="Anderson 1995" TYPE="JOURNAL_ARTICLE">
<AU>Anderson E, Lambert M</AU>
<TI>Short-term dynamically oriented psychotherapy: a review and meta-analysis</TI>
<SO>Clinical Psychology Review</SO>
<YR>1995</YR>
<VL>15</VL>
<NO>6</NO>
<PG>503-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Beck-1961" MODIFIED="2014-05-01 20:44:34 +0100" MODIFIED_BY="Anne Lawson" NAME="Beck 1961" TYPE="JOURNAL_ARTICLE">
<AU>Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J</AU>
<TI>An inventory for measuring depression</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1961</YR>
<VL>4</VL>
<NO>6</NO>
<PG>561-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Blagys-2000" MODIFIED="2014-05-06 20:31:56 +0100" MODIFIED_BY="Anne Lawson" NAME="Blagys 2000" TYPE="JOURNAL_ARTICLE">
<AU>Blagys MD, Hilsenroth MJ</AU>
<TI>Distinctive activities of short-term psychodynamic-interpersonal psychotherapy: a review of the comparative psychotherapy process literature</TI>
<SO>Clinical Psychology: Science and Practice</SO>
<YR>2000</YR>
<VL>7</VL>
<PG>167-88</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chandler-2013" MODIFIED="2014-05-06 20:32:47 +0100" MODIFIED_BY="Anne Lawson" NAME="Chandler 2013" TYPE="OTHER">
<AU>Chandler J, Churchill R, Higgins J, Lasserson T, Tovey D</AU>
<TI>Methodological standards for the conduct of new Cochrane intervention reviews, 2013</TI>
<SO>www.editorial-unit.cochrane.org/sites/editorial-unit.cochrane.org/files/uploads/MECIR_conduct_standards%202.3%2002122013.pdf</SO>
<YR>(accessed 6 May 2014)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cohen-1988" MODIFIED="2014-05-01 20:49:42 +0100" MODIFIED_BY="Anne Lawson" NAME="Cohen 1988" TYPE="BOOK">
<AU>Cohen J</AU>
<SO>Statistical Power Analysis for the Behavioral Sciences</SO>
<YR>1988</YR>
<EN>2nd</EN>
<PB>Lawrence Erlbaum</PB>
<CY>Hillsdale, NJ</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cook-2010" MODIFIED="2014-05-15 12:27:52 +0100" MODIFIED_BY="Jessica Sharp" NAME="Cook 2010" TYPE="JOURNAL_ARTICLE">
<AU>Cook JM, Biyanova T, Elhai J, Schnurr PP, Coyne JC</AU>
<TI>What do psychotherapists really do in practice? An internet study of over 2000 practitioners</TI>
<SO>Psychotherapy: Theory, Research, Practice,Training</SO>
<YR>47</YR>
<PG>260-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cramer-1990" MODIFIED="2014-05-01 20:55:42 +0100" MODIFIED_BY="Anne Lawson" NAME="Cramer 1990" TYPE="JOURNAL_ARTICLE">
<AU>Cramer B, Robert-Tissot C, Stern D, Serpa-Rusconi S, De Muralt M, Besson G, et al</AU>
<TI>Outcome evaluation in brief mother-infant psychotherapy</TI>
<SO>Infant Mental Health Journal</SO>
<YR>1990</YR>
<VL>11</VL>
<PG>278-300</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Crits_x002d_Christoph-1992" MODIFIED="2014-05-01 20:55:52 +0100" MODIFIED_BY="Anne Lawson" NAME="Crits-Christoph 1992" TYPE="JOURNAL_ARTICLE">
<AU>Crits-Christoph P</AU>
<TI>The efficacy of brief dynamic psychotherapy: a meta-analysis</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1992</YR>
<VL>149</VL>
<NO>2</NO>
<PG>151-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davanloo-1980" NAME="Davanloo 1980" TYPE="BOOK">
<AU>Davanloo H</AU>
<SO>Short-Term Dynamic Psychotherapy</SO>
<YR>1980</YR>
<PB>Jason Aronson</PB>
<CY>New York, NY</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davanloo-2000" MODIFIED="2014-05-06 20:33:26 +0100" MODIFIED_BY="Anne Lawson" NAME="Davanloo 2000" TYPE="BOOK">
<AU>Davanloo H</AU>
<SO>Intensive Short-term Dynamic Psychotherapy</SO>
<YR>2000</YR>
<PB>John Wiley &amp; Sons</PB>
<CY>Chichester, UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-de-Jonghe-1994" MODIFIED="2014-05-01 20:57:18 +0100" MODIFIED_BY="Anne Lawson" NAME="de Jonghe 1994" TYPE="JOURNAL_ARTICLE">
<AU>de Jonghe F, Rijnierse P, Janssen R</AU>
<TI>Psychoanalytic supportive psychotherapy</TI>
<SO>Journal of American Psychoanalytic Association</SO>
<YR>1994</YR>
<VL>42</VL>
<PG>421-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Derogatis-1994" MODIFIED="2014-05-01 20:59:05 +0100" MODIFIED_BY="Anne Lawson" NAME="Derogatis 1994" TYPE="BOOK">
<AU>Derogatis LR</AU>
<SO>Symptom Checklist-90 - Revised: Administration, Scoring, and Procedures Manual</SO>
<YR>1994</YR>
<EN>3rd</EN>
<PB>National Computers Systems</PB>
<CY>Minneapolis, MN</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dewald-1964" MODIFIED="2014-05-01 20:59:49 +0100" MODIFIED_BY="Anne Lawson" NAME="Dewald 1964" TYPE="BOOK">
<AU>Dewald PA</AU>
<SO>A Dynamic Approach</SO>
<YR>1964</YR>
<PB>Blackwell Scientific Publications</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Diener-2007" MODIFIED="2014-05-01 21:00:25 +0100" MODIFIED_BY="Anne Lawson" NAME="Diener 2007" TYPE="JOURNAL_ARTICLE">
<AU>Diener M, Hilsenroth M, Weinberger J</AU>
<TI>Therapist affect focus and patient outcomes in psychodynamic psychotherapy: a meta-analysis</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2007</YR>
<VL>164</VL>
<PG>936-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Driessen-2010" MODIFIED="2014-05-07 17:41:18 +0100" MODIFIED_BY="Anne Lawson" NAME="Driessen 2010" TYPE="JOURNAL_ARTICLE">
<AU>Driessen E, Cuijpers P, de Maat S, Abbass A, de Jonghe F, Dekker J</AU>
<TI>The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis</TI>
<SO>Clinical Psychology Review</SO>
<YR>2010</YR>
<VL>30</VL>
<PG>25-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2014-05-06 20:34:11 +0100" MODIFIED_BY="Anne Lawson" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder CE</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-EuroQol-1990" MODIFIED="2014-05-01 21:01:51 +0100" MODIFIED_BY="Anne Lawson" NAME="EuroQol 1990" TYPE="JOURNAL_ARTICLE">
<AU>EuroQol</AU>
<TI>EuroQol - a new facility for the measurement of health related quality of life</TI>
<SO>Health Policy</SO>
<YR>1990</YR>
<VL>16</VL>
<PG>199-208</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Felitti-1998" MODIFIED="2014-05-06 20:35:11 +0100" MODIFIED_BY="Anne Lawson" NAME="Felitti 1998" TYPE="JOURNAL_ARTICLE">
<AU>Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, et al</AU>
<TI>Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study</TI>
<SO>American Journal of Preventive Medicine</SO>
<YR>1998</YR>
<VL>14</VL>
<NO>4</NO>
<PG>245-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hamilton-1959" MODIFIED="2014-05-01 21:04:28 +0100" MODIFIED_BY="Anne Lawson" NAME="Hamilton 1959" TYPE="JOURNAL_ARTICLE">
<AU>Hamilton M</AU>
<TI>The assessment of anxiety states by rating</TI>
<SO>British Journal of Medical Psychology</SO>
<YR>1959</YR>
<VL>32</VL>
<PG>50-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Henningsen-2011" MODIFIED="2014-05-07 17:42:06 +0100" MODIFIED_BY="Anne Lawson" NAME="Henningsen 2011" TYPE="BOOK_SECTION">
<AU>Henningsen P</AU>
<TI>Psychodynamic interpersonal therapy for somatoform disorders - a manualized short-term psychotherapy</TI>
<SO>In Practice of Psychodynamic Psychotherapy</SO>
<YR>2011</YR>
<ED>Beutel M, Doering S, Leichsenring F, Reich G</ED>
<PB>Hogrefe</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2013-06-11 09:01:49 +0100" MODIFIED_BY="Chris Champion" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7414</NO>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008a" MODIFIED="2014-05-01 21:07:11 +0100" MODIFIED_BY="Anne Lawson" NAME="Higgins 2008a" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008b" MODIFIED="2014-05-01 21:07:49 +0100" MODIFIED_BY="Anne Lawson" NAME="Higgins 2008b" TYPE="OTHER">
<AU>Higgins JPT, Altman DG, editors</AU>
<TI>Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hobson-1985" MODIFIED="2014-05-06 21:22:41 +0100" MODIFIED_BY="Anne Lawson" NAME="Hobson 1985" TYPE="BOOK">
<AU>Hobson RF</AU>
<SO>Forms of Feeling: the Heart of Psychotherapy</SO>
<YR>1985</YR>
<PB>Tavistock Publications</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Horowitz-1976" MODIFIED="2014-04-16 12:14:15 +0100" MODIFIED_BY="[Empty name]" NAME="Horowitz 1976" TYPE="BOOK">
<AU>Horowitz MJ</AU>
<SO>Stress Response Syndromes</SO>
<YR>1976</YR>
<PB>Aronson</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Horowitz-1984" MODIFIED="2014-05-01 21:14:10 +0100" MODIFIED_BY="Anne Lawson" NAME="Horowitz 1984" TYPE="BOOK">
<AU>Horowitz M, Marmar C, Krupnick J, Wilner N, Kaltreider N, Wallerstein R</AU>
<SO>Personality Styles and Brief Psychotherapy</SO>
<YR>1984</YR>
<PB>Basic Books</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Horowitz-1988" MODIFIED="2014-05-01 21:17:29 +0100" MODIFIED_BY="Anne Lawson" NAME="Horowitz 1988" TYPE="JOURNAL_ARTICLE">
<AU>Horowitz LM, Rosenberg SE, Baer BA, Ureno G, Villasenor VS</AU>
<TI>Inventory of interpersonal problems: psychometric properties and clinical applications</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1988</YR>
<VL>56</VL>
<PG>885-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lazar-2010" MODIFIED="2014-05-01 21:19:33 +0100" MODIFIED_BY="Anne Lawson" NAME="Lazar 2010" TYPE="BOOK">
<AU>Lazar SG</AU>
<SO>Psychotherapy is Worth it: a Comprehensive Review of its Cost-effectiveness</SO>
<YR>2010</YR>
<PB>American Psychiatric Publishing</PB>
<CY>Arlington, VA</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leichsenring-2004" NAME="Leichsenring 2004" TYPE="JOURNAL_ARTICLE">
<AU>Leichsenring F, Rabung S, Leibing E</AU>
<TI>The efficacy of short-term psychodynamic psychotherapies in specific psychiatric disorders</TI>
<SO>Archive of General Psychiatry</SO>
<YR>2004</YR>
<VL>61</VL>
<PG>1208-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leichsenring-2014" MODIFIED="2014-05-01 21:20:09 +0100" MODIFIED_BY="Anne Lawson" NAME="Leichsenring 2014" TYPE="JOURNAL_ARTICLE">
<AU>Leichsenring F, Klein S</AU>
<TI>Evidence for psychodynamic psychotherapy in specific mental disorders: a systematic review</TI>
<SO>Psychoanalytic Psychotherapy</SO>
<YR>2014</YR>
<VL>28</VL>
<NO>1</NO>
<PG>4-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lemma-2010" MODIFIED="2014-05-01 21:21:17 +0100" MODIFIED_BY="Anne Lawson" NAME="Lemma 2010" TYPE="JOURNAL_ARTICLE">
<AU>Lemma A, Target M, Fonagy P</AU>
<TI>The development of a brief psychodynamic protocol for depression: dynamic interpersonal therapy (DIT)</TI>
<SO>Psychoanalytic Psychotherapy</SO>
<YR>2010</YR>
<VL>24:4</VL>
<PG>329-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Luborsky-1984" MODIFIED="2014-05-01 21:22:41 +0100" MODIFIED_BY="Anne Lawson" NAME="Luborsky 1984" TYPE="BOOK">
<AU>Luborsky L</AU>
<SO>Principles of Psychoanalytic Psychotherapy: a Manual for Supportive-Expressive Treatment</SO>
<YR>1984</YR>
<PB>Basic Books</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Malan-1976" MODIFIED="2014-04-16 12:14:15 +0100" MODIFIED_BY="[Empty name]" NAME="Malan 1976" TYPE="BOOK">
<AU>Malan D</AU>
<SO>The Frontier of Brief Psychotherapy</SO>
<YR>1976</YR>
<PB>Plenum</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Malan-1979" MODIFIED="2013-03-11 13:05:44 +0000" MODIFIED_BY="[Empty name]" NAME="Malan 1979" TYPE="BOOK">
<AU>Malan D</AU>
<SO>Individual Psychotherapy and the Science of Psychodynamics</SO>
<YR>1979</YR>
<PB>London: Butterworth</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Malan-1986" MODIFIED="2014-05-01 21:24:09 +0100" MODIFIED_BY="Anne Lawson" NAME="Malan 1986" TYPE="JOURNAL_ARTICLE">
<AU>Malan D</AU>
<TI>Beyond interpretation: initial evaluation and technique in short-term dynamic psychotherapy</TI>
<SO>International Journal of Intensive Short-Term Dynamic Psychotherapy</SO>
<YR>1986</YR>
<VL>1</VL>
<PG>59-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Malan-1992" MODIFIED="2014-05-15 13:11:59 +0100" MODIFIED_BY="Anne Lawson" NAME="Malan 1992" TYPE="BOOK">
<AU>Malan D, Osimo F</AU>
<SO>Psychodynamics, Training, and Outcome in Brief Psychotherapy</SO>
<YR>1992</YR>
<PB>Butterworth-Heinemann</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Malhi-2009" MODIFIED="2014-05-01 21:27:27 +0100" MODIFIED_BY="Anne Lawson" NAME="Malhi 2009" TYPE="JOURNAL_ARTICLE">
<AU>Malhi GS, Adams D, Porter R, Wignall A, Lampe L, O'Connor N, et al</AU>
<TI>Clinical practice recommendations for depression</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>2009</YR>
<VL>119</VL>
<PG>8-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mann-1973" MODIFIED="2013-07-01 00:50:51 +0100" MODIFIED_BY="[Empty name]" NAME="Mann 1973" TYPE="BOOK">
<AU>Mann J</AU>
<SO>Time Limited Psychotherapy</SO>
<YR>1973</YR>
<PB>Harvard University Press</PB>
<CY>Cambridge</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McCullough-2003" MODIFIED="2014-05-01 21:28:24 +0100" MODIFIED_BY="Anne Lawson" NAME="McCullough 2003" TYPE="BOOK">
<AU>McCullough L, Kuhn N, Andrews S, Kaplan A, Wolf J, Hurley CL</AU>
<SO>Treating Affect Phobia. A Manual for Short-Term Dynamic Psychotherapy</SO>
<YR>2003</YR>
<PB>Guilford Press</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Melzack-1975" MODIFIED="2014-05-01 21:28:46 +0100" MODIFIED_BY="Anne Lawson" NAME="Melzack 1975" TYPE="JOURNAL_ARTICLE">
<AU>Melzack R</AU>
<TI>The McGill Pain Questionnaire: major properties and scoring methods</TI>
<SO>Pain</SO>
<YR>1975</YR>
<VL>1</VL>
<PG>277-99</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Messer-1995" MODIFIED="2014-05-01 21:29:16 +0100" MODIFIED_BY="Anne Lawson" NAME="Messer 1995" TYPE="BOOK">
<AU>Messer SB, Warren CS</AU>
<SO>Models of Brief Psychodynamic Therapy: a Comparative Approach</SO>
<YR>1995</YR>
<PB>Guilford</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Milrod-1997" MODIFIED="2014-04-16 12:14:15 +0100" MODIFIED_BY="[Empty name]" NAME="Milrod 1997" TYPE="BOOK">
<AU>Milrod B, Busch F, Cooper A, Shapiro T</AU>
<SO>Manual of Panic Focused Psychodynamic Psychotherapy</SO>
<YR>1997</YR>
<PB>American Psychiatric Publishing</PB>
<CY>Arlington</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Monsen-1999" MODIFIED="2014-05-01 21:29:43 +0100" MODIFIED_BY="Anne Lawson" NAME="Monsen 1999" TYPE="JOURNAL_ARTICLE">
<AU>Monsen JT, Monsen K</AU>
<TI>Affects and affect consciousness - a psychotherapy model integrating Silvan Tomkins' affect and script theory within the framework of self-psychology</TI>
<SO>Progress in Self-Psychology</SO>
<YR>1999</YR>
<VL>15</VL>
<PG>287-306</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Norcross-2013" MODIFIED="2014-05-15 12:31:12 +0100" MODIFIED_BY="Jessica Sharp" NAME="Norcross 2013" TYPE="JOURNAL_ARTICLE">
<AU>Norcross JC, Rogan JD</AU>
<TI>Psychologists conducting Psychotherapy in 2012: current practices and historical trends among Division 29 members</TI>
<SO>Psychotherapy (Chic)</SO>
<YR>2012</YR>
<VL>50</VL>
<NO>4</NO>
<PG>490-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pollack-1991" MODIFIED="2014-05-06 20:41:45 +0100" MODIFIED_BY="Anne Lawson" NAME="Pollack 1991" TYPE="BOOK_SECTION">
<AU>Pollack J, Flegenheimer W, Winston A</AU>
<TI>Brief adaptive psychotherapy</TI>
<SO>Handbook of Short-Term Dynamic Psychotherapy</SO>
<YR>1991</YR>
<PG>199-219</PG>
<ED>Crits-Christoph P, Barber J</ED>
<PB>Basic Books</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2012" MODIFIED="2014-05-01 21:31:49 +0100" MODIFIED_BY="Anne Lawson" NAME="RevMan 2012" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2012</YR>
<EN>5.2</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shedler-2010" MODIFIED="2014-05-01 21:32:10 +0100" MODIFIED_BY="Anne Lawson" NAME="Shedler 2010" TYPE="JOURNAL_ARTICLE">
<AU>Shedler J</AU>
<TI>The efficacy of psychodynamic psychotherapy</TI>
<SO>American Psychologist</SO>
<YR>2010</YR>
<VL>February-March</VL>
<PG>98-109</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sifneos-1972" MODIFIED="2013-07-01 00:52:51 +0100" MODIFIED_BY="[Empty name]" NAME="Sifneos 1972" TYPE="BOOK">
<AU>Sifneos P</AU>
<SO>Short-Term Psychotherapy and Emotional Crisis</SO>
<YR>1972</YR>
<PB>Harvard University Press</PB>
<CY>Cambridge</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stern-1995" MODIFIED="2014-04-16 12:14:15 +0100" MODIFIED_BY="[Empty name]" NAME="Stern 1995" TYPE="BOOK">
<AU>Stern D</AU>
<SO>The Motherhood Constellation</SO>
<YR>1995</YR>
<PB>Basic Books</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Strupp-1984" MODIFIED="2014-05-01 21:33:50 +0100" MODIFIED_BY="Anne Lawson" NAME="Strupp 1984" TYPE="BOOK">
<AU>Strupp HH, Binder JL</AU>
<SO>Psychotherapy in a New Key: a Guide to Time Limited Dynamic Psychotherapy</SO>
<YR>1984</YR>
<PB>Basic</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Svartberg-1991" NAME="Svartberg 1991" TYPE="JOURNAL_ARTICLE">
<AU>Svartberg M, Stiles T</AU>
<TI>Comparative effects of short-term psychodynamic psychotherapy: a meta-analysis</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1991</YR>
<VL>59</VL>
<NO>5</NO>
<PG>704-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Town-2011" MODIFIED="2014-05-01 21:35:16 +0100" MODIFIED_BY="Anne Lawson" NAME="Town 2011" TYPE="JOURNAL_ARTICLE">
<AU>Town J, Abbass A, Hardy G</AU>
<TI>Short-term psychodynamic psychotherapy for personality disorders: a critical review of randomised controlled trials</TI>
<SO>Journal of Personality Disorders</SO>
<YR>2011</YR>
<VL>26</VL>
<NO>6</NO>
<PG>723-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Town-2012" MODIFIED="2014-05-01 21:37:25 +0100" MODIFIED_BY="Anne Lawson" NAME="Town 2012" TYPE="JOURNAL_ARTICLE">
<AU>Town JM, Diener MJ, Abbass A, Leichsenring F, Driessen E, Rabung S</AU>
<TI>A meta-analysis of psychodynamic psychotherapy outcomes: evaluating the effects of research-specific procedures</TI>
<SO>Psychotherapy</SO>
<YR>2012</YR>
<VL>49</VL>
<NO>3</NO>
<PG>276-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Town-2013" MODIFIED="2014-05-16 11:06:08 +0100" MODIFIED_BY="Jessica Sharp" NAME="Town 2013" TYPE="JOURNAL_ARTICLE">
<AU>Town JM, Driessen E</AU>
<TI>Emerging evidence for intensive short-term dynamic psychotherapy with personality disorders and somatic disorders</TI>
<SO>Psychiatric Annals</SO>
<YR>2013</YR>
<VL>43</VL>
<NO>11</NO>
<PG>502-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ulvenes-2012" MODIFIED="2014-05-01 21:37:57 +0100" MODIFIED_BY="Anne Lawson" NAME="Ulvenes 2012" TYPE="JOURNAL_ARTICLE">
<AU>Ulvenes PG, Berggraf L, Hoffart A, Stiles TC, Svartberg M, McCullough L, et al</AU>
<TI>Different processes for different therapies: therapist actions, therapeutic bond, and outcome</TI>
<SO>Psychotherapy</SO>
<YR>2012</YR>
<VL>49</VL>
<PG>291-302</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weissman-1978" MODIFIED="2014-05-01 21:38:13 +0100" MODIFIED_BY="Anne Lawson" NAME="Weissman 1978" TYPE="JOURNAL_ARTICLE">
<AU>Weissman MM, Prusoff BA, Thompson DW, Harding PS, Myers JK</AU>
<TI>Social adjustment by self-report in a community sample and in psychiatric outpatients</TI>
<SO>Journal of Nervous and Mental Disease</SO>
<YR>1978</YR>
<VL>166</VL>
<PG>317-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Werman-1984" MODIFIED="2014-05-06 21:14:45 +0100" MODIFIED_BY="Anne Lawson" NAME="Werman 1984" TYPE="BOOK">
<AU>Werman DS</AU>
<SO>The Practice of Supportive Psychotherapy</SO>
<YR>1984</YR>
<PB>Brunner/Mazel</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wittchen-2011" MODIFIED="2014-05-01 21:38:51 +0100" MODIFIED_BY="Anne Lawson" NAME="Wittchen 2011" TYPE="JOURNAL_ARTICLE">
<AU>Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, et al</AU>
<TI>The size and burden of mental disorders and other disorders of the brain in Europe 2010</TI>
<SO>European Neuropsychopharmacology</SO>
<YR>2011</YR>
<VL>21</VL>
<PG>655-79</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2014-05-15 16:33:48 +0100" MODIFIED_BY="Anne Lawson">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2014-05-15 13:06:00 +0100" MODIFIED_BY="Anne Lawson" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2014-05-06 22:12:32 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Abbass-2008">
<CHAR_METHODS MODIFIED="2014-05-06 09:16:08 +0100" MODIFIED_BY="Anne Lawson">
<P>Multicentre RCT of 2 parallel conditions</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 14:31:58 +0100" MODIFIED_BY="Anne Lawson">
<P>27 participants referred from physicians or mental health professionals</P>
<P>Inclusion criteria: aged 18-70 years, &#8805; 1 DSM IV Personality Disorder. People with co-morbid non-psychotic symptom disorders were acceptable</P>
<P>Exclusion criteria: psychosis, organic brain syndrome, mental retardation, current substance dependence, acute suicidal behaviour, violent behaviour, no new psychotropic medication in the previous 3 months</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 22:12:32 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: intensive STDP, manualised, based on <LINK REF="REF-Davanloo-2000" TYPE="REFERENCE">Davanloo 2000</LINK>
<BR/>Control: minimal contact wait-list (mean duration 14.8 weeks)<BR/>5 therapists with over 5 years training and experience in ISTDP. Mean number of sessions 27.7. All sessions videotaped, adherence rated through sampling of videotapes using adherence rating scale<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 14:11:51 +0100" MODIFIED_BY="Anne Lawson">
<P>BSI, IIP, GAF Symptoms and Social Occupational, medication use and cost, work hours and function, all measured at pre therapy, post therapy, and at 1 and 2 year follow-up<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-26 13:51:40 +0100" MODIFIED_BY="Jessica Sharp"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-15 12:56:43 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Alstrom-1984a">
<CHAR_METHODS MODIFIED="2014-05-06 09:19:49 +0100" MODIFIED_BY="Anne Lawson">
<P>Single-centre RCT, between 1973 and 1979, parallel design with 4 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 21:27:58 +0100" MODIFIED_BY="Anne Lawson">
<P>Inclusion criteria: 18-60 years old, sought help for social phobia at outpatient services</P>
<P>Exclusion criteria: any form of continuous treatment for the previous 6 months; drug abuse; dementia; neurological signs of brain damage; symptoms of endogenous depression, schizophrenia, obsessive-compulsive neurosis or mental retardation; poor knowledge of Swedish language. Study included 42 social phobic men and women. They were all assessed as not suitable for insight-oriented psychotherapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-15 12:56:43 +0100" MODIFIED_BY="Anne Lawson">
<P>Common to each group - psychoeducation, information on prolonged exposure in vivo, encouragement to participate in anxiety-provoking situations. Participants could continue to take medications<BR/>Control: basal therapy - included the above, and meetings once a month for 20-30 min</P>
<P>Intervention 1: behavioural therapy (prolonged exposure in vivo)</P>
<P>Intervention 2: relaxation therapy</P>
<P>Intervention 3: psychodynamically oriented supportive therapy, based on <LINK REF="REF-Dewald-1964" TYPE="REFERENCE">Dewald 1964</LINK>, 30-min appointments once/week for 3 months (~ 12 appointments). No mention of manual for therapy, measures of therapist adherence</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 13:52:37 +0100" MODIFIED_BY="Anne Lawson">
<P>Measured pre-treatment, end (post-) treatment, and 9 months follow-up<BR/>Measures were scales constructed by the study authors to measure indirect manifestations of anxiety (target phobia, other phobias, OCD symptom), direct manifestations of anxiety, ego-restriction and social functions, and a global rating. In addition, intellectual ability was measured with the Synonyms Reasoning Block test, personality with the Eysenck Personality Inventory, and the Cesarec-Marke Personality Schedule. Therapist rated measures</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 09:22:50 +0100" MODIFIED_BY="Anne Lawson">
<P>Free anxiety measures and global symptom data used</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-15 12:57:03 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Alstrom-1984b">
<CHAR_METHODS MODIFIED="2014-05-06 09:23:39 +0100" MODIFIED_BY="Anne Lawson">
<P>Single-centre RCT, between 1973 and 1979, parallel design with 4 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 09:24:11 +0100" MODIFIED_BY="Anne Lawson">
<P>Inclusion criteria: 18-60 years old, sought help for agoraphobic syndromes at outpatient services</P>
<P>Exclusion criteria: any form of continuous treatment for the previous 6 months; drug abuse; dementia; neurological signs of brain damage; symptoms of endogenous depression, schizophrenia, obsessive-compulsive neurosis or mental retardation; poor knowledge of Swedish language. Study included 73 agoraphobic women. They were all assessed as not suitable for insight-oriented psychotherapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-15 12:57:03 +0100" MODIFIED_BY="Anne Lawson">
<P>Common to each group - psychoeducation, information on prolonged exposure in vivo, encouragement to participate in anxiety-provoking situations. Participants could continue to take medications<BR/>Control: basal therapy - included the above, and meetings once a month for 20-30 min</P>
<P>Intervention 1: behavioural therapy (prolonged exposure in vivo)</P>
<P>Intervention 2: relaxation therapy</P>
<P>Intervention 3: psychodynamically oriented supportive therapy, based on <LINK REF="REF-Dewald-1964" TYPE="REFERENCE">Dewald 1964</LINK>, 30-min appointments once/week for 3 months (~ 12 appointments). No mention of manual for therapy, measures of therapist adherence</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 13:52:41 +0100" MODIFIED_BY="Anne Lawson">
<P>Measured pre-treatment, end (post-) treatment, and 9 months follow-up<BR/>Measures were scales constructed by the authors to measure indirect manifestations of anxiety (target phobia, other phobias, OCD symptom), interpersonal relations, direct manifestations of anxiety, ego-restriction and social functions, and a global rating. In addition, intellectual ability was measured with the Synonyms Reasoning Block test, personality with the Eysenck Personality Inventory, and the Cesarec-Marke Personality Schedule. Therapist rated measures. Global scale and free anxiety measures were used in this review</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-08 10:07:46 +0100" MODIFIED_BY="Anne Lawson">
<P>Both <LINK REF="STD-Alstrom-1984a" TYPE="STUDY">Alstrom 1984a</LINK> and <LINK REF="STD-Alstrom-1984b" TYPE="STUDY">Alstrom 1984b</LINK> in this review used the same methods<BR/>Free anxiety measures, interpersonal relations and global symptom data used.<BR/>Could not use 9-month follow-up data as more than 20% of sample lost to follow-up</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 14:45:48 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Baldoni-1995">
<CHAR_METHODS MODIFIED="2014-05-06 14:21:15 +0100" MODIFIED_BY="Anne Lawson">
<P>Single-centre RCT, 2-year study, parallel design</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 09:29:50 +0100" MODIFIED_BY="Anne Lawson">
<P>36 women with urethral syndrome (urinary symptoms and pain without organic lesions) aged 18-63 years (mean 40). All complained of urgency, dysuria and tenesmus at the first evaluation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 14:45:37 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: STDP (<LINK REF="REF-Davanloo-1980" TYPE="REFERENCE">Davanloo 1980</LINK>; <LINK REF="REF-Malan-1979" TYPE="REFERENCE">Malan 1979</LINK>). The psychotherapy consisted of 12-16 weekly sessions lasting 1 hr conducted by a single psychotherapist</P>
<P>Control: "traditional urological treatment", which included medical therapy (anticholinergic and alpha-adrenoceptor antagonist drugs) and urethral dilation</P>
<P>Both groups had 3-4 months of therapy for a mean of 14 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 14:45:47 +0100" MODIFIED_BY="Anne Lawson">
<P>Pre-, 6 months post-, 4 years post-treatment. Presence and nature of urinary disorders such as urgency, dysuria, tenesmus; number of day and night micturitions; pain in the pelvic area and its features; the Symptom Questionnaire, which can discriminate between psychiatric patients and others and between various psychological discomfort levels by assessing anxiety, depression, somatic symptoms and hostility. Continuous data from Symptom Questionnaire used as obtained from authors</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 13:53:39 +0100" MODIFIED_BY="Anne Lawson">
<P>4 participants allocated to STDP group were given antidepressant pharmacotherapy (a combination of amitriptyline and mianserin) but 2 stopped treatment before completion and are not considered in the results<BR/>Data obtained from authors in form of means, standard deviations for outcomes of interest: anxiety, depression and somatic symptoms of Symptom Questionnaire<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-15 12:48:11 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Bressi-2010">
<CHAR_METHODS MODIFIED="2014-05-06 09:37:12 +0100" MODIFIED_BY="Anne Lawson">
<P>Single-centre RCT, 1-year study, parallel design</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-15 12:48:11 +0100" MODIFIED_BY="Anne Lawson">
<P>30 participants were each randomised to receive STPP or TAU</P>
<P>Inclusion criteria: 18-60 years old with a main diagnosis of an anxiety disorder or depressive disorder; participants were not to have been on psychotropic medication for a period of at least 2 weeks (4 weeks for monoamine oxidase inhibitors).</P>
<P>Exclusion criteria: mental retardation; history of organic mental disorders, schizophrenia, bipolar disorders or substance use; severe axis II personality disorder; currently undergoing treatment. An independent interview confirmed DSM IV - TR diagnoses using the SCID</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 14:46:13 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: STPP derived from <LINK REF="REF-Malan-1976" TYPE="REFERENCE">Malan 1976</LINK> and <LINK REF="REF-Malan-1992" TYPE="REFERENCE">Malan 1992</LINK> based on a 40-session treatment plan. Therapists were 4 psychiatrists with experience (12.3 mean years) in STPP. Therapists received weekly individual and group supervision and were given verbatim transcripts of sessions. Adherence was rated and additional supervision provided when STPP techniques were not being applied. Treatment sessions were audio-recorded. Concomitant psychotropic medication was only allowed for the first 3 weeks of the study</P>
<P>Control: TAU consisted of routine psychiatric treatment: drug treatment (selective serotonin reuptake inhibitors/serotonin noradrenaline (norepinephrine) reuptake inhibitors) and ongoing clinical interviews with a minimum of 1 session per month of and a maximum of 4 sessions a month for 40 weeks. Interviews monitored drug treatment (compliance, side effects, dose adjustment) and general clinical state</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 13:29:20 +0100" MODIFIED_BY="Anne Lawson">
<P>Primary outcome measures included the Clinical Global Impression Scale, the SCL-90-R, and the SCL-90-GSI. The IIP was included as a measure of interpersonal functioning. Measures were completed at recruitment and 12-months post admission</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 13:28:01 +0100" MODIFIED_BY="Anne Lawson">
<P>IIP, SCL-90-GSI, anxiety and depression subscales used in analyses</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 22:12:33 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Brom-1989">
<CHAR_METHODS MODIFIED="2014-05-06 09:43:04 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT with 4 parallel conditions</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 14:26:44 +0100" MODIFIED_BY="Anne Lawson">
<P>112 participants diagnosed with PTSD with DSM-III criteria, with the condition that not more than 5 years had elapsed since the incurring event. Recruited through a general assessment with 1 of the study authors, and a further interview to ensure the participant could cope with a confronting therapy. Aged 18-73 years (mean 42.0), 79% were women, 21% were men</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 22:12:33 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention 1: trauma desensitisation (mean length of treatment 15.0 sessions)</P>
<P>Intervention 2: hypnotherapy (mean 14.4 sessions)</P>
<P>Intervention 3: brief psychodynamic therapy (mean length 18.8 sessions) based on <LINK REF="REF-Horowitz-1976" TYPE="REFERENCE">Horowitz 1976</LINK>
</P>
<P>Control: wait-list group (4 months long)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 09:45:02 +0100" MODIFIED_BY="Anne Lawson">
<P>Pre-, post- and 3 months post-treatment. SCL-90, with 5 subscales; STAI; State-Trait Anger Inventory; Dutch Personality Questionnaire; Introversion-Extroversion scale of the Amsterdam Biographical Questionnaire; scale for internal vs. external control<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 09:45:22 +0100" MODIFIED_BY="Anne Lawson">
<P>SCL-90 total score and STAI data used in the review<BR/>Unable to use personality data as it was reported only into subscales</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-15 12:57:58 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Burnand-2002">
<CHAR_METHODS MODIFIED="2014-05-06 09:46:27 +0100" MODIFIED_BY="Anne Lawson">
<P>10-week, single-centre RCT, with 2 parallel arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 14:26:46 +0100" MODIFIED_BY="Anne Lawson">
<P>From 110 eligible participants, 95 were randomised to either the experimental or control group. Consecutively referred from acute outpatient clinic, aged 20-65 years</P>
<P>Inclusion criteria: diagnosis of MMD confirmed using the SCID, with HDRS score &gt; 20</P>
<P>Exclusion criteria: bipolar disorder, psychotic symptoms, severe substance dependence, organic disorder, intolerance to clomipramine</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-15 12:57:58 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: Intensive nursing care plus 10 sessions of STPP provided by experienced nurses.</P>
<P>Control: Intensive nursing plus clomipramine plus supportive care including individual sessions aimed at providing empathic listening, guidance, support, and facilitation of an alliance by one carefully designated caregiver.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 09:47:58 +0100" MODIFIED_BY="Anne Lawson">
<P>Depression severity was measured at intake and termination using the SCID, HRSD and the Health Sickness Rating Scale. Outcome data were also collected on the GAS and hospital days and sick days were independently recorded</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 09:48:13 +0100" MODIFIED_BY="Anne Lawson">
<P>GAS total score and HAM-D rating used in this review. GAS scores required reversing for analysis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 22:12:37 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Carrington-1979">
<CHAR_METHODS MODIFIED="2014-05-06 22:12:35 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT of STPP (<LINK REF="REF-Mann-1973" TYPE="REFERENCE">Mann 1973</LINK>) versus cognitive therapy and wait-list controls</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 09:50:08 +0100" MODIFIED_BY="Anne Lawson">
<P>Inclusion criteria: African-American women with depression (Feighner Criteria), BDI of 20-40, aged 20-50 years</P>
<P>Exclusion criteria: hallucinations or delusions, substance addiction and antisocial personality</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 22:12:37 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: STPP 12 x 50-min sessions according to Mann's time-limited model (<LINK REF="REF-Mann-1973" TYPE="REFERENCE">Mann 1973</LINK>)</P>
<P>Control: wait-list</P>
<P>Psychotherapy provided by doctoral level graduate psychology students with variable but relatively little experience</P>
<P>Supervision was provided in groups</P>
<P>Treatment adherence rated from audiotapes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 14:24:39 +0100" MODIFIED_BY="Anne Lawson">
<P>Self report ratings were used including the BDI, Beck Hopelessness Scale. VAS</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 09:50:55 +0100" MODIFIED_BY="Anne Lawson">
<P>BDI used as primary depression measure</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 22:45:01 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Cooper-2003">
<CHAR_METHODS MODIFIED="2014-05-06 09:51:34 +0100" MODIFIED_BY="Anne Lawson">
<P>Single-centre RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 21:34:38 +0100" MODIFIED_BY="Anne Lawson">
<P>Large consecutive series of 3222 primiparous women identified through birth records of Addenbrooke's Hospital, Cambridge, UK, screened between January 1990 and August 1992 for mood disturbance in the early post-partum period, using postal administration of EPDS. EPDS score of &#8805; 12 assessed; women with PPD invited to take part</P>
<P>Inclusion criteria: 15-mile radius to hospital, English as first language</P>
<P>Exclusion: delivered prematurely, if infant had any gross congenital abnormality, if they did not have a singleton birth or were intending to move out of the area during the study period</P>
<P>206 women identified; 193 agreed to take part</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 14:50:31 +0100" MODIFIED_BY="Anne Lawson">
<P>Women assigned to 1 of 4 conditions</P>
<P>Intervention 1: CBT </P>
<P>Intervention 2: psychodynamic therapy (as described by <LINK REF="REF-Cramer-1990" TYPE="REFERENCE">Cramer 1990</LINK>; <LINK REF="REF-Stern-1995" TYPE="REFERENCE">Stern 1995</LINK>)</P>
<P>Intervention 3: non-directive counselling</P>
<P>Control: "routine primary care"<BR/>Therapy was conducted in women's homes on a weekly basis from 8 to 18 weeks post-partum<BR/>There were 6 study therapists: specialist in each of the 3 research treatments and 3 non-specialists<BR/>A Therapist Rating Scale was administered to participant to measure adherence to treatment</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 22:45:01 +0100" MODIFIED_BY="Anne Lawson">
<P>Follow-up at 4.5, 9 and 18 months. 5-year follow-up for women who had completed therapy<BR/>Symptoms of depression, as measured using the EPDS. Also, measures of infant-mother attachment and behaviour</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 09:55:45 +0100" MODIFIED_BY="Anne Lawson">
<P>Primary care condition used as minimal treatment control<BR/>EPDS data used in depression outcome of review<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-15 12:58:26 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Creed-2003">
<CHAR_METHODS MODIFIED="2014-05-06 14:50:40 +0100" MODIFIED_BY="Anne Lawson">
<P>Multicentre RCT with 3 parallel conditions. Participants were stratified by hospital and severity</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 09:57:41 +0100" MODIFIED_BY="Anne Lawson">
<P>257 adults with severe IBS recruited from gastroenterology clinics</P>
<P>Inclusion criteria: Rome I criteria for IBS satisfied, IBS symptoms &gt; 6 months, failure to respond to usual medical treatment for &#8805; 3 months, severe abdominal pain, no contraindications to psychotherapy or paroxetine, ability to complete questionnaires, aged 18-65 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-15 12:58:26 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention 1: PIT based on <LINK REF="REF-Hobson-1985" TYPE="REFERENCE">Hobson 1985</LINK>, manualised, for 1 long, 2-hr session, and 7, 45-min sessions over 3 months</P>
<P>Intervention 2: paroxetine 20 mg orally each day for 3 months<BR/>Control: 'TAU', continuing to see gastroenterologist or GP for duration of study<BR/>For the psychotherapy or paroxetine groups, after 3 months they returned to GP to decide on further management</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-07 17:19:19 +0100" MODIFIED_BY="Anne Lawson">
<P>Trial entry, 3 months, 1-year post-treatment. IBS symptoms - VAS of severity of abdominal pain, record of days of pain, change in symptoms. SF-36 (health related quality of life), GSI of SCL-90, healthcare costs, utilisation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 09:59:30 +0100" MODIFIED_BY="Anne Lawson">
<P>VAS scale data for abdominal pain used for somatic symptoms<BR/>SCL-90 score data used for general psychiatric symptom measures in long-term follow-up comparison; 20% of sample lost in the 3-month follow-up assessment</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 21:35:58 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Dare-2001">
<CHAR_METHODS MODIFIED="2014-05-06 14:53:00 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT of 3 forms of therapy vs. routine care for anorexia nervosa</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 14:26:55 +0100" MODIFIED_BY="Anne Lawson">
<P>84 participants with DSM-IV anorexia nervosa</P>
<P>Exclusion criteria: people with severe low weight, severe health consequences or suicidality</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 14:53:34 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention 1: 1 year of focal analytic therapy (derived from <LINK REF="REF-Malan-1976" TYPE="REFERENCE">Malan 1976</LINK>) (mean 24.9 sessions)</P>
<P>Intervention 2: 7 months of cognitive analytic therapy (mean 12.9 sessions)</P>
<P>Intervention 3: 1 year of family therapy</P>
<P>Control: routine care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 21:35:58 +0100" MODIFIED_BY="Anne Lawson">
<P>Primary outcome measure was body weight measured as body mass index. Morgan-Russell Assessment Schedule for anorexia nervosa</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 10:01:41 +0100" MODIFIED_BY="Anne Lawson">
<P>Both individual psychotherapies were methods of STPP</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 21:36:17 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-de-Jonghe-2001">
<CHAR_METHODS MODIFIED="2014-05-06 10:02:27 +0100" MODIFIED_BY="Anne Lawson">
<P>Single-centre RCT with 2 parallel arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 21:36:17 +0100" MODIFIED_BY="Anne Lawson">
<P>Consecutive newly registered psychiatric clinic outpatients</P>
<P>Inclusion criteria: aged 18-60 years, DSM-III-R major depression, HDRS baseline score of at least 14 points and informed consent</P>
<P>Exclusion criteria: presence of psycho-organic disorder, drug abuse, psychotic disorder, with or without dissociative disorder; communication barrier; participant was not considered 'reliable' enough to participate; participation was physically impossible; contraindication for 1 of the antidepressants in the trial; adequate pharmacotherapy treatment for the current major depressive episode; pregnancy</P>
<P>167 people were randomised to each arm, but 38 refused after randomisation. 129 participants started the trial</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 21:14:45 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: combined treatment arm with psychotherapy and pharmacotherapy for 24 weeks. Psychotherapy was SPSP, based on <LINK REF="REF-Werman-1984" TYPE="REFERENCE">Werman 1984</LINK> or <LINK REF="REF-de-Jonghe-1994" TYPE="REFERENCE">de Jonghe 1994</LINK>; 18 sessions of 45 min, the first 8 weekly and the last 8 biweekly, performed by 6 psychotherapists who were not the psychiatrists providing medication; all psychotherapists had at least 5 years of experience in psychoanalytic supportive therapy. The therapy was manualised (by the study authors) and there were weekly sessions to assess adherence to therapy. The pharmacotherapy was a stepwise approach in which participants where in the case of intolerance or inefficacy the treatment was changed from fluoxetine, to amitriptyline, then moclobemide</P>
<P>Control: pharmacotherapy alone for 24 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 14:27:18 +0100" MODIFIED_BY="Anne Lawson">
<P>Measures were the HDRS, the SCL-90 Depression scale, the CGI Improvement and Severity scales, and the QLDS. These were measured at pre- and post-treatment. Remission rates were also measured at 8, 16 and 24 weeks. The study used ITT data (including participants who refused treatment after randomisation), completers only data, and a per-protocol set (all participants who started with the treatment to which they were allocated)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 10:07:29 +0100" MODIFIED_BY="Anne Lawson">
<P>HDRS Depression score and QLDS data used in short-term measures of ITT sample. CGI-Severity data only available for per-protocol sample and risk of attrition bias noted</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 22:12:39 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Emmelkamp-2006">
<CHAR_METHODS MODIFIED="2014-05-06 22:12:38 +0100" MODIFIED_BY="Anne Lawson">
<P>Single-centre RCT with 2 parallel conditions and a wait-list control</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 14:27:21 +0100" MODIFIED_BY="Anne Lawson">
<P>62 participants with a avoidant personality disorder, aged 23-65 years</P>
<P>Exclusion criteria: avoidant personality disorder not the primary diagnosis, history of psychotic disorder, high risk of suicide, undergoing psychotherapy treatment or in receipt of therapy in previous 3 years, unable to complete questionnaires</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 22:12:39 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: treatment involved 20 scheduled sessions over a 6-month period. Both active therapies were manual guided, treatment adherence was monitored and rated using audiotapes. BDT directed at defence and affect restructuring using interventions based on <LINK REF="REF-Malan-1976" TYPE="REFERENCE">Malan 1976</LINK>; <LINK REF="REF-Malan-1979" TYPE="REFERENCE">Malan 1979</LINK>; and in some cases incorporating supportive interventions informed by <LINK REF="REF-Luborsky-1984" TYPE="REFERENCE">Luborsky 1984</LINK> and others</P>
<P>Control: wait-list control group received no treatment between pre-assessment and follow-up 20 weeks later</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 14:27:23 +0100" MODIFIED_BY="Anne Lawson">
<P>Assessment measures conducted pre-treatment, immediately post-treatment and 6 months' follow-up. This involved an independent evaluation of personality disorder diagnosis and participant self report measures tapping personality disordered beliefs, avoidant personality traits, anxiety symptoms, social phobia and avoidant behaviours</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-26 14:11:48 +0100" MODIFIED_BY="[Empty name]">
<P>LWASQ used for measure of anxiety</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-15 12:59:01 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Guthrie-1993">
<CHAR_METHODS MODIFIED="2014-05-06 10:23:18 +0100" MODIFIED_BY="Anne Lawson">
<P>12-week, single-centre RCT with 2 parallel conditions</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 14:27:28 +0100" MODIFIED_BY="Anne Lawson">
<P>102 participants who had been diagnosed with IBS and had been experiencing symptoms for &gt; 1 year, and who had been treated for a minimum of 6 months with no improvement on bulking agents, antispasmodic therapy, or both</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-15 12:59:01 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: dynamic psychotherapy based on the conversational model of <LINK REF="REF-Hobson-1985" TYPE="REFERENCE">Hobson 1985</LINK> consisting of 1 long 2-hr session, and 6 follow-up sessions or a control group at attended on 3 occasions (2, 4 and 8 weeks) to discuss their daily bowel habits</P>
<P>Control: standard care</P>
<P>All participants continued standard medical treatment in the gastroenterology clinic</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 10:24:35 +0100" MODIFIED_BY="Anne Lawson">
<P>Pre-, post- 12-week trial. BDI, Symptoms Rating Test, PAS (a modified PSE)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 22:48:11 +0100" MODIFIED_BY="Anne Lawson">
<P>Same trial as Guthrie (1991) but further data analysis and later follow-up<BR/>BDI score used at end-treatment<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 22:49:29 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Guthrie-1999">
<CHAR_METHODS MODIFIED="2014-05-06 10:26:44 +0100" MODIFIED_BY="Anne Lawson">
<P>2 year, multicentre RCT with 2 parallel conditions</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 14:27:30 +0100" MODIFIED_BY="Anne Lawson">
<P>110 participants referred from consultant psychiatrists who had received treatment for &gt; 6 months</P>
<P>Inclusion criteria: aged 18-65 years with no improvement in psychological symptoms while in psychiatric treatment</P>
<P>Exclusion criteria: schizophrenia, dementia, brain damage, learning difficulties and limited command of English</P>
<P>69 were female and the mean age was 41.4 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 21:22:41 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: psychodynamic-interpersonal therapy, manualised, based on <LINK REF="REF-Hobson-1985" TYPE="REFERENCE">Hobson 1985</LINK> for 8 sessions</P>
<P>Control: 'TAU' under the care of their consultant psychiatrist</P>
<P>Adherence was checked through supervision, audiotapes and used of the SPRS</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 22:49:29 +0100" MODIFIED_BY="Anne Lawson">
<P>Pre-, post- and 6 months follow-up<BR/>GSI of SCL-90-R, SF-36 (health status), Euro-Qol5D (quality of life), all self rated. Direct treatment costs, non-treatment costs, indirect costs</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 13:28:37 +0100" MODIFIED_BY="Anne Lawson">
<P>SCL-90-GSI and Depression subscale data used; could not use 6-month follow-up data as dropout rate was &gt; 20%<BR/>SF-36 only presented as subscales, no overall measures to use; however, Social Functioning and Pain scale included; Euro-QoL5D data not presented in a form to be useable in review</P>
<P>SF-36 data required reversing for analysis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 21:59:45 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Guthrie-2001">
<CHAR_METHODS MODIFIED="2014-05-06 10:32:19 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT with 2 parallel treatment conditions</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 14:27:37 +0100" MODIFIED_BY="Anne Lawson">
<P>119 participants presenting to the emergency department with an episode of deliberate self poisoning, aged 18-65 years, able to read and write English, live within the catchment area of the hospital, registered with a GP, not need inpatient psychiatric treatment</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 21:59:45 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: PIT, manualised, based on <LINK REF="REF-Hobson-1985" TYPE="REFERENCE">Hobson 1985</LINK>, 4 sessions within 1 week of presentation, 50-min long, in the participant's home</P>
<P>Control: 'TAU' - often consists of assessment by emergency department doctor or junior psychiatrist, one-third referred for outpatient psychiatric treatment, some to addiction services, the remainder to GPs</P>
<P>Adherence to treatment through weekly supervision, audiotaping, rating by SPRS</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 10:34:29 +0100" MODIFIED_BY="Anne Lawson">
<P>Entry, 1 month, 6 months. Beck Scale for Suicidal Ideation, detailed description of episodes of self harm, healthcare utilisation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 10:34:41 +0100" MODIFIED_BY="Anne Lawson">
<P>BDI data at 6-month follow-up used; &gt; 20% loss to follow-up in data at end of treatment</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 21:22:41 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Hamilton-2000">
<CHAR_METHODS MODIFIED="2014-05-06 10:37:32 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT with 2 parallel treatment conditions</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 14:27:48 +0100" MODIFIED_BY="Anne Lawson">
<P>71 participants fulfilling criteria for functional dyspepsia, having continuous symptoms for 6 months, had been unresponsive to at least 2 medical treatments</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 21:22:41 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: psychodynamic-interpersonal therapy, based on <LINK REF="REF-Hobson-1985" TYPE="REFERENCE">Hobson 1985</LINK>, manualised, 1 x 3-hr session and 6 x 50-min sessions</P>
<P>Control: supportive therapy, with session length and number identical to psychodynamic-interpersonal therapy</P>
<P>Adherence to therapy by therapists was measured through SPRS rating of audiotapes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 10:39:08 +0100" MODIFIED_BY="Anne Lawson">
<P>Entry, end of 12-week intervention, 12-month follow-up. Self rating of dyspeptic symptoms, gastroenterological rating of dyspeptic symptoms, SCL-90-R and GSI, healthcare use (gastroenterology clinic visits, medications, inpatient stays, procedures)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 14:27:51 +0100" MODIFIED_BY="Anne Lawson">
<P>Participants with reflux were included in the study, but a subanalysis was performed excluding them<BR/>Data used for somatic symptoms and SCL-90 scores at end of treatment. More than 20% of participants were lost to follow-up, so 1-year follow-up data were not used</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-15 12:55:21 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Levy-Berg-2009">
<CHAR_METHODS MODIFIED="2014-05-06 10:41:22 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT with 2 parallel conditions</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 22:51:01 +0100" MODIFIED_BY="Anne Lawson">
<P>Consecutively recruited participants from Swedish outpatient clinics meeting DSM-IV diagnostic criteria for generalised anxiety disorder</P>
<P>Exclusion criteria: participants with major depression excluded</P>
<P>Total participant group was 61, 80% with at least 1 personality disorder</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 14:59:34 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: affect-focused body psychotherapy: manualised treatment (<LINK REF="STD-Monsen-2000" TYPE="STUDY">Monsen 2000</LINK>) provided once weekly for 1 year. Described as an integration of bodily techniques and the exploration of affects within a psychodynamic frame of reference. Treatment quality and adherence monitored through regular supervision. 7/38 participants treated continued in therapy after 1 year. 11/28 received psychotherapy, 6 of whom continued in treatment after 1 year</P>
<P>Control: TAU: at the discretion of the treating psychiatric clinic</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 10:44:08 +0100" MODIFIED_BY="Anne Lawson">
<P>Outcome measures collected at baseline and about 1 and 2 years after the beginning of treatment. Outcome measures used included SCL-90, BAI, WHO Well-being Index, SCID screen questionnaire</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-15 12:55:21 +0100" MODIFIED_BY="Anne Lawson">
<P>Data from BAI and SCL-90-GSI score - anxiety items used in the review</P>
<P>7 participants in the STPP group received further treatment a year after the start of therapy, therefore measures at two years after start of therapy not used.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-15 12:55:59 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Linnet-2001">
<CHAR_METHODS MODIFIED="2014-05-06 10:50:06 +0100" MODIFIED_BY="Anne Lawson">
<P>Single-centre RCT with 2 parallel conditions</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-15 12:55:59 +0100" MODIFIED_BY="Anne Lawson">
<P>32 adults (23 women, 9 men) with atopic dermatitis. Aged 18-60 years (mean 28.3), diagnosed with mild to moderate atopic dermatitis by a dermatologist, with no other somatic or psychiatric disease</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 14:59:53 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: psychodynamic psychotherapy, based on <LINK REF="REF-Malan-1979" TYPE="REFERENCE">Malan 1979</LINK>, for 11-18 sessions (mean 15.5) over 6 months</P>
<P>Control: no treatment</P>
<P>Both groups were instructed to continue their dermatological treatment and keep it as stable as possible</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 10:52:31 +0100" MODIFIED_BY="Anne Lawson">
<P>STAI, SCORAD at entry, 6 months (end-treatment), 12 months (6 months post-treatment)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 10:52:50 +0100" MODIFIED_BY="Anne Lawson">
<P>SCORAD and STAI data scores used in review</P>
<P>Loss of &gt; 20% at 12-month follow-up, so these data were not used in the review</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-15 13:00:18 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Maina-2005">
<CHAR_METHODS MODIFIED="2014-05-06 10:54:13 +0100" MODIFIED_BY="Anne Lawson">
<P>Single-centre RCT with 3 parallel arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 22:12:44 +0100" MODIFIED_BY="Anne Lawson">
<P>30 participants recruited from the wait-list for BDT at the Mood and Anxiety Disorders unit, Department of Neuroscience of the University of Turin, Italy. Inclusion criteria: BDT wait-list: participant request for psychotherapeutic approach; presence of a focal problem, a recent precipitant life event or both; aged 18-60 years</P>
<P>Exclusion criteria: evidence of mental retardation, organic mental disorders, psychotic disorders, bipolar disorders, substance abuse, severe axis II pathology</P>
<P>Inclusion for study: dysthymic disorder, minor depressive disorder or adjustment disorder with depressed mood; CGI-S score &gt; 2</P>
<P>Exclusion: current suicidal ideation, current pharmacological treatment, evidence of severe or unstable or active neurological or physical diseases, and on the wait-list for &gt; 1 month</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-15 13:00:18 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention 1: STPP based on <LINK REF="REF-Malan-1976" TYPE="REFERENCE">Malan 1976</LINK>, 15-30 sessions (mean 19.6) for 45 min, provided by psychiatrists with personal training in psychodynamic psychotherapy. Case notes reviewed by experienced BDT therapist for supervised treatment adherence</P>
<P>Intervention 2: brief supportive therapy </P>
<P>Control: wait-list where they were contacted weekly by telephone</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 22:12:52 +0100" MODIFIED_BY="Anne Lawson">
<P>HAM-D, HAM-A, CGI-I, CGI-S. Intake, post-treatment, 6-month follow-up, 12-mo follow-up for both treatment conditions. Wait-list controls were only measured at intake and post-treatment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:01:02 +0100" MODIFIED_BY="Anne Lawson">
<P>Data from HAM-D, HAM-A and CGI-S at post-treatment used in the review</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 21:40:38 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Maina-2010">
<CHAR_METHODS MODIFIED="2013-07-03 11:50:27 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of STPP</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 21:40:30 +0100" MODIFIED_BY="Anne Lawson">
<P>57 adult outpatients who met the DSM-IV [21] criteria for a primary diagnosis of OCD with concurrent MDD</P>
<P>Inclusion criteria: obsessive-compulsive symptoms had to have been present for at least 1 year prior to the study entry; Y-BOCS [23, 24] total score of 6 16 had to be reached, 17-item HAM-D [25] score of 6 15 at the baseline evaluation</P>
<P>Exclusion criteria: lifetime diagnosis of bipolar disorder, schizophrenia, other psychotic disorders, mental retardation or drug abuse; organic brain syndrome or medical illness that would contraindicate the use of fluvoxamine or sertraline; severe axis II psychopathology (cluster A personality disorder, antisocial personality disorder and borderline personality disorder according to the DSM-IV) that would contraindicate the treatment with BDT; pregnant or nursing women and women of childbearing potential not using adequate contraceptive measures; ongoing psychological treatment</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 15:02:12 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: STPP derived from <LINK REF="REF-Malan-1976" TYPE="REFERENCE">Malan 1976</LINK> 10 up to 16 sessions. Treatment was interpretive and used clarification. "Manuals" were noted but not described or referenced. Therapist experience was unclear as they were only noted to be trained in psychodynamic psychotherapy. STPP was combined with antidepressant medications</P>
<P>Control: antidepressant medications</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 21:40:38 +0100" MODIFIED_BY="Anne Lawson">
<P>Primary outcomes: Y-BOCS and 17-item HAM-D</P>
<P>Secondary efficacy measures: included the CGI-S, CGI-I and GAF</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-28 07:08:50 +0100" MODIFIED_BY="[Empty name]">
<P>CGI-S as general measure</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-15 13:00:39 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Marmar-1988">
<CHAR_METHODS MODIFIED="2014-05-06 11:08:48 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT with 2 parallel conditions</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 21:41:10 +0100" MODIFIED_BY="Anne Lawson">
<P>61 women who sought treatment following the death of their husbands. DSM-III axis I diagnoses were 29 cases of adjustment disorder, 17 cases of PTSD, 10 cases of major depressive episode, and 5 cases of major depressive episode and PTSD</P>
<P>Exclusion criteria: past or present psychotic illness, previous psychiatric hospitalisation, history of drug or alcohol abuse, concurrent psychological treatment, pending litigation, or widowhood &lt; 4 months' or &gt; 3 years' duration</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-15 13:00:39 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: BDT (<LINK REF="REF-Horowitz-1984" TYPE="REFERENCE">Horowitz 1984</LINK>) for 12 weekly sessions conducted by 11 faculty therapists with a mean 9.3 years of experience<BR/>
</P>
<P>Control: Mutual-help group treatment led by women who had experienced the deaths of their own husbands<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:11:18 +0100" MODIFIED_BY="Anne Lawson">
<P>Pre-, 4 months post-treatment, 1-year follow-up<BR/>Stress measures: Impact Event Scale (self report), Stress Response Rating Scale (clinician report). SCL-90, short BDI, clinician report Brief Psychiatric Rating Scale. SAS, GAS</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:11:25 +0100" MODIFIED_BY="Anne Lawson">
<P>SCL-90, BDI, SAS and SCL-90 subscale data used in review</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-15 13:06:00 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Milrod-2007">
<CHAR_METHODS MODIFIED="2014-05-15 13:06:00 +0100" MODIFIED_BY="Anne Lawson">
<P>Randomised controlled design with 2 parallel arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 22:52:45 +0100" MODIFIED_BY="Anne Lawson">
<P>Inclusion criteria: participants were required to have a primary diagnosis of DSM-IV panic disorder, a minimum severity score on the DSM-IV Anxiety Disorder Interview Schedule, and a minimum of 1 weekly panic attack. Participants with co-morbid depression, personality disorders and severe agoraphobia</P>
<P>Exclusion criteria: psychosis, bipolar disorder, active substance abuse and participants were required to discontinue existing psychotherapy treatments</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-15 13:02:00 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: Panic-focused brief psychodynamic psychotherapy (<LINK REF="REF-Milrod-1997" TYPE="REFERENCE">Milrod 1997</LINK>) was provided by 8 therapists trained in the model, each with a minimum of 2 years' experience using psychodynamic psychotherapy for this client group.</P>
<P>Control: Applied relaxation provided by 6 trained and experienced therapists.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:14:39 +0100" MODIFIED_BY="Anne Lawson">
<P>Outcome was examined at baseline, termination, and at 2, 4, 6 and 12 months post treatment termination. Severity of panic disorder, HAM-A, HAM-D and the Sheehan Disability Scale were all rated by independent raters, blinded to treatment group. Clinician administered instruments measures frequency of panic attacks and other anxiety-related symptom data</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-07 17:21:48 +0100" MODIFIED_BY="Anne Lawson">
<P>HAM-A and HAM-D data used. Sheehan Disability Scale provided data on social adjustment</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-07 09:40:35 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Monsen-2000">
<CHAR_METHODS MODIFIED="2014-05-06 11:15:43 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT of matched pairs of participants in 2 parallel conditions</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-07 09:40:11 +0100" MODIFIED_BY="Anne Lawson">
<P>40 participants (35 women), all employees of a large Norwegian office company, self referred to company's health service because of pain problems</P>
<P>Inclusion criteria: diagnosis of pain disorder associated with psychological factors according to the DSM-IV</P>
<P>Exclusion criteria: pain associated with other medical conditions, such as spine prolapse, neuralgia or chronic disorders manifested in organ systems other than the musculoskeletal system (such as irritable colon)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 21:42:09 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: PBT: a variant of the affect-consciousness treatment model, based on <LINK REF="REF-Monsen-1999" TYPE="REFERENCE">Monsen 1999</LINK>. The PBT group received a mean of 33 individual, 1-hr sessions during a period of 9 months (ranging from 15 to 41 sessions). Psychotherapy was performed by the project leader who was a well-qualified clinical psychologist and physiotherapist</P>
<P>Control: received TAU: 3 participants received traditional physiotherapy, 5 participants received both traditional physiotherapy and pain-reducing medication, 3 participants received pain-reducing medication and 1 participant received psychological counselling. 8 participants in the control group received no treatment during the intervention period. The treatment was performed by the project leader who was a well-qualified clinical psychologist and physiotherapist</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-07 09:40:35 +0100" MODIFIED_BY="Anne Lawson">
<P>Measured at pre-treatment, post, and 1 year follow-up. Measures were VAS Pain scale, SCL-90-R, IIP-C, Minnesota Multiphase Personality Inventory, Affect-Consciousness Scales and job advancement</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:20:00 +0100" MODIFIED_BY="Anne Lawson">
<P>Data used from SCL-90 scores, IIP and VAS for pain</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-07 09:42:28 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Piper-1990">
<CHAR_METHODS MODIFIED="2014-05-06 22:24:24 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT (participants matched in pairs by QOR, sex and age, then assigned to 1 condition or another) with cross-over design. Wait-list controls were used here for comparison</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 14:29:52 +0100" MODIFIED_BY="Anne Lawson">
<P>105 psychiatric outpatients referred from a walk-in clinic. Axis I DSM-III diagnoses were affective (31%), adjustment (23%), anxiety (7%) and impulse control (8%). 32% of participants had axis II diagnoses. Mean age 31 years, 65% female</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-07 09:42:28 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: short-term individual psychotherapy, manualised, based on <LINK REF="REF-Malan-1976" TYPE="REFERENCE">Malan 1976</LINK> and <LINK REF="REF-Strupp-1984" TYPE="REFERENCE">Strupp 1984</LINK>, for a maximum of 20 weekly 50-min sessions (actual mean 18.6)</P>
<P>Control: wait-list subsequently received STI therapy. Sessions were audio-recorded, rated by Therapist Intervention Rating System. 8 therapists, mean experience 11.5 years (range 4-35)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 22:13:08 +0100" MODIFIED_BY="Anne Lawson">
<P>QOR, SAS, Interpersonal Dependency Scale (2 subscales used), Interpersonal Behaviour Scale, GSI of SCL-90, BDI, Trait Anxiety Scale, Rosenberg's Pre-(therapy, wait-list), post (therapy, wait), follow-up/post-therapy, then overall follow-up - 5-month intervals. Self-Esteem Scale, Insight Scale, life satisfaction by 7-point Likert scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:24:50 +0100" MODIFIED_BY="Anne Lawson">
<P>Only immediately post-treatment data used for SCL-90, BDI and Trait Anxiety Scale<BR/>Unable to use SAS data as not presented with means and standard deviations</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-07 17:22:51 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Sattel-2012">
<CHAR_METHODS MODIFIED="2014-05-06 11:41:44 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT of STPP for people with multisomatoform disorders</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 14:29:59 +0100" MODIFIED_BY="Anne Lawson">
<P>211 participants with multisomatoform disorders</P>
<P>Exclusion criteria: people SF-36 &lt; 40, hypochondriasis, cognitive impairment, severe somatic illness, serious mental illness</P>
<P>67/107 were females, mean age 47.9 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 21:59:50 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: 12 weekly sessions of modified PIT specifically adapted to the needs of participants in bodily distress, manual authored by <LINK REF="REF-Henningsen-2011" TYPE="REFERENCE">Henningsen 2011</LINK>. Treatment was 3 phases focusing on building therapeutic relationships, working on emotions about the bodily symptoms and termination future planning</P>
<P>Control: enhanced TAU: this included "education and counselling regarding the therapeutic alternatives based on the evidence-based guidelines for the treatment of somatoform disorders/functional somatic syndromes in primary and somatic specialist care"</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-07 17:22:51 +0100" MODIFIED_BY="Anne Lawson">
<P>SF-36 (Physician and Patient forms), PHQ somatisation, HQ Depression, Health Anxiety/Whiteley Index; healthcare utilisation: visit counts, medication use</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:44:29 +0100" MODIFIED_BY="Anne Lawson">
<P>Primary general measure SF-36 MCS. Somatic measure used was SF-36 PCS</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 22:24:36 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Shefler-1995">
<CHAR_METHODS MODIFIED="2014-05-06 22:24:31 +0100" MODIFIED_BY="Anne Lawson">
<P>Single-centre RCT with cross-over design</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 14:30:18 +0100" MODIFIED_BY="Anne Lawson">
<P>33 participants referred from a walk-in psychiatric clinic, 9 men, 24 women, aged 23-42 years<BR/>Exclusion criteria: schizophrenia and any subtypes, bipolar disorder, schizoid characters, obsessional characters with major defences of isolation and intellectualisation, borderline conditions and psychosomatic disorders; also, further suitability for therapy<BR/>Only 45 of 404 participants from the clinic were deemed suitable for TLP. This was attributed to only 15% of participants being suitable for psychodynamic therapy due to higher percentages of participants with psychoses, and severe social and personality disorders in the centre's catchment area.<BR/>DSM-III-R diagnoses were performed<BR/>Axis I: 9 participants received no diagnosis, 7 participants had anxiety disorders, 6 participants had depressive disorders, 10 participants had adjustment disorders and 1 participant had a life-phase problem<BR/>Axis II: 5 participants had diagnoses (not given)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 22:24:36 +0100" MODIFIED_BY="Anne Lawson">
<P>TLP, based on <LINK REF="REF-Mann-1973" TYPE="REFERENCE">Mann 1973</LINK>, 12 weekly 50-min sessions, or wait-list control, then cross-over into other condition. All 9 therapists were graduates in TLP courses</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 14:38:00 +0100" MODIFIED_BY="Anne Lawson">
<P>Assessments done at pre-treatment, mid (end TLP or wait), end TLP and wait, follow-up 6 months, follow-up 12 months<BR/>Target Complaints Scale, SCT, BSI-53 (brief revision of SCL-90), HSRS, GAS</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:48:52 +0100" MODIFIED_BY="Anne Lawson">
<P>BSI-53 data used for general psychiatric symptoms measure comparison</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 22:13:10 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Sloane-1975">
<CHAR_METHODS MODIFIED="2014-05-06 14:30:28 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT with 3 conditions. Participants matched within conditions by sex and severity of neurosis as measured by Eysenck Personality Inventory</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 21:43:11 +0100" MODIFIED_BY="Anne Lawson">
<P>94 adults who had applied for treatment at a university psychiatric outpatient clinic, aged 18-45 years, not too mildly ill or too disturbed to risk waiting for 4 months</P>
<P>Exclusion criteria: psychotic, mentally retarded, organic brain damage, or primarily in need of drug therapy. Participants were mostly in early 20s, 60% female</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 22:13:10 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention 1: psychoanalytically oriented therapy (no manual or reference provided)</P>
<P>Intervention 2: behaviour therapy</P>
<P>Control: wait-list control</P>
<P>Therapies were 4 months of weekly sessions, 14.2 for psychoanalytic therapy, mean 13.2 sessions for behaviour therapy. 3 therapists per therapy condition, range of experience 6-20 years. External rating used for adherence</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:51:46 +0100" MODIFIED_BY="Anne Lawson">
<P>Measured at pre-treatment, post-treatment, 1-year follow-up<BR/>3 target symptoms rated, SSIAM</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 14:30:34 +0100" MODIFIED_BY="Anne Lawson">
<P>Most frequent symptoms were, in decreasing order, generalised anxiety, interpersonal difficulties, low self esteem, generalised worry and bodily complaints. One-third of participants had personality disorders<BR/>Data for Target symptoms used at post-treatment. Unable to use data at other follow-up times as some of the sample went on to continue or have treatment.<BR/>SSIAM data not presented in parameters that could be combined with other continuous data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-07 16:47:23 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Svedlund-1983">
<CHAR_METHODS MODIFIED="2014-05-06 11:54:27 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT with 2 parallel conditions</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 21:43:29 +0100" MODIFIED_BY="Anne Lawson">
<P>102 participants with IBS, aged 16-60 years (mean 24), 70 females</P>
<P>Exclusion criteria: other somatic or mental disorders requiring treatment, had previous abdominal surgery affecting the gastrointestinal tract, were on a disability pension or were not fluent in Swedish</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-07 16:47:23 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: brief dynamic psychotherapy, based on <LINK REF="REF-Malan-1979" TYPE="REFERENCE">Malan 1979</LINK>, for 10 x 1-hr long sessions over 3 months (mean 7.4 sessions), with medical TAU</P>
<P>Control: TAU - bulk-forming agents and, when appropriate, anticholinergic drugs, antacids and minor tranquillisers</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 14:30:56 +0100" MODIFIED_BY="Anne Lawson">
<P>Pre, post and 15 months (after start of psychotherapy)<BR/>Mental symptoms by CPRS and somatic symptoms, all rated by psychiatrist. On follow-up, participant rating. In addition, SSIAM</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:57:59 +0100" MODIFIED_BY="Anne Lawson">
<P>Additional data provided by study author used for psychiatric symptoms, anxiety symptoms, depression symptoms and somatic symptoms. SSIAM data used for social adjustment measure<BR/>Data used for somatic symptoms, and anxiety, depression and general symptoms. SSIAM for social adjustment<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 22:13:11 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-S_x00f8_rensen-2010">
<CHAR_METHODS MODIFIED="2014-05-06 11:59:14 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT with 3 parallel conditions</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:59:45 +0100" MODIFIED_BY="Anne Lawson">
<P>Participants were required to meet ICD-10 criteria for hypochondriasis and experience significant levels of health anxiety, as indicated by a score of &gt; 17 on the HAI. Having received previous adequate cognitive behavioural or psychodynamic treatment was an exclusion criteria</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 22:13:11 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention 1: STPP was a 16-session, 50-min weekly treatment. Treatment was not manualised and described as a "relational approach" using common dynamic interventions</P>
<P>Intervention 2: CBT involved 8 individual sessions, followed by 8 group sessions that included mindfulness training. Treatment was manualised and supervision was provided by the inventor of the model</P>
<P>Control: wait-list control lasted 6-months. Participants were asked to keep in touch with their GP but no further contact was pre-arranged</P>
<P>All therapy sessions were audiotaped and 12 sessions from each treatment arm were randomly selected and independently rated to evaluate therapist adherence to specific and non-specific components of psychotherapy</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 12:01:39 +0100" MODIFIED_BY="Anne Lawson">
<P>The HAI and HAM-A were described a primary outcome measures and secondary outcome measures included the HAM-D and BAI. Independent trained raters, blinded to treatment group, provided observer ratings using the HAM-D and HAM-A. Outcome data were collected prior to treatment onset and 1 year after the end of treatment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 12:01:41 +0100" MODIFIED_BY="Anne Lawson">
<P>Data from HAM-D and HAM-A used in review</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 14:31:21 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Vitriol-2009">
<CHAR_METHODS MODIFIED="2014-05-06 12:02:49 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT with 2 parallel conditions</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 14:31:18 +0100" MODIFIED_BY="Anne Lawson">
<P>Consecutive women, aged &gt; 20 years, diagnosed with severe depression in primary care clinics were referred for evaluation. Participants meeting ICD-10 criteria for severe depression, HAM-D score &gt; 20 and reporting past traumatic life experiences were included in the trial</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 14:31:21 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: participants were randomised to receive either standard treatment, described as supportive psychotherapy provided by a psychologist. The 3-month brief psychodynamic intervention treatment was non-manualised weekly psychotherapy focused on, "developing a cognitive understanding of personal characteristics and behaviours that allowed the repetition of traumatic experiences past and present. Behavioural changes that would alter the relationship between the victim and aggressor were addressed." An initial assessment session with a multidisciplinary team was described as using a psychodynamic orientation</P>
<P>Control: standard treatment</P>
<P>Participants in both groups received pharmacological treatment as appropriate</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 12:06:21 +0100" MODIFIED_BY="Anne Lawson">
<P>Outcome data was collected pre-treatment, at 3 months (or on treatment completion) and at 6 months. An external rater administered the HAM-D, and a different external rater administered the OQ-45.2 and PTO</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 12:06:54 +0100" MODIFIED_BY="Anne Lawson">
<P>Subscale data from the OQ-45 used in review for measurement of general psychiatric symptoms, interpersonal problems and social adjustment. HAM-D ratings were used for depression and the PTO for a measure of anxiety symptoms</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 14:31:26 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Wiborg-1996">
<CHAR_METHODS MODIFIED="2014-05-06 12:07:47 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT with 2 parallel conditions</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 14:31:26 +0100" MODIFIED_BY="Anne Lawson">
<P>40 participants (23 women, 17 men) with panic disorder, with or without agoraphobia</P>
<P>Inclusion criteria: at least 1 panic attack per week in the 3-week period prior to inclusion into the study. There was co-morbidity: 3 participants had GAD, 3 had participants social phobia, 3 participants had hypochondriasis, 14 participants had simple phobia, 2 participants had secondary major depressive episode, 2 participants had secondary OCD</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 12:10:21 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention: clomipramine with brief dynamic psychotherapy (manualised, based on <LINK REF="REF-Davanloo-1980" TYPE="REFERENCE">Davanloo 1980;</LINK> <LINK REF="REF-Malan-1976" TYPE="REFERENCE">Malan 1976;</LINK> <LINK REF="REF-Strupp-1984" TYPE="REFERENCE">Strupp 1984</LINK>)<BR/>Control: clomipramine alone<BR/>Clomipramine was administered with a flexible step-up procedure (during which time benzodiazepines were allowed), until a dosage of 150 mg/day, for 36 weeks<BR/>BDP was administered by 1 therapist with experience (years not given), 1 weekly visit for 15 weeks, with 3 sessions given before the start of pharmacotherapy</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 14:18:08 +0100" MODIFIED_BY="Anne Lawson">
<P>Pre-, during (weekly), post-, 18 months follow-up. Overall: SCL-90, STAI, GAS, CGI. Panic attack diary, PAAS, HAM-A, Sheehan Disability Scale, Phobia Scale, HRSD, Medical Events Checklist (register adverse effects of clomipramine)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 13:39:47 +0100" MODIFIED_BY="Anne Lawson">
<P>SCL-90, HAM-D, and HAM-A, Sheehan Disability Scale - Social Functioning data used<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 22:13:55 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Winston-1994">
<CHAR_METHODS MODIFIED="2014-05-06 12:21:29 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT with 3 parallel conditions</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 12:22:50 +0100" MODIFIED_BY="Anne Lawson">
<P>93 psychiatric outpatients</P>
<P>Inclusion criteria: aged 18-60 years; evidence of at least 1 close personal relationship; no evidence of psychosis, organic brain syndrome, or mental retardation; no active DSM-III-R axis III medical diagnosis; no evidence of current substance abuse; no acute suicidal behaviour; no history of violent behaviour or destructive impulse control problems; and no use of psychotropic medications, such as lithium, neuroleptics or antidepressants in the past year</P>
<P>Exclusion criteria: axis II diagnoses of schizoid, paranoid, schizotypal, narcissistic and borderline personality disorders</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 22:13:55 +0100" MODIFIED_BY="Anne Lawson">
<P>Intervention 1: STDP, manualised, based on <LINK REF="REF-Davanloo-1980" TYPE="REFERENCE">Davanloo 1980</LINK>
<BR/>Intervention 2: BAP based on <LINK REF="REF-Pollack-1991" TYPE="REFERENCE">Pollack 1991</LINK>
<BR/>Control: waiting list (mean wait-list time 14.9 weeks)<BR/>24 therapists (13 for STDP, 11 for BAP), mean experience 11.6 years, mean number of sessions, both techniques combined, 40.3<BR/>All sessions videotaped, adherence rated through systematic scales<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 12:24:05 +0100" MODIFIED_BY="Anne Lawson">
<P>Assessed at pre-treatment and 1 month post-treatment: GSI of SCL-90-R, SAS, target complaints rating<BR/>6 months post: target complaints</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 12:24:08 +0100" MODIFIED_BY="Anne Lawson">
<P>SCL-90 and SAS data used in review</P>
<P>STDP and BAP entered separately as contrasting forms of STPP models</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>BAI: Beck Anxiety Inventory; BAP: brief adaptive psychotherapy; BDI: Beck Depression Inventory; BDT: brief dynamic therapy; BSI: Brief Symptom Inventory; CBT: cognitive behavioural therapy; CGI: Clinical Global Impressions; CGI-I: Clinical Global Impression - Improvement scale; CGI-S: Clinical Global Impression - Severity scale; CPRS: complex regional pain syndrome; DSM-III: Diagnostic and Statistical Manual of Mental Disorders - third edition; DSM-IV: Diagnostic and Statistical Manual of Mental Disorders - fourth edition; EPDS: Edinburgh Postnatal Depression Scale; GAF: Global Assessment of Functioning; GAS: Global Assessment Scale; GP: general practitioner; GSI: Global Severity Index; HAI: Health Anxiety Inventory; HAM-A: Hamilton Anxiety Rating Scale; HAM-D: Hamilton Depression Rating Scale; HDRS: Hamilton Depression Rating Scale; HQ: Health Questionnaire; hr: hour; IBS: irritable bowel syndrome; ICD-10: International Statistical Classification of Diseases and Health Related Problems 10th Revision; IIP: Inventory of Interpersonal Problems; ISTDP: intensive short-term dynamic psychotherapy; ITT: intention to treat; LWASQ: Lehrer Woolfolk Anxiety Symptom Questionnaire; MDD: major depressive disorder; min: minute; OCD: obsessive-compulsive disorder; OQ: Outcome Questionnaire; PAAS: Panic Attack and Anxiety Scale; PBT: psychodynamic body therapy; PHQ: Patient Health Questionnaire; PIT: psychodynamic interpersonal therapy; PPD: postpartum depression; PTO: Post-traumatic Stress Treatment Outcome scale; PTSD: post-traumatic stress disorder; QLDS: Quality of Life Depression Scale; QOR Quality of Object Relations; RCT: randomised controlled trial; SAS: Social Adjustment Scale; SCID: Structured Clinical Interview for DSM-IV Disorders; SCL-90: Symptom Checklist-90; SCL-90-GSI: Symptom Checklist-90 Global Severity Index; SCL-90-R: Symptom Checklist-90 - Revised; SCORAD: Scoring of Atopic Dermatitis Index; SF-36 MCS: 36-item Short Form - Mental Component Summary; SF-36 PCS: 36-item Short Form - Physical Component Summary; SF-36: 36-item Short Form; SPRS: Sydney Psychosocial Reintegration Scale; SPSP: short psychodynamic supportive psychotherapy; SSIAM: Structured and Scaled Interview to Assess Maladjustment; STAI: State-trait Anxiety Inventory; STDP: short-term dynamic psychotherapy; STPP: short-term psychodynamic psychotherapy; TAU: treatment as usual; TLP: time-limited psychotherapy; VAS: visual analogue scale; WHO: World Health Organization; Y-BOCS: Yale-Brown Obsessive Compulsive Scale.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2014-05-07 17:24:16 +0100" MODIFIED_BY="Anne Lawson" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:06:55 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Brodaty-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:06:55 +0100" MODIFIED_BY="Anne Lawson">
<P>Length of sessions only 30 min</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:19:24 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Budman-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:19:24 +0100" MODIFIED_BY="Anne Lawson">
<P>Compared individual STPP to an active treatment: group STPP</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:19:20 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Fairburn-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:19:20 +0100" MODIFIED_BY="Anne Lawson">
<P>Short-form focal therapy compared with an active treatment: cognitive behavioural approach</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:19:14 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Gallagher-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:19:14 +0100" MODIFIED_BY="Anne Lawson">
<P>Compared STPP with 2 active treatments: behavioural therapy and cognitive therapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-07 17:24:16 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Gallagher_x002d_Thompson-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-07 17:24:16 +0100" MODIFIED_BY="Anne Lawson">
<P>Brief psychodynamic therapy compared with an active treatment, cognitive-behavioural therapy, for clinically depressed family carers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:19:45 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Gilbert-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:19:45 +0100" MODIFIED_BY="Anne Lawson">
<P>Group therapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:19:57 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Hall-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:19:57 +0100" MODIFIED_BY="Anne Lawson">
<P>Randomised controlled trial of 30 females with anorexia nervosa. Excluded because the treatment group was a combined individual psychodynamic psychotherapy and family therapy approach</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:46:03 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Hardy-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:46:03 +0100" MODIFIED_BY="Anne Lawson">
<P>Psychodynamic-interpersonal therapy was compared with an active control: cognitive behavioural therapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:46:47 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Hellerstein-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:46:47 +0100" MODIFIED_BY="Anne Lawson">
<P>STDP was compared with an active treatment control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:46:55 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Knekt-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:46:55 +0100" MODIFIED_BY="Anne Lawson">
<P>Compared STPP with active comparators</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:47:26 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Maina-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:47:26 +0100" MODIFIED_BY="Anne Lawson">
<P>Participants included in this long-term follow-up study only include remitters who were not a randomised sample of original participants</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:47:41 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-McLean-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:47:41 +0100" MODIFIED_BY="Anne Lawson">
<P>Short-term psychotherapy was compared with active controls in people with depression</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:47:45 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Morris-1975">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:47:45 +0100" MODIFIED_BY="Anne Lawson">
<P>Group therapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:47:50 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Nanzer-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:47:50 +0100" MODIFIED_BY="Anne Lawson">
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:48:22 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Piper-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:48:22 +0100" MODIFIED_BY="Anne Lawson">
<P>A randomised controlled trial comparing 2 active forms of therapy, interpretive and supportive forms of short-term individual psychotherapy, in adult outpatients with a variety of axis I and II diagnoses</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:48:40 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Shapiro-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:48:40 +0100" MODIFIED_BY="Anne Lawson">
<P>Exploratory (relationship-oriented) therapy, a "nonspecific dynamic therapy" was compared was an active control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:49:04 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Shapiro-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:49:04 +0100" MODIFIED_BY="Anne Lawson">
<P>Psychodynamic-interpersonal therapy was compared with an active control, cognitive behavioural therapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:49:27 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Simpson-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:49:27 +0100" MODIFIED_BY="Anne Lawson">
<P>Use of a brief therapy by general practitioners in people with chronic depression. Method of psychotherapy used was "Freudian psychoanalysis", which is not a standard STPP</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:52:04 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Sjodin-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:52:04 +0100" MODIFIED_BY="Anne Lawson">
<P>Short-term psychotherapy in combination with medical treatment was compared with medical treatment only in people with chronic peptic ulcer disease. This was a study from 20 years ago before the introduction of triple therapy for the eradication of <I>Helicobacter pylori</I>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:52:16 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Svartberg-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:52:16 +0100" MODIFIED_BY="Anne Lawson">
<P>STDP was compared with cognitive therapy, an active treatment control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 22:13:58 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Thompson-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 22:13:58 +0100" MODIFIED_BY="Anne Lawson">
<P>STDP was compared with 2 active treatments and a delayed treatment condition. Data for the wait-list could not be compared with the treatment as it was a partially case-controlled study, with the participants in the wait-list groups ultimately being incorporated into the treatment conditions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 18:53:41 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Vinnars-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 18:53:41 +0100" MODIFIED_BY="Anne Lawson">
<P>Control group was an active psychotherapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>min: minutes; STDP: short-term dynamic psychotherapy; STPP: short-term psychodynamic psychotherapy.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2014-05-07 17:33:51 +0100" MODIFIED_BY="Anne Lawson" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2014-05-07 17:24:49 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Barber-2012">
<CHAR_METHODS MODIFIED="2014-04-04 15:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of STPP versus placebo and versus medication management</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 18:55:08 +0100" MODIFIED_BY="Anne Lawson">
<P>156 adults with major depression</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-07 17:24:49 +0100" MODIFIED_BY="Anne Lawson">
<P>STPP 16 weeks' time limited. <LINK REF="REF-Luborsky-1984" TYPE="REFERENCE">Luborsky 1984</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 18:55:17 +0100" MODIFIED_BY="Anne Lawson">
<P>HAM-D, remission and response</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-04-11 12:55:33 +0100" MODIFIED_BY="Jessica Sharp">
<P>NCT00043550</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-05-06 18:56:29 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Beutel-2014">
<CHAR_METHODS MODIFIED="2014-05-06 18:55:50 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT of STPP vs. care as usual</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 18:56:03 +0100" MODIFIED_BY="Anne Lawson">
<P>157 women with major depression and breast cancer</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-04-04 16:10:35 +0100" MODIFIED_BY="[Empty name]">
<P>STPP 20 sessions maximum <LINK REF="REF-Luborsky-1984" TYPE="REFERENCE">Luborsky 1984</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 18:56:29 +0100" MODIFIED_BY="Anne Lawson">
<P>Hospital Anxiety and Depression Scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-04-11 12:55:41 +0100" MODIFIED_BY="Jessica Sharp">
<P>ISRCTN96793588</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-05-06 19:02:55 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Bressi-2011">
<CHAR_METHODS MODIFIED="2014-05-06 18:57:02 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT of STPP vs. CBT vs. routine care</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-04-04 15:55:36 +0100" MODIFIED_BY="[Empty name]">
<P>35 adults with panic disorder</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 18:59:45 +0100" MODIFIED_BY="Anne Lawson">
<P>STPP <LINK REF="REF-Malan-1976" TYPE="REFERENCE">Malan 1976</LINK> vs. CBT</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 19:02:55 +0100" MODIFIED_BY="Anne Lawson">
<P>HAM-D, HAM-A, PAAAS, TAS-20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-05-06 19:46:30 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Faramarzi-2013">
<CHAR_METHODS MODIFIED="2014-05-06 19:03:44 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT of STPP vs. medical management</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 19:46:30 +0100" MODIFIED_BY="Anne Lawson">
<P>49 participants with functional dyspepsia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 19:04:04 +0100" MODIFIED_BY="Anne Lawson">
<P>STPP <LINK REF="REF-Luborsky-1984" TYPE="REFERENCE">Luborsky 1984</LINK> vs. medical management</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 19:05:40 +0100" MODIFIED_BY="Anne Lawson">
<P>PAGI-SYM: measure of gastrointestinal symptoms; DSQ 40; TAS-20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-04-11 13:01:50 +0100" MODIFIED_BY="Jessica Sharp">
<P>IRCT201102285931N1</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-05-06 19:05:54 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Gibbons-2012">
<CHAR_METHODS MODIFIED="2014-04-04 16:02:38 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of STPP</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-04-04 16:02:09 +0100" MODIFIED_BY="[Empty name]">
<P>40 adults with major depression</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 19:05:50 +0100" MODIFIED_BY="Anne Lawson">
<P>STPP 12 session limited time, <LINK REF="REF-Luborsky-1984" TYPE="REFERENCE">Luborsky 1984</LINK>. Treatment as usual</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 19:05:54 +0100" MODIFIED_BY="Anne Lawson">
<P>Basis 24, HAM-D</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-05-06 22:24:41 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Kompoliti-2014">
<CHAR_METHODS MODIFIED="2014-05-06 22:24:41 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT of STPP. Cross-over after wait-list</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 19:06:07 +0100" MODIFIED_BY="Anne Lawson">
<P>15 with functional movement disorders</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 19:06:09 +0100" MODIFIED_BY="Anne Lawson">
<P>STPP <LINK REF="REF-Davanloo-1980" TYPE="REFERENCE">Davanloo 1980</LINK>. 12 sessions time limited</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 19:06:35 +0100" MODIFIED_BY="Anne Lawson">
<P>CGI, HAM-D, Beck Anxiety Inventory</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-05-06 22:14:02 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Leichsenring-2013">
<CHAR_METHODS MODIFIED="2014-05-06 22:14:02 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT of STPP vs. CBT vs. wait-list</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 19:06:56 +0100" MODIFIED_BY="Anne Lawson">
<P>495 adults with social anxiety disorder</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 19:06:58 +0100" MODIFIED_BY="Anne Lawson">
<P>STPP <LINK REF="REF-Luborsky-1984" TYPE="REFERENCE">Luborsky 1984</LINK> up to 25 sessions</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-04-04 16:16:06 +0100" MODIFIED_BY="[Empty name]">
<P>Liebowitz Social Anxiety Scale, Social Phobia and Anxiety Inventory, Beck Depression Inventory, Inventory of Interpersonal Problems</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-04-11 13:10:39 +0100" MODIFIED_BY="Jessica Sharp">
<P>ISRCTN53517394</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-05-07 17:25:23 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Reneses-2013">
<CHAR_METHODS MODIFIED="2014-05-06 19:07:33 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT of STPP vs. psychiatric treatment as usual</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 19:07:36 +0100" MODIFIED_BY="Anne Lawson">
<P>44 with borderline personality disorder</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 19:07:54 +0100" MODIFIED_BY="Anne Lawson">
<P>20 sessions of psychic representation focused psychotherapy</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-07 17:25:23 +0100" MODIFIED_BY="Anne Lawson">
<P>Severity global index of SCL-90-R, Barratt Impulsivity Scale scores, Social Adaptation Self-Evaluation Scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-05-06 19:11:29 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Scheidt-2013">
<CHAR_METHODS MODIFIED="2014-05-06 19:09:54 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT of STPP vs. treatment as usual for fibromyalgia plus anxiety or depression</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 19:10:33 +0100" MODIFIED_BY="Anne Lawson">
<P>46 females with fibromyalgia and an International Classification of Diseases, 10th Revision diagnosis of a co-morbid depression or anxiety disorder</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 19:10:51 +0100" MODIFIED_BY="Anne Lawson">
<P>Participants were randomised to receive either an adapted version of STPP (25 sessions, 1 session/week) or treatment as usual (4 consultations/6 months)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 19:11:29 +0100" MODIFIED_BY="Anne Lawson">
<P>Fibromyalgia Impact Questionnaire, Hospital Anxiety and Depression Scale, Pain Disability Index, Symptom Checklist 27 and health-related quality of life</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-05-06 22:24:45 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Shaw-2001">
<CHAR_METHODS MODIFIED="2014-05-06 22:24:45 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT of STPP versus wait-list control. Cross-over design</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-04-04 20:03:42 +0100" MODIFIED_BY="[Empty name]">
<P>54 adults with mixed common mental disorders</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 21:22:41 +0100" MODIFIED_BY="Anne Lawson">
<P>12 weeks of STPP (psychodynamic interpersonal therapy, <LINK REF="REF-Hobson-1985" TYPE="REFERENCE">Hobson 1985</LINK>) delivered by psychiatry trainees</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 19:12:18 +0100" MODIFIED_BY="Anne Lawson">
<P>SCL-90-R and Inventory of Interpersonal Problems</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-05-06 19:13:19 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Zipfel-2014">
<CHAR_METHODS MODIFIED="2014-05-06 19:12:33 +0100" MODIFIED_BY="Anne Lawson">
<P>Multicentre, randomised controlled efficacy trial in adults with anorexia nervosa of STPP vs. enhanced CBT vs. optimised treatment as usual</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 19:12:41 +0100" MODIFIED_BY="Anne Lawson">
<P>242 participants with anorexia nervosa</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 19:12:56 +0100" MODIFIED_BY="Anne Lawson">
<P>10 months of focal psychodynamic therapy, enhanced CBT or optimised treatment as usual</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 19:13:19 +0100" MODIFIED_BY="Anne Lawson">
<P>Weight gain (body mass index), rate of weight gain. Hence, does not include outcomes measures of interest in this review</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-04-11 13:22:42 +0100" MODIFIED_BY="Jessica Sharp">
<P>ISRCTN72809357</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES>
<P>CBT: cognitive behavioural therapy; CGI: Clinical Global Impression; DSQ: Defense Style Questionnaire; HAM-A: Hamilton Anxiety Rating Scale; HAM-D: Hamilton Depression Rating Scale; PAAS: Panic and Anticipatory Anxiety Scale; PAGI-SYM: Patient Assessment of Upper Gastrointestinal Symptoms; RCT: randomised controlled trial; SCL-90-R: Symptom Checklist-90 - Revised; STPP: short-term psychodynamic psychotherapy; TAS-20: 20-item Toronto Alexithymia Scale.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2014-05-15 16:33:48 +0100" MODIFIED_BY="Anne Lawson" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2014-05-15 14:20:47 +0100" MODIFIED_BY="Jessica Sharp" STUDY_ID="STD-ISRCTN38209986">
<CHAR_STUDY_NAME MODIFIED="2014-05-15 13:42:18 +0100" MODIFIED_BY="Jessica Sharp">
<P>Improving Psychodynamic Psychotherapy in Primary Care: Randomised Evaluation of Dynamic Interpersonal Therapy (DIT)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-05-15 13:45:02 +0100" MODIFIED_BY="Jessica Sharp">
<P>Single-blind, multi-site RCT </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-15 13:36:44 +0100" MODIFIED_BY="Jessica Sharp">
<P>1. Aged over 18 years, male or female </P>
<P>2. Current diagnosis of Major depressive disorder (MDD) with or without dysthymic disorder according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria </P>
<P>3. Hamilton Depression Rating Scale score above 14 </P>
<P>4. Patient Health Questionnaire (PHQ) score above 10 </P>
<P>5. Confirmed need for high-intensity treatment either at triage, following referral, or by low-intensity worker and supervisor</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-15 13:37:28 +0100" MODIFIED_BY="Jessica Sharp">
<P>Dynamic Interpersonal Therapy vs Enhanced Wait List, Enhanced Wait list condition involving low-level routine clinical care with elements of low-intensity treatment.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-15 13:39:11 +0100" MODIFIED_BY="Jessica Sharp">
<P>Primary outcome measure: Hamilton Depression Rating Scale (HDRS-17)</P>
<P>Secondary outcome measures: Beck Depression Inventory (BDI-II); Brief Symptom Inventory (BSI); EuroQOL (EQ-5D); MINI+ (Mini-International MINI international neuropsychiatric interview); Reflective Function Questionnaire (RFQ-54); Revised Social Adjustment Scale (SAS-r) </P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-05-15 13:39:29 +0100" MODIFIED_BY="Jessica Sharp">
<P>20/06/2012</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2014-05-15 14:20:47 +0100" MODIFIED_BY="Jessica Sharp">
<P>Ms Tara  McFarquhar, email: <A HREF="https://mail.google.com/mail/?view=cm&amp;fs=1&amp;tf=1&amp;to=tara.mcfarquhar@annafreud.org">tara.mcfarquhar@annafreud.org</A>
</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2014-05-15 13:42:18 +0100" MODIFIED_BY="Jessica Sharp"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2014-05-15 14:20:47 +0100" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-NCT01141426">
<CHAR_STUDY_NAME MODIFIED="2014-05-06 19:38:52 +0100" MODIFIED_BY="Anne Lawson">
<P>Halifax Treatment Refractory Depression Trial</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-05-06 19:39:35 +0100" MODIFIED_BY="Anne Lawson">
<P>RCT of STPP (Davanloo) vs. community treatment as usual</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 19:39:39 +0100" MODIFIED_BY="Anne Lawson">
<P>Treatment-resistant depression</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-04-04 15:38:10 +0100" MODIFIED_BY="[Empty name]">
<P>Davanloo's model of STPP</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 19:42:49 +0100" MODIFIED_BY="Anne Lawson">
<P>Primary outcome measures: Hamilton Rating Scale for Depression<BR/>Secondary outcome measures: GAD-7, Inventory of Interpersonal Problems, 32-item Toronto Alexithymia Scale, SF-12, CORE-OM, Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry, PHQ-9, Patient Health Questionnaire - somatic symptom scale</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-04-04 15:39:46 +0100" MODIFIED_BY="[Empty name]">
<P>2012</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2014-05-15 14:20:47 +0100" MODIFIED_BY="Anne Lawson">
<P>Joel Town DClinPsy, telephone: 1-902-473-2543, email: joel.town@dal.ca</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2014-05-15 16:23:32 +0100" MODIFIED_BY="Jessica Sharp" STUDY_ID="STD-NCT02076867">
<CHAR_STUDY_NAME MODIFIED="2014-05-15 13:47:00 +0100" MODIFIED_BY="Jessica Sharp">
<P>Halifax Somatic Symptom Disorder Trial: A Randomized Parallel Group Cross-Over Study of Intensive Short-Term Dynamic Psychotherapy Compared to Medical Treatment as Usual for Somatic Symptoms in the Emergency Department</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-05-15 13:47:21 +0100" MODIFIED_BY="Jessica Sharp">
<P>Randomized Parallel Group Cross-Over Study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-15 13:51:15 +0100" MODIFIED_BY="Jessica Sharp">
<P>Men and women aged 18-65 years with somatic symptom and related disorders (as assessed by the Structured Clinical Interview for DSM Disorders 5th Edition Research Version (SCID-5-RV))</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-15 16:23:32 +0100" MODIFIED_BY="Jessica Sharp">
<P>Intervention: Intensive Short-Term Dynamic Psychotherapy</P>
<P>Control: Medical Care As Usual (MCAU)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-15 13:54:05 +0100" MODIFIED_BY="Jessica Sharp">
<P>Primary outcome measure: Change in Somatic Symptom Severity score using the SOMS-7</P>
<P>Secondary outcome measures:  Patient Health Questionnaire-depression scale (PHQ-9); Whiteley Index for Health Anxiety; Short Form Health Survey (SF-12); Inventory of Interpersonal Problems (IIP-32); Presence of somatic symptom and related disorder diagnosis using the Structured Clinical Interview for DSM Disorders Version 5</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-05-15 13:54:15 +0100" MODIFIED_BY="Jessica Sharp">
<P>March 2014</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2014-05-15 13:54:45 +0100" MODIFIED_BY="Jessica Sharp">
<P>Joel Town DClinPsy, telephone: 1-902-473-2543, email: joel.town@dal.ca</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<FOOTNOTES>
<P>CORE-OM: Clinical Outcomes in Routine Evaluation Outcome Measure; GAD-7: 7-item Generalized Anxiety Disorder Scale; PHQ-9: 9-item Patient Health Questionnaire; RCT: randomised controlled trial; SF-12: 12-item Short-Form Health Survey; STPP: short-term psychodynamic psychotherapy.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2014-05-15 12:55:38 +0100" MODIFIED_BY="Anne Lawson">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2014-05-06 21:40:17 +0100" MODIFIED_BY="Anne Lawson" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:21:07 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Abbass-2008">
<DESCRIPTION>
<P>Quote: "Randomized and stratified by age and sex...randomised cards were used so the screener was blind to the allocation before selection of a card"</P>
<P>Comment: randomised cards</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 18:22:40 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alstrom-1984a">
<DESCRIPTION>
<P>Comment: inadequate description</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 18:15:02 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alstrom-1984b">
<DESCRIPTION>
<P>Comment: inadequate description</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:26:37 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Baldoni-1995">
<DESCRIPTION>
<P>Quote: "randomly selected on the basis of the psychotherapist's schedule. i.e. when a treatment could be started, the urologists were asked to send the first patient"</P>
<P>Comment: sequence generated by a non-random approach</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 19:22:48 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bressi-2010">
<DESCRIPTION>
<P>Quote: "block randomization...then randomly allocated using computer generated random number"</P>
<P>Comment: selection bias unlikely</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:21:23 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Brom-1989">
<DESCRIPTION>
<P>Comment: randomisation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 09:48:23 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Burnand-2002">
<DESCRIPTION>
<P>Comment: no reference to sequence generation method: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:18 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Carrington-1979">
<DESCRIPTION>
<P>Comment: insufficient information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 19:23:29 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cooper-2003">
<DESCRIPTION>
<P>Quote: "allocated randomly to a treatment group by the study recruiter, who drew one of four coloured balls from a bag"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 09:59:37 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Creed-2003">
<DESCRIPTION>
<P>Quote: "Stratified". "Randomization was performed in blocks of 12 subjects using randomization lists supplied by the trial statistician drawn from a computer generated series of random numbers"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 10:01:54 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Dare-2001">
<DESCRIPTION>
<P>Stratified randomisation method called the 'minimisation method' was used. Method of sequence generation was unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:28 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Emmelkamp-2006">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:34 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Guthrie-1993">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 10:31:09 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Guthrie-1999">
<DESCRIPTION>
<P>Quote: "Randomization was carried out using a computer generated series of random numbers provided by the trial statistician"</P>
<P>Comment: low risk of selection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 10:36:30 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Guthrie-2001">
<DESCRIPTION>
<P>Quote: "Patients were assigned using...randomization lists provided by statistician"</P>
<P>Comment: low risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 10:39:38 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Hamilton-2000">
<DESCRIPTION>
<P>Quote: "Randomization was performed using a computer-generated series of random numbers supplied by the trial statistician"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 10:46:29 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Levy-Berg-2009">
<DESCRIPTION>
<P>Quote: "we assigned patients to either of the two treatment groups using a random number table"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:41 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Linnet-2001">
<DESCRIPTION>
<P>Comment: inadequate description</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 21:40:17 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Maina-2005">
<DESCRIPTION>
<P>Quote: "Patients were randomised into 3 different blocks of 10 subjects, then randomly assigned to ..."</P>
<P>Comment: not enough information on procedure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:08:25 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Maina-2010">
<DESCRIPTION>
<P>Comment: random selection of balls</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:55 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Marmar-1988">
<DESCRIPTION>
<P>Comment: inadequate description</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:14:48 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Milrod-2007">
<DESCRIPTION>
<P>Quote: "subjects were randomly assigned using a computer generated treatment assignment list"</P>
<P>Comment: unlikely to produce bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:20:14 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Monsen-2000">
<DESCRIPTION>
<P>Quote: "randomised in two groups of twenty patients each"</P>
<P>Comment: randomised but not clearly described how</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:00 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Piper-1990">
<DESCRIPTION>
<P>Quote: "The research coordinator matched patients in pairs...and randomly assigned one member to the immediate therapy condition and the other member to the delayed therapy control condition"</P>
<P>Comment: insufficient information about the sequence generation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:44:33 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Sattel-2012">
<DESCRIPTION>
<P>Comment: a computer program generated a blocked randomisation list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:04 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Shefler-1995">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:52:45 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Sloane-1975">
<DESCRIPTION>
<P>Quote: "After interviewing and testing, the patients were randomly assigned...Within this random assignment, patients were matched within the three groups in terms of sex and severity of neurosis"</P>
<P>Comment: insufficient information to determine possible selection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:58:03 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Svedlund-1983">
<DESCRIPTION>
<P>Comment: stratified by gender and randomised. Details of method not provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 12:01:47 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-S_x00f8_rensen-2010">
<DESCRIPTION>
<P>Quote: "randomised allocation was computer generated in permuted blocks of eight. The block sizes were concealed until the end of the trial"</P>
<P>Comment: low risk of selection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:10 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Vitriol-2009">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-22 19:43:04 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wiborg-1996">
<DESCRIPTION>
<P>Quote: "randomised using computerized random number generator and sealed envelopes"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:13 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Winston-1994">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:23 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-de-Jonghe-2001">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2014-05-06 14:34:14 +0100" MODIFIED_BY="Anne Lawson" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 09:18:33 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Abbass-2008">
<DESCRIPTION>
<P>Comment: additional information provided by lead author indicating the use of randomised cards in sealed envelopes thus minimising risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 18:22:26 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alstrom-1984a">
<DESCRIPTION>
<P>Comment: inadequate description</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 18:20:26 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alstrom-1984b">
<DESCRIPTION>
<P>Comment: inadequate description</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 09:36:30 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Baldoni-1995">
<DESCRIPTION>
<P>Comment: not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 09:42:07 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Bressi-2010">
<DESCRIPTION>
<P>Quote: "block randomization...then randomly allocated using computer generated random number"</P>
<P>Comment: no further details; therefore, insufficient information to conclude on concealment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 09:45:17 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Brom-1989">
<DESCRIPTION>
<P>Comment: not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 09:48:30 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Burnand-2002">
<DESCRIPTION>
<P>Quote: "random assignment process included stratification by presence of personality disorders..."</P>
<P>Comment: no further details therefore insufficient details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:18 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Carrington-1979">
<DESCRIPTION>
<P>Comment: insufficient information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 09:56:02 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Cooper-2003">
<DESCRIPTION>
<P>Quote: "...the assignment of each therapy to a different coloured ball having been defined at the start of the study and maintained until the end"</P>
<P>Comment: concealment not blinded; therefore, high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 09:59:46 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Creed-2003">
<DESCRIPTION>
<P>Comment: an independent trial administrator co-ordinated the allocation process and clinicians and researchers were blinded to allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 10:01:56 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Dare-2001">
<DESCRIPTION>
<P>Sealed envelopes were used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:29 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Emmelkamp-2006">
<DESCRIPTION>
<P>Quote: "Patients were randomly assigned"</P>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:34 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Guthrie-1993">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 10:31:19 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Guthrie-1999">
<DESCRIPTION>
<P>Quote: "Allocation of patients to trial groups was carried out by a trial secretary who was not involved in the assessment of patients"</P>
<P>Comment: method deemed to minimise risk of selection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 10:36:35 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Guthrie-2001">
<DESCRIPTION>
<P>Comment: high risk of bias due to open random allocation schedule based on "random list of numbers"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:38 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Hamilton-2000">
<DESCRIPTION>
<P>Comment: insufficient information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 10:46:35 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Levy-Berg-2009">
<DESCRIPTION>
<P>Comment: unclear whether the allocation used an open random number table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-18 18:07:25 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Linnet-2001">
<DESCRIPTION>
<P>Comment; Inadequate description</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:01:34 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Maina-2005">
<DESCRIPTION>
<P>Comment: not enough information on procedure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:44 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Maina-2010">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:55 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Marmar-1988">
<DESCRIPTION>
<P>Comment: inadequate description</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:57 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Milrod-2007">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:20:17 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Monsen-2000">
<DESCRIPTION>
<P>Comment: not clearly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:01 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Piper-1990">
<DESCRIPTION>
<P>Comment: insufficient information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:44:53 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Sattel-2012">
<DESCRIPTION>
<P>Quote: "After receiving informed consent, we submitted a randomisation request and the centre returned the result for the patient in question within 24 h. The patients completed the baseline assessment independently immediately after providing informed consent and delivered the assessment to the study therapist in person or by post. Thereafter, the therapist disclosed the group assignment to the patient and treatment began"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:05 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Shefler-1995">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:52:45 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Sloane-1975">
<DESCRIPTION>
<P>Comment: insufficient information to determine possible selection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:07 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Svedlund-1983">
<DESCRIPTION>
<P>Comment: inadequate description</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 12:01:52 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-S_x00f8_rensen-2010">
<DESCRIPTION>
<P>Quote: "Concealment of allocation from the initial assessor was ensured by a procedure involving centralized telephone randomisation"</P>
<P>Comment: low risk of selection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:10 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Vitriol-2009">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-07 19:22:24 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wiborg-1996">
<DESCRIPTION>
<P>Quote: "sealed envelopes"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:14 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Winston-1994">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:24 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-de-Jonghe-2001">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2014-05-07 17:23:37 +0100" MODIFIED_BY="Anne Lawson" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:26:11 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Abbass-2008">
<DESCRIPTION>
<P>Comment: no psychotherapist was blinded to the treatment delivered</P>
<P>Blinding participants to treatment group not possible</P>
<P>Primary measures: self reports (BSI, IIP): low risk</P>
<P>Insufficient information on blinding of clinician ratings of GAF-S, therefore overall bias considered unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:26:19 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Alstrom-1984a">
<DESCRIPTION>
<P>Comment: therapists outcome ratings (free anxiety and global symptoms) were unblinded thus considered a high risk of detection bias</P>
<P>Blinding participants to treatment group not possible</P>
<P>No psychotherapist was blinded to the treatment delivered</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:32:41 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Alstrom-1984b">
<DESCRIPTION>
<P>Comment: therapists were raters of some cases and may have been unblinded: high risk</P>
<P>Blinding participants to treatment group not possible</P>
<P>No psychotherapist was blinded to the treatment delivered</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:26:41 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Baldoni-1995">
<DESCRIPTION>
<P>Comment: self report questionnaires only: low risk</P>
<P>Blinding participants to treatment group not possible</P>
<P>No psychotherapist was blinded to the treatment delivered</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 13:28:13 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Bressi-2010">
<DESCRIPTION>
<P>Comment: self report data (IIP, SCL-90-GSI and anxiety and depression subscales) considered low risk of detection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:26:45 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Brom-1989">
<DESCRIPTION>
<P>Comment: self reports used (SCL90, STAI, Stait Trait Anger Inventory): low risk</P>
<P>No psychotherapist was blinded to the treatment delivered</P>
<P>Blinding participants to treatment group not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 09:48:44 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Burnand-2002">
<DESCRIPTION>
<P>Quote: "All raters were independent...[however]...individuals who rated the presence and severity of major depression and HSRS score at 10 weeks were not blinded to treatment assignment"</P>
<P>Comment: high risk of detection bias due to raters not being blinded to treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:26:51 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Carrington-1979">
<DESCRIPTION>
<P>Comment: self report only. Low risk</P>
<P>No psychotherapist was blinded to the treatment delivered</P>
<P>Blinding participants to treatment group not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 09:56:09 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Cooper-2003">
<DESCRIPTION>
<P>Comment: self report data (EPDS) considered low risk of detection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:26:53 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Creed-2003">
<DESCRIPTION>
<P>Comment: self report data (SCL-90, SF-36, VAS) considered low risk of detection bias</P>
<P>No psychotherapist was blinded to the treatment delivered</P>
<P>Blinding participants to treatment group not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:26:56 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Dare-2001">
<DESCRIPTION>
<P>Some ratings were done by unblinded clinicians</P>
<P>No psychotherapist was blinded to the treatment delivered</P>
<P>Blinding participants to treatment group not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 10:22:37 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Emmelkamp-2006">
<DESCRIPTION>
<P>Comment: self report data (LWASQ) considered low risk of detection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 10:26:07 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Guthrie-1993">
<DESCRIPTION>
<P>Comment: self report measures (BDI) considered low risk of detection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:27:36 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Guthrie-1999">
<DESCRIPTION>
<P>Comment: self report measures (SCL-90-GSI and Depression subscale, SF-36 social functioning scale and pain scale) considered low risk of detection bias</P>
<P>No psychotherapist was blinded to the treatment delivered</P>
<P>Blinding participants to treatment group not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 10:36:50 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Guthrie-2001">
<DESCRIPTION>
<P>Comment: self report ratings (BDI) considered low risk of detection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:27:56 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Hamilton-2000">
<DESCRIPTION>
<P>Quote: "The gastroenterologists remained blind to the treatment groups"</P>
<P>Comment: physician were blinded to treatment, therefore, scores on somatic symptoms at termination: low risk of bias</P>
<P>Participants could not be blinded to treatment allocation</P>
<P>Self report data on the SCL-90: low risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:28:58 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Levy-Berg-2009">
<DESCRIPTION>
<P>Comment: participants could not be blinded to treatment group. Risk of detection bias considered low based on use of participant self report measures. No psychotherapist was blinded to the treatment delivered</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 22:51:43 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Linnet-2001">
<DESCRIPTION>
<P>Comment: self reported anxiety symptoms (low risk) plus blind rating but unclear how blinded rater was using the SCORAD (unclear risk). No psychotherapist was blinded to the treatment delivered. Blinding participants to treatment group not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:32:46 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Maina-2005">
<DESCRIPTION>
<P>Comment:</P>
<P>Blinded outcome rater HAM-D, HAM-A, CGI: low risk</P>
<P>No psychotherapist was blinded to the treatment he or she delivered by definition</P>
<P>Blinding participants to treatment group not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 11:08:29 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Maina-2010">
<DESCRIPTION>
<P>Comment: raters were blinded and not therapists or treaters in study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:29:10 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Marmar-1988">
<DESCRIPTION>
<P>Quote: "In every case the independent evaluator (who) was not the same person as the treating clinician"</P>
<P>Self reports (BDI, SCL90, SAS): low risk</P>
<P>Blinding participants to treatment group not possible</P>
<P>No psychotherapist was blinded to the treatment delivered</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-07 17:21:53 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Milrod-2007">
<DESCRIPTION>
<P>Comment:</P>
<P>Use of self report ratings (Sheehan Disability Scale) and blinded observer raters for depression and anxiety ratings deemed low risk of detection bias</P>
<P>No psychotherapist was blinded to the treatment delivered</P>
<P>Blinding participants to treatment group not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:29:44 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Monsen-2000">
<DESCRIPTION>
<P>Comment: mainly self report measures used (SCL, VAS, IIP): low risk</P>
<P>Blind ratings of Affect Consciousness Scales: low risk</P>
<P>No psychotherapist was blinded to the treatment delivered</P>
<P>Blinding participants to treatment group not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 11:25:10 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Piper-1990">
<DESCRIPTION>
<P>Comment: self report data (SCL-90, BDI, STAI) considered low risk of detection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 11:44:59 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Sattel-2012">
<DESCRIPTION>
<P>Comment: self report measures were used. Healthcare use was recorded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 11:49:04 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Shefler-1995">
<DESCRIPTION>
<P>Comment: self report data (BSI) considered low risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 11:53:07 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Sloane-1975">
<DESCRIPTION>
<P>Quote: "assessors were blind as to type of therapy in most cases, but a few patients inadvertently gave clues to their therapist&#8217;s identity...A comparison of outcome ratings did not reveal any bias toward any group"</P>
<P>Comment: method for observer ratings on patient Target complaint ratings and SSIAM indicate an unclear risk of possible bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:30:57 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Svedlund-1983">
<DESCRIPTION>
<P>Comment: therapists were raters of some cases and may have been unblinded (CPRS, SSIAM): high risk</P>
<P>Self reports (social adjustment): low risk</P>
<P>No psychotherapist was blinded to the treatment delivered</P>
<P>Blinding participants to treatment group not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-07 17:23:37 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-S_x00f8_rensen-2010">
<DESCRIPTION>
<P>Quote: "It was not possible to blind the patients and therapists to the group allocation, but the raters assessing outcome were blinded with respect to group assignment. The blinding was evaluated"</P>
<P>Comments: self report data (Health Anxiety Inventory, BAI) considered low risk of detection bias. Objective ratings (HAMA, HAMD) considered low risk of detection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:31:23 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Vitriol-2009">
<DESCRIPTION>
<P>Comment: observer-rated outcome ratings (HAM-D) and participant self report ratings (OQ-45, PTO) considered a low risk of detection bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 14:31:27 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Wiborg-1996">
<DESCRIPTION>
<P>Comment: self report outcome data (SCL-90) considered low risk of detection bias. Insufficient information on blinding of observer-rated measures (HAM-D, HAM-A, Sheehan Disability Scale); therefore, bias considered unclear</P>
<P>No psychotherapist was blinded to the treatment delivered</P>
<P>Blinding participants to treatment group not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 15:06:23 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Winston-1994">
<DESCRIPTION>
<P>Comment: self report ratings (SCL-90, SAS) considered low risk of bias</P>
<P>No psychotherapist was blinded to the treatment delivered</P>
<P>Blinding participants to treatment group not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-06 10:18:33 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-de-Jonghe-2001">
<DESCRIPTION>
<P>Quote: "Patients and treating physicians were not masked to randomisation, the raters were not informed about the treatment condition and were instructed to restrict themselves to discussion of the HRSD items"</P>
<P>Comment: the use of independent raters to rate depression (HSRD) minimises a risk of detection bias - low risk. However, physician rated psychiatric symptoms (CGI-S) scores bring a high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2014-05-15 12:55:38 +0100" MODIFIED_BY="Anne Lawson" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 09:19:25 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Abbass-2008">
<DESCRIPTION>
<P>Comment: 1 drop-out only and ITT analysis performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 14:26:20 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Alstrom-1984a">
<DESCRIPTION>
<P>Comment: all participants completed treatment but only 8/10 in the control group provided follow-up data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 09:27:56 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Alstrom-1984b">
<DESCRIPTION>
<P>Comment: significant dropout rate (12/73 participants) but how handled was not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 09:36:53 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Baldoni-1995">
<DESCRIPTION>
<P>Comment: did not include drop-outs in analysis but reported on clinical status</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 14:33:12 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Bressi-2010">
<DESCRIPTION>
<P>Quote: "intention-to-treat analysis was performed...observation carried forward for participants who did not complete the trial"</P>
<P>Comment: ITT controlled for incomplete data. 80% completed the trial, with equal non-completers across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 09:46:11 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Brom-1989">
<DESCRIPTION>
<P>Comment: even distribution of drop-outs</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 09:48:57 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Burnand-2002">
<DESCRIPTION>
<P>Comment: 22% excluded from analyses because they did not begin treatment, mostly due to exclusion characteristics. This was similar across group, and ITT analyses were conducted</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 09:51:11 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Carrington-1979">
<DESCRIPTION>
<P>Comment: no missing data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 14:33:20 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Cooper-2003">
<DESCRIPTION>
<P>Comment: incomplete data (&gt; 20%) at 5-year follow-up; however, comparison between completer only analyses versus ITT aimed to address attrition bias in respect to drop-out</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 14:26:54 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Creed-2003">
<DESCRIPTION>
<P>Comment: all participants followed and measured and ITT analyses used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 10:02:09 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Dare-2001">
<DESCRIPTION>
<P>ITT analyses were performed. None of the differences between treatments in the rates of engagement was statistically significant</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 21:37:05 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Emmelkamp-2006">
<DESCRIPTION>
<P>Quote: "Six patients in total withdrew before the post treatment assessment...forty-six (46/62) cases for follow-up analyses"</P>
<P>Comment: ITT not reported. Follow-up data likely to be effected by missing data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 21:37:18 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Guthrie-1993">
<DESCRIPTION>
<P>Quote: "data for drop-outs have been included in the results that indicate the overall efficacy of treatments"</P>
<P>Comment: similar drop-outs between groups, data collected for all but 2 of dropouts and included in analyses</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 10:31:58 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Guthrie-1999">
<DESCRIPTION>
<P>Comment: data analysed using ITT and adequate description of number and reason for drop-outs</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 10:37:09 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Guthrie-2001">
<DESCRIPTION>
<P>Quote: "psychological assessments were completed in 74.8% patients at the end of treatment, and 78.9% at follow-up"</P>
<P>Comment: significant attrition reported. No ITT described and insufficient information provided about reasons for incomplete information suggest risk of attrition bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 14:28:02 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Hamilton-2000">
<DESCRIPTION>
<P>Comment: at end of treatment, 37/37 in the experimental group completed outcome data and 31/36 in the control group. Treatment drop-out was similar across groups but none of the participants in the control group provided outcome data: this would suggest attrition bias. At follow-up, these figures were 31/37 in the experimental group and 27/36 in the control group. In total, data were available for 79.5% of participants at 1-year follow-up. ITT analysis performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-15 12:55:38 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Levy-Berg-2009">
<DESCRIPTION>
<P>Comment: at a year after start of therapy, 28% in the TAU did not complete outcome assessments, otherwise missing data was minimal and comparable between groups. ITT controlled for incomplete data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 10:53:27 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Linnet-2001">
<DESCRIPTION>
<P>Comment: the study authors found and reported evidence of attrition bias in anxiety levels in the control group without statistically controlling for bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 21:40:27 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Maina-2005">
<DESCRIPTION>
<P>Comment: no drop-outs</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 14:33:47 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Maina-2010">
<DESCRIPTION>
<P>Comment: ITT analysis and low dropout rate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 11:11:53 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Marmar-1988">
<DESCRIPTION>
<P>Comment: missing data imputed using last values carried forward procedure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 11:15:31 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Milrod-2007">
<DESCRIPTION>
<P>Quote: "rates of dropout [between groups]... differed significantly....The analysis adhered to intention to the treat principle"</P>
<P>Comment: attrition 7% in psychodynamic group compared with 34% in applied relaxation training group. ITT analyses controlled for outcome attrition</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 11:21:47 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Monsen-2000">
<DESCRIPTION>
<P>Quote: "all patients participated in the assessments at T1 [pre-treatment], T2 [post-treatment] and T3 [1-year follow-up], except one person in the control group absent at T3 due to complications after child birth"</P>
<P>Comment: proportion of missing data not likely to have relevant impact</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 14:34:02 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Piper-1990">
<DESCRIPTION>
<P>Comment: it was reported that 11 in the immediate therapy condition and 9 in the delayed therapy condition dropped out, and 67/86 provided follow-up data. Insufficient information was provided on reasons for missing data to determine judgement of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 11:45:21 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Sattel-2012">
<DESCRIPTION>
<P>Quote: "Analyses...were based on the intent to-treat method for all participants and confirmed that the missing data for the primary and secondary outcomes were missing at random... Multiple imputations were used to replace missing data, which consisted mainly of patients who were lost to follow-up (n = 26). We performed sensitivity analyses to estimate the potential differences in the imputed outcomes v. those derived from incomplete data"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 14:30:27 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Shefler-1995">
<DESCRIPTION>
<P>Quote: "the numbers represent the number of patients who had complete ratings on all three occasions"</P>
<P>Comment: completer only analyses presented and no data on participant drop-out</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 14:30:53 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Sloane-1975">
<DESCRIPTION>
<P>Comment: at termination (4 months), attrition across groups was small: intervention 0/30, control 3/33. At follow-up, although a large percentage of participants received additional treatment, data for these participants versus those who did not require additional therapy suggested total sample data remained valid</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 21:43:44 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Svedlund-1983">
<DESCRIPTION>
<P>Quote: "dropouts can be ruled out as contributing to different outcomes"</P>
<P>Comment: only 1 drop-out from each group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-08 13:47:19 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-S_x00f8_rensen-2010">
<DESCRIPTION>
<P>Quote: "we used a modified ITT analysis" and "missing data were imputed using the last observation carried forward procedure"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 14:31:25 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Vitriol-2009">
<DESCRIPTION>
<P>Comment: a similar level of attrition was present in the intervention group (9/45) compared with standard treatment (11/46) but there may have been differences in the reasons for drop-out between groups: 4 in the intervention group "got better". However, outcome data were available for 91% of participants at 3 months and 81% at 6 months and ITT analyses were conducted thus minimising possible effects of missing data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 12:20:17 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Wiborg-1996">
<DESCRIPTION>
<P>Comment: all evaluated at all points</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 14:31:37 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Winston-1994">
<DESCRIPTION>
<P>Quote: "the patients who dropped out of the study were similar to the treated patients in both demographic characteristics and diagnosis, although no formal analyses were conducted because of the small number of dropouts"</P>
<P>Comment: 6/31 participants in STDP dropped out vs. 2/32 in BAP: this is considered significant enough to warrant analysis to rule out attrition bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-06 10:18:57 +0100" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-de-Jonghe-2001">
<DESCRIPTION>
<P>Comment: ITT analyses conducted and ITT data used in analyses of depression and social adjustment, thus minimising the risk of attrition bias. Per-protocol data used for examining CGI, therefore, high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2014-05-06 14:34:14 +0100" MODIFIED_BY="Anne Lawson" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:06 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Abbass-2008">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 09:23:24 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Alstrom-1984a">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:08 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Alstrom-1984b">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 09:36:55 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Baldoni-1995">
<DESCRIPTION>
<P>Comment: did not include complete outcome data on all measures for entry in a meta-analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 09:42:43 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Bressi-2010">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:16 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Brom-1989">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:32:06 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Burnand-2002">
<DESCRIPTION>
<P>Comment: &#8805; 1 outcomes of interest were reported incompletely so that they cannot be entered in a meta-analysis (e.g., HAM-D not provided at discharge)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:19 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Carrington-1979">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes. &#8805; 1 outcomes of interest reported incompletely; however, additional data obtained from study authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:21 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Cooper-2003">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:22 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Creed-2003">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 10:02:17 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Dare-2001">
<DESCRIPTION>
<P>Some measures of the Morgan Russell Schedule were not reported by therapy group, rather for the whole group only. The stated reason for this was that there were no intra-group differences</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:33 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Emmelkamp-2006">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:35 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Guthrie-1993">
<DESCRIPTION>
<P>Comment: insufficient Information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:32:23 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Guthrie-1999">
<DESCRIPTION>
<P>Comment: &#8805; 1 outcomes are reported incompletely so that they cannot be entered in a meta-analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:37 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Guthrie-2001">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:39 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Hamilton-2000">
<DESCRIPTION>
<P>Comment: insufficient information provided to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:40 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Levy-Berg-2009">
<DESCRIPTION>
<P>Comment: incomplete information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 10:53:49 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Linnet-2001">
<DESCRIPTION>
<P>Comment: &#8805; 1 outcomes are reported incompletely so that they could not be entered in a meta-analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:43 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Maina-2005">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:50 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Maina-2010">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:56 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Marmar-1988">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:58 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Milrod-2007">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:59 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Monsen-2000">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:41:14 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Piper-1990">
<DESCRIPTION>
<P>Comment: &#8805; 1 outcomes are reported incompletely so they could not be entered in a meta-analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:03 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Sattel-2012">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:05 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Shefler-1995">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:54:19 +0100" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Sloane-1975">
<DESCRIPTION>
<P>Comment: &#8805; 1 outcomes of interest are reported incompletely so that they cannot be entered in a meta-analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:08 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Svedlund-1983">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes. Additional information was obtained from the authors to be entered in a meta-analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:09 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-S_x00f8_rensen-2010">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:11 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Vitriol-2009">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:12 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Wiborg-1996">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:14 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Winston-1994">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:27 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-de-Jonghe-2001">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement. No published report on pre-specified outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2014-05-06 14:34:15 +0100" MODIFIED_BY="Anne Lawson" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:07 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Abbass-2008">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:07 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Alstrom-1984a">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:09 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Alstrom-1984b">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 09:37:02 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Baldoni-1995">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:15 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Bressi-2010">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:17 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Brom-1989">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:17 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Burnand-2002">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:19 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Carrington-1979">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:21 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Cooper-2003">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:22 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Creed-2003">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:23 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Dare-2001">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:33 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Emmelkamp-2006">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:36 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Guthrie-1993">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:36 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Guthrie-1999">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:37 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Guthrie-2001">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:39 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Hamilton-2000">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:40 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Levy-Berg-2009">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:42 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Linnet-2001">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:43 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Maina-2005">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:51 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Maina-2010">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:56 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Marmar-1988">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:58 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Milrod-2007">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:59 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Monsen-2000">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:02 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Piper-1990">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:04 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Sattel-2012">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:06 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Shefler-1995">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:07 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Sloane-1975">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:09 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Svedlund-1983">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 12:02:37 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-S_x00f8_rensen-2010">
<DESCRIPTION>
<P>Model of STPP is restricted from using core psychodynamic techniques and questionable as to whether or not it is a bona fide versus a "built to under perform" control model of STPP</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:11 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Vitriol-2009">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:13 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Wiborg-1996">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:34:15 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Winston-1994">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 14:33:28 +0100" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-de-Jonghe-2001">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2012-12-04 00:05:52 +0000" MODIFIED_BY="[Empty name]"/>
<ADDITIONAL_TABLES MODIFIED="2014-05-15 13:08:18 +0100" MODIFIED_BY="Anne Lawson">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2014-05-15 13:08:18 +0100" MODIFIED_BY="Anne Lawson" NO="1">
<TITLE>Properties of studies</TITLE>
<TABLE COLS="9" ROWS="34">
<TR>
<TD>
<P>
<B>Study</B>
</P>
</TD>
<TD>
<P>
<B>Diagnosis</B>
</P>
</TD>
<TD>
<P>
<B>Manualised</B>
</P>
</TD>
<TD>
<P>
<B>Observer</B>
</P>
<P>
<B>rated</B>
</P>
</TD>
<TD>
<P>
<B>Medication</B>
</P>
<P>
<B>on both arms</B>
</P>
</TD>
<TD>
<P>
<B>Wait-list/</B>
</P>
<P>
<B>minimal</B>
</P>
<P>
<B>treatment</B>
</P>
<P>
<B>control</B>
</P>
</TD>
<TD>
<P>
<B>20 or fewer </B>
</P>
<P>
<B>sessions</B>
</P>
</TD>
<TD>
<P>
<B>Malan/</B>
</P>
<P>
<B>Davanloo</B>
</P>
</TD>
<TD>
<P>
<B>Hobson/</B>
</P>
<P>
<B>PIT</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Abbass-2008" TYPE="STUDY">Abbass 2008</LINK>
</P>
</TD>
<TD>
<P>Mixed: personality disorders</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Alstrom-1984a" TYPE="STUDY">Alstrom 1984a</LINK>
</P>
</TD>
<TD>
<P>Anxiety: social phobia</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Alstrom-1984b" TYPE="STUDY">Alstrom 1984b</LINK>
</P>
</TD>
<TD>
<P>Anxiety: agoraphobia</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Baldoni-1995" TYPE="STUDY">Baldoni 1995</LINK>
</P>
</TD>
<TD>
<P>Somatic/medical: urethral syndrome</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bressi-2010" TYPE="STUDY">Bressi 2010</LINK>
</P>
</TD>
<TD>
<P>Mixed: depressive and anxiety disorders</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Brom-1989" TYPE="STUDY">Brom 1989</LINK>
</P>
</TD>
<TD>
<P>Anxiety: PTSD</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Burnand-2002" TYPE="STUDY">Burnand 2002</LINK>
</P>
</TD>
<TD>
<P>Depression: major depression</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Carrington-1979" TYPE="STUDY">Carrington 1979</LINK>
</P>
</TD>
<TD>
<P>Depression: Feighner Criteria</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Cooper-2003" TYPE="STUDY">Cooper 2003</LINK>
</P>
</TD>
<TD>
<P>Depression: postpartum depression</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Creed-2003" TYPE="STUDY">Creed 2003</LINK>
</P>
</TD>
<TD>
<P>Somatic/medical: IBS</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dare-2001" TYPE="STUDY">Dare 2001</LINK>
</P>
</TD>
<TD>
<P>Anorexia nervosa</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes/No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-de-Jonghe-2001" TYPE="STUDY">de Jonghe 2001</LINK>
</P>
</TD>
<TD>
<P>Depression: major depression</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Emmelkamp-2006" TYPE="STUDY">Emmelkamp 2006</LINK>
</P>
</TD>
<TD>
<P>Mixed: personality disorders</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Guthrie-1993" TYPE="STUDY">Guthrie 1993</LINK>
</P>
</TD>
<TD>
<P>Somatic/medical: IBS</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Guthrie-1999" TYPE="STUDY">Guthrie 1999</LINK>
</P>
</TD>
<TD>
<P>Mixed diagnoses: general outpatient referrals</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Guthrie-2001" TYPE="STUDY">Guthrie 2001</LINK>
</P>
</TD>
<TD>
<P>Mixed diagnoses: self poisoning presenting to emergency</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Hamilton-2000" TYPE="STUDY">Hamilton 2000</LINK>
</P>
</TD>
<TD>
<P>Somatic/medical: functional dyspepsia</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Levy-Berg-2009" TYPE="STUDY">Levy Berg 2009</LINK>
</P>
</TD>
<TD>
<P>Anxiety: generalised anxiety disorder</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Linnet-2001" TYPE="STUDY">Linnet 2001</LINK>
</P>
</TD>
<TD>
<P>Somatic/medical: atopic dermatitis</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Maina-2005" TYPE="STUDY">Maina 2005</LINK>
</P>
</TD>
<TD>
<P>Mixed: mood and anxiety disorders</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Maina-2010" TYPE="STUDY">Maina 2010</LINK>
</P>
</TD>
<TD>
<P>Mixed: OCD and depression</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Marmar-1988" TYPE="STUDY">Marmar 1988</LINK>
</P>
</TD>
<TD>
<P>Mixed: major depression, PTSD, adjustment disorders</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Milrod-2007" TYPE="STUDY">Milrod 2007</LINK>
</P>
</TD>
<TD>
<P>Anxiety: panic disorder</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Monsen-2000" TYPE="STUDY">Monsen 2000</LINK>
</P>
</TD>
<TD>
<P>Somatic/medical: pain syndromes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Piper-1990" TYPE="STUDY">Piper 1990</LINK>
</P>
</TD>
<TD>
<P>Mixed: mood, anxiety, adjustment, axis II</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Sattel-2012" TYPE="STUDY">Sattel 2012</LINK>
</P>
</TD>
<TD>
<P>Somatic/medical: multisomatoform disorders</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Shefler-1995" TYPE="STUDY">Shefler 1995</LINK>
</P>
</TD>
<TD>
<P>Mixed: anxiety, depression, adjustment disorders</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Sloane-1975" TYPE="STUDY">Sloane 1975</LINK>
</P>
</TD>
<TD>
<P>Mixed: 'psychoneuroses' and axis II</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-S_x00f8_rensen-2010" TYPE="STUDY">Sørensen 2010</LINK>
</P>
</TD>
<TD>
<P>Anxiety: hypochondriasis</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Svedlund-1983" TYPE="STUDY">Svedlund 1983</LINK>
</P>
</TD>
<TD>
<P>Somatic/medical: IBS</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Vitriol-2009" TYPE="STUDY">Vitriol 2009</LINK>
</P>
</TD>
<TD>
<P>Depression: severe major depression</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK>
</P>
</TD>
<TD>
<P>Anxiety: panic disorder</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Winston-1994" TYPE="STUDY">Winston 1994</LINK>
</P>
</TD>
<TD>
<P>Mixed: personality disorders</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>OCD: obsessive-compulsive disorder; IBS: irritable bowel syndrome; PIT: psychodynamic interpersonal therapy; PTSD: post-traumatic stress disorder.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2014-05-07 18:08:23 +0100" MODIFIED_BY="Anne Lawson" NO="2">
<TITLE MODIFIED="2014-04-16 12:14:15 +0100" MODIFIED_BY="[Empty name]">Subgroup analyses</TITLE>
<TABLE COLS="8" ROWS="13">
<TR>
<TD>
<P>
<B>Outcome or subgroup</B>
</P>
</TD>
<TD>
<P>
<B>Manualised</B>
</P>
<P>
<B>(SMD (95% CI)</B>
</P>
</TD>
<TD>
<P>
<B>Observer-rated outcomes</B>
</P>
<P>
<B>(SMD (95% CI)</B>
</P>
</TD>
<TD>
<P>
<B>Medications on both arms</B>
</P>
<P>
<B>(SMD (95% CI)</B>
</P>
</TD>
<TD>
<P>
<B>Wait-list or minimal treatment controls</B>
</P>
<P>
<B>(SMD (95% CI)</B>
</P>
</TD>
<TD>
<P>
<B>20 or fewer sessions</B>
</P>
<P>
<B>(SMD (95% CI)</B>
</P>
</TD>
<TD>
<P>
<B>Malan/</B>
</P>
<P>
<B>Davanloo</B>
</P>
<P>
<B>(SMD (95% CI)</B>
</P>
</TD>
<TD>
<P>
<B>Hobson/</B>
</P>
<P>
<B>PIT</B>
</P>
<P>
<B>(SMD (95% CI)</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1.1 Reduction in general psychiatric symptoms: short-term</P>
</TD>
<TD VALIGN="TOP">
<P>-0.49 (-0.72 to -0.27)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.87 (-1.37 to -0.37)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.38 (-0.59 to -0.16)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.67 (-0.92 to -0.43)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.69 (-1.08 to -0.30)</P>
</TD>
<TD VALIGN="TOP">
<P>-1.28 (-2.06 to -0.49)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.19 (-0.39 to 0.01)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1.2 Reduction in general psychiatric symptoms: medium-term</P>
</TD>
<TD VALIGN="TOP">
<P>-0.09 (-0.34 to 0.15)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.37 (-0.66 to -0.08)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.31 (-0.66 to 0.04)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.50 (-1.01 to 0.01)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.23 (-0.44 to -0.02)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.11 (-0.64 to 0.43)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.09 (-0.36 to 0.18)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1.3 Reduction in general psychiatric symptoms: long-term</P>
</TD>
<TD VALIGN="TOP">
<P>-0.44 (-1.26 to 0.39)</P>
</TD>
<TD VALIGN="TOP">
<P>-2.01 (-4.29 to 0.27)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.91 (-1.56 to -0.26)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.60 (-1.11 to -0.08)</P>
</TD>
<TD VALIGN="TOP">
<P>-1.51 (-3.14 to 0.12)</P>
</TD>
<TD VALIGN="TOP">
<P>-2.73 (-6.30 to 0.84)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.06 (-0.39 to 0.26)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1.4 Reduction in somatic symptoms: short-term</P>
</TD>
<TD VALIGN="TOP">
<P>-0.11 (-0.33 to 0.12)</P>
</TD>
<TD VALIGN="TOP">
<P>-1.22 (-3.62 to 1.17)</P>
</TD>
<TD VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD VALIGN="TOP">
<P>-0.34 (-0.92 to 0.25)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.60 (-1.34 to 0.13)</P>
</TD>
<TD VALIGN="TOP">
<P>-1.71 (-5.73 to 2.30)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.11 (-0.33 to 0.12)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1.5 Reduction in somatic symptoms: medium-term</P>
</TD>
<TD VALIGN="TOP">
<P>-1.91 (-5.18 to 1.35)</P>
</TD>
<TD VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD VALIGN="TOP">
<P>-1.58 (-3.56 to 0.39)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.94 (-1.71 to -0.17)</P>
</TD>
<TD VALIGN="TOP">
<P>-1.91 (-5.18 to 1.35)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1.6 Reduction in somatic symptoms: long-term</P>
</TD>
<TD VALIGN="TOP">
<P>0.05 (-0.27 to 0.37)</P>
</TD>
<TD VALIGN="TOP">
<P>-6.61 (-7.62 to -5.59)</P>
</TD>
<TD VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD VALIGN="TOP">
<P>-2.21 (-5.49 to 1.07)</P>
</TD>
<TD VALIGN="TOP">
<P>-3.38 (-9.68 to 2.91)</P>
</TD>
<TD VALIGN="TOP">
<P>0.05 (-0.27 to 0.37)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1.7 Reduction in anxiety symptoms: short-term</P>
</TD>
<TD VALIGN="TOP">
<P>-0.45 (-0.80 to -0.10)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.82 (-1.43 to -0.21)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.50 (-1.16 to 0.17)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.47 (-0.74 to -0.20)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.74 (-1.23 to -0.25)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.97 (-1.90 to -0.05)</P>
</TD>
<TD VALIGN="TOP">
<P>0.00 (-0.27 to 0.27)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1.8 Reduction in anxiety symptoms: medium-term</P>
</TD>
<TD VALIGN="TOP">
<P>-0.10 (-0.34 to 0.14)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.28 (-0.56 to -0.01)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.24 (-0.64 to 0.16)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.60 (-1.26 to 0.06)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.57 (-1.05 to -0.08)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.83 (-2.45 to 0.79)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.13 (-0.40 to 0.14)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1.9 Reduction in anxiety symptoms: long-term</P>
</TD>
<TD VALIGN="TOP">
<P>-0.45 (-1.12 to 0.23)</P>
</TD>
<TD VALIGN="TOP">
<P>-1.58 (-3.37 to 0.21)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.82 (-1.47 to -0.17)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.32 (-0.69 to 0.05)</P>
</TD>
<TD VALIGN="TOP">
<P>-1.35 (-2.73 to 0.03)</P>
</TD>
<TD VALIGN="TOP">
<P>-1.64 (-3.45 to 0.18)</P>
</TD>
<TD VALIGN="TOP">
<P>Not estimable</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1.10 Reduction in depressive symptoms: short-term</P>
</TD>
<TD VALIGN="TOP">
<P>-0.56 (-0.81 to -0.31)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.66 (-0.99 to -0.32)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.43 (-0.63 to -0.23)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.71 (-1.20 to -0.22)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.68 (-0.99 to -0.36)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.93 (-1.16 to -0.70)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.26 (-0.45 to -0.06)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1.11 Reduction in depressive symptoms: medium-term</P>
</TD>
<TD VALIGN="TOP">
<P>-0.14 (-0.34 to 0.07)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.57 (-1.00 to -0.14)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.51 (-0.99 to -0.04)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.29 (-0.79 to 0.22)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.33 (-0.61 to -0.05)</P>
</TD>
<TD VALIGN="TOP">
<P>-1.40 (-2.22 to -0.59)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.20 (-0.44 to 0.04)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1.12 Reduction in depressive symptoms: long-term</P>
</TD>
<TD VALIGN="TOP">
<P>-0.26 (-0.93 to 0.41)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.41 (-0.75 to -0.06)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.65 (-1.29 to -0.01)</P>
</TD>
<TD VALIGN="TOP">
<P>-0.35 (-0.86 to 0.16)</P>
</TD>
<TD VALIGN="TOP">
<P>-1.00 (-2.22 to 0.21)</P>
</TD>
<TD VALIGN="TOP">
<P>-1.59 (-3.61 to 0.44)</P>
</TD>
<TD VALIGN="TOP">
<P>Not estimable</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CI: confidence interval; PIT: psychodynamic interpersonal therapy; SMD: standardised mean difference.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2014-05-06 22:12:09 +0100" MODIFIED_BY="Anne Lawson">
<COMPARISON ID="CMP-001" MODIFIED="2014-05-06 22:12:09 +0100" MODIFIED_BY="Anne Lawson" NO="1">
<NAME>STPP versus wait-list/treatment as usual/minimal treatment</NAME>
<CONT_OUTCOME CHI2="132.93950912325113" CI_END="-0.4078119895121388" CI_START="-1.0023580517150141" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.7050850206135765" ESTIMABLE="YES" I2="85.7077853489103" I2_Q="53.82826307003026" ID="CMP-001.01" MODIFIED="2013-11-27 23:26:07 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="-4.440892098500626E-16" P_Q="0.0700888075668109" P_Z="3.339894790605958E-6" Q="8.66330847822974" RANDOM="YES" SCALE="10.176517180618989" SORT_BY="STUDY" STUDIES="19" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.37759609542594513" TOTALS="YES" TOTAL_1="722" TOTAL_2="702" UNITS="" WEIGHT="100.00000000000003" Z="4.648727270418741">
<NAME>Reduction in general psychiatric symptoms: short-term</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.03478457204194954" CI_END="0.05256308459234499" CI_START="-0.7152404861365285" DF="1" EFFECT_SIZE="-0.3313387007720917" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.01" MODIFIED="2013-11-14 11:54:07 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8520478563439275" P_Z="0.09072044748170435" STUDIES="2" TAU2="0.0" TOTAL_1="59" TOTAL_2="48" WEIGHT="10.095011637101305" Z="1.691609533884061">
<NAME>anxiety disorders</NAME>
<CONT_DATA CI_END="0.2146195893857803" CI_START="-0.9621575410303291" EFFECT_SIZE="-0.3737689758222744" ESTIMABLE="YES" MEAN_1="169.6" MEAN_2="193.3" ORDER="163" SD_1="57.9" SD_2="67.7" SE="0.30020376386973874" STUDY_ID="STD-Brom-1989" TOTAL_1="26" TOTAL_2="20" WEIGHT="4.918474110814626"/>
<CONT_DATA CI_END="0.20670044046314073" CI_START="-0.8064728813860544" EFFECT_SIZE="-0.29988622046145685" ESTIMABLE="YES" MEAN_1="1.16" MEAN_2="1.4" MODIFIED="2011-08-05 17:22:54 +0100" MODIFIED_BY="[Empty name]" ORDER="103" SD_1="0.83" SD_2="0.74" SE="0.2584673315022564" STUDY_ID="STD-Levy-Berg-2009" TOTAL_1="33" TOTAL_2="28" WEIGHT="5.17653752628668"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.9855078395171832" CI_END="-0.19292637064568466" CI_START="-0.6681583660583903" DF="2" EFFECT_SIZE="-0.43054236835203746" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.02" MODIFIED="2013-11-14 11:54:15 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6109416469205897" P_Z="3.8332190880584595E-4" STUDIES="3" TAU2="0.0" TOTAL_1="145" TOTAL_2="136" WEIGHT="16.26759120472347" Z="3.5513077567757145">
<NAME>depressive disorders</NAME>
<CONT_DATA CI_END="-0.16657159901594953" CI_START="-1.1031719588577216" EFFECT_SIZE="-0.6348717789368356" ESTIMABLE="YES" MEAN_1="-62.8" MEAN_2="-58.3" MODIFIED="2012-02-09 19:28:00 +0000" MODIFIED_BY="[Empty name]" ORDER="101" SD_1="6.8" SD_2="7.2" SE="0.23893305367587264" STUDY_ID="STD-Burnand-2002" TOTAL_1="35" TOTAL_2="39" WEIGHT="5.2922467795147385"/>
<CONT_DATA CI_END="-0.005546127675956247" CI_START="-0.7083163807193711" EFFECT_SIZE="-0.3569312541976637" ESTIMABLE="YES" MEAN_1="2.34" MEAN_2="2.81" MODIFIED="2012-02-15 13:35:58 +0000" MODIFIED_BY="[Empty name]" ORDER="127" SD_1="1.3" SD_2="1.32" SE="0.17928142011454723" STUDY_ID="STD-de-Jonghe-2001" TOTAL_1="71" TOTAL_2="57" WEIGHT="5.614468881219265"/>
<CONT_DATA CI_END="0.08076071582739824" CI_START="-0.8090220051967714" EFFECT_SIZE="-0.36413064468468653" ESTIMABLE="YES" MEAN_1="59.09" MEAN_2="65.6" MODIFIED="2011-05-13 17:51:12 +0100" MODIFIED_BY="[Empty name]" ORDER="86" SD_1="18.35" SD_2="17.05" SE="0.22698955900278323" STUDY_ID="STD-Vitriol-2009" TOTAL_1="39" TOTAL_2="40" WEIGHT="5.360875543989466"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="106.50895505708736" CI_END="0.19933731179581082" CI_START="-2.6786632651009223" DF="3" EFFECT_SIZE="-1.2396629766525558" ESTIMABLE="YES" I2="97.18333543091092" ID="CMP-001.01.03" MODIFIED="2013-06-28 07:28:27 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.09132291317324823" STUDIES="4" TAU2="2.0791995473753464" TOTAL_1="214" TOTAL_2="205" WEIGHT="20.381700127217165" Z="1.688460250294042">
<NAME>somatoform disorders</NAME>
<CONT_DATA CI_END="0.47722241967882817" CI_START="-0.47722241967882817" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.67" MEAN_2="0.67" ORDER="164" SD_1="0.48" SD_2="0.52" SE="0.2434853004662829" STUDY_ID="STD-Hamilton-2000" TOTAL_1="37" TOTAL_2="31" WEIGHT="5.265644039823757"/>
<CONT_DATA CI_END="-0.06435263167482463" CI_START="-1.3459636614690456" EFFECT_SIZE="-0.7051581465719351" ESTIMABLE="YES" MEAN_1="0.4" MEAN_2="0.66" ORDER="165" SD_1="0.26" SD_2="0.44" SE="0.3269475969720375" STUDY_ID="STD-Monsen-2000" TOTAL_1="20" TOTAL_2="20" WEIGHT="4.748203045366431"/>
<CONT_DATA CI_END="-0.01328541603327199" CI_START="-0.5558339246873867" EFFECT_SIZE="-0.28455967036032936" ESTIMABLE="YES" MEAN_1="-41.9" MEAN_2="-38.3" MODIFIED="2013-06-28 07:28:27 +0100" MODIFIED_BY="[Empty name]" ORDER="116" SD_1="12.0" SD_2="13.2" SE="0.1384077750748657" STUDY_ID="STD-Sattel-2012" TOTAL_1="107" TOTAL_2="104" WEIGHT="5.798221900516501"/>
<CONT_DATA CI_END="-3.3654483539536524" CI_START="-4.755932774245089" EFFECT_SIZE="-4.060690564099371" ESTIMABLE="YES" MEAN_1="7.96" MEAN_2="11.34" ORDER="167" SD_1="0.62" SD_2="0.99" SE="0.3547219314383837" STUDY_ID="STD-Svedlund-1983" TOTAL_1="50" TOTAL_2="50" WEIGHT="4.569631141510476"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="14.499114752527916" CI_END="-0.22207696354869794" CI_START="-0.7723778201466056" DF="7" EFFECT_SIZE="-0.49722739184765175" ESTIMABLE="YES" I2="51.72119043488809" ID="CMP-001.01.04" MODIFIED="2013-06-23 14:06:40 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.04298372544695839" P_Z="3.9729721534724455E-4" STUDIES="8" TAU2="0.07718551062771432" TOTAL_1="235" TOTAL_2="248" WEIGHT="39.118544847616654" Z="3.5418726627942085">
<NAME>mixed disorders</NAME>
<CONT_DATA CI_END="-0.07528938358518322" CI_START="-1.2397071967878333" EFFECT_SIZE="-0.6574982901865083" ESTIMABLE="YES" MEAN_1="0.62" MEAN_2="1.05" MODIFIED="2011-05-13 17:54:49 +0100" MODIFIED_BY="[Empty name]" ORDER="163" SD_1="0.5" SD_2="0.76" SE="0.297050818889385" STUDY_ID="STD-Bressi-2010" TOTAL_1="24" TOTAL_2="24" WEIGHT="4.93835674361973"/>
<CONT_DATA CI_END="0.26345787628771294" CI_START="-0.5178010261514407" EFFECT_SIZE="-0.12717157493186387" ESTIMABLE="YES" MEAN_1="1.82" MEAN_2="1.92" ORDER="168" SD_1="0.79" SD_2="0.77" SE="0.19930440268332075" STUDY_ID="STD-Guthrie-1999" TOTAL_1="52" TOTAL_2="49" WEIGHT="5.512484345448592"/>
<CONT_DATA CI_END="-0.9165004357418889" CI_START="-3.1677652651336263" EFFECT_SIZE="-2.0421328504377576" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="4.5" ORDER="169" SD_1="1.3" SD_2="0.5" SE="0.5743128055284248" STUDY_ID="STD-Maina-2005" TOTAL_1="10" TOTAL_2="10" WEIGHT="3.251850515691696"/>
<CONT_DATA CI_END="0.4286625213575942" CI_START="-0.6419613296663657" EFFECT_SIZE="-0.1066494041543857" ESTIMABLE="YES" MEAN_1="3.32" MEAN_2="3.45" MODIFIED="2013-06-23 14:06:40 +0100" MODIFIED_BY="[Empty name]" ORDER="128" SD_1="1.4" SD_2="1.0" SE="0.2731233480484601" STUDY_ID="STD-Maina-2010" TOTAL_1="25" TOTAL_2="29" WEIGHT="5.087348924426943"/>
<CONT_DATA CI_END="0.1716755970661068" CI_START="-0.8397039016579364" EFFECT_SIZE="-0.3340141522959148" ESTIMABLE="YES" MEAN_1="0.93" MEAN_2="1.15" ORDER="170" SD_1="0.66" SD_2="0.64" SE="0.25800971515335885" STUDY_ID="STD-Marmar-1988" TOTAL_1="31" TOTAL_2="30" WEIGHT="5.17929205614445"/>
<CONT_DATA CI_END="-0.20068986544780287" CI_START="-0.9904649257069884" EFFECT_SIZE="-0.5955773955773956" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.9" ORDER="171" SD_1="0.5" SD_2="0.5" SE="0.20147693184385795" STUDY_ID="STD-Piper-1990" TOTAL_1="47" TOTAL_2="57" WEIGHT="5.501006831896028"/>
<CONT_DATA CI_END="-0.1591213359729039" CI_START="-1.6212049293476039" EFFECT_SIZE="-0.8901631326602538" ESTIMABLE="YES" MEAN_1="64.31" MEAN_2="72.31" ORDER="172" SD_1="10.33" SD_2="6.84" SE="0.3729873622442628" STUDY_ID="STD-Shefler-1995" TOTAL_1="16" TOTAL_2="16" WEIGHT="4.45208256986102"/>
<CONT_DATA CI_END="0.0801174767886747" CI_START="-0.9202732872009383" EFFECT_SIZE="-0.4200779052061318" ESTIMABLE="YES" MEAN_1="5.27" MEAN_2="6.45" ORDER="173" SD_1="2.7" SD_2="2.84" SE="0.255206414985318" STUDY_ID="STD-Sloane-1975" TOTAL_1="30" TOTAL_2="33" WEIGHT="5.196122860528198"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.5971913759947267" CI_END="-0.6195497090815627" CI_START="-1.3432809483743502" DF="2" EFFECT_SIZE="-0.9814153287279564" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.05" MODIFIED="2012-03-15 17:54:53 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.44996058335558964" P_Z="1.0629707300649023E-7" STUDIES="2" TAU2="0.0" TOTAL_1="69" TOTAL_2="65" WEIGHT="14.137152183341419" Z="5.315616056761534">
<NAME>personality disorders</NAME>
<CONT_DATA CI_END="-0.20553817584489553" CI_START="-1.8251079898724936" EFFECT_SIZE="-1.0153230828586945" ESTIMABLE="YES" MEAN_1="27.1" MEAN_2="58.6" ORDER="174" SD_1="22.6" SD_2="36.5" SE="0.4131631567729198" STUDY_ID="STD-Abbass-2008" TOTAL_1="14" TOTAL_2="13" WEIGHT="4.195625171843142"/>
<CONT_DATA CI_END="-0.14893827719688413" CI_START="-1.2844953621940276" EFFECT_SIZE="-0.7167168196954559" ESTIMABLE="YES" MEAN_1="38.92" MEAN_2="44.15" MODIFIED="2012-02-15 14:41:09 +0000" MODIFIED_BY="[Empty name]" ORDER="175" SD_1="7.19" SD_2="7.18" SE="0.28968825293583783" STUDY_ID="STD-Winston-1994" TOTAL_1="25" TOTAL_2="26" WEIGHT="4.984581059226235"/>
<CONT_DATA CI_END="-0.6606322302122886" CI_START="-1.8134659488335299" EFFECT_SIZE="-1.2370490895229092" ESTIMABLE="YES" MEAN_1="35.83" MEAN_2="44.15" MODIFIED="2012-02-15 14:41:36 +0000" MODIFIED_BY="[Empty name]" ORDER="128" SD_1="6.12" SD_2="7.18" SE="0.2940956384185236" STUDY_ID="STD-Winston-1994" TOTAL_1="30" TOTAL_2="26" WEIGHT="4.956945952272042"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.151259638256776" CI_END="-0.08267831510333823" CI_START="-0.4611837712391159" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.27193104317122707" ESTIMABLE="YES" I2="34.972668441393054" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2013-11-28 12:59:16 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.18813347174100004" P_Q="0.5896149681293734" P_Z="0.004859419101069787" Q="1.056571422584334" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="219" TOTAL_2="218" UNITS="" WEIGHT="100.0" Z="2.816208021597568">
<NAME>Reduction in general psychiatric symptoms: medium-term</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="5.313935396045705E-32" CI_END="0.0030374234769874886" CI_START="-0.940915173740472" DF="0" EFFECT_SIZE="-0.46893887513174226" ESTIMABLE="YES" I2="100.0" ID="CMP-001.02.01" MODIFIED="2013-06-11 11:54:18 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.051492721825295164" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="35" WEIGHT="16.07844028263785" Z="1.9473505532337778">
<NAME>depressive disorders</NAME>
<CONT_DATA CI_END="0.0030374234769875996" CI_START="-0.940915173740472" EFFECT_SIZE="-0.4689388751317422" ESTIMABLE="YES" MEAN_1="53.48" MEAN_2="63.44" MODIFIED="2011-05-13 17:57:26 +0100" MODIFIED_BY="[Empty name]" ORDER="88" SD_1="22.87" SD_2="18.9" SE="0.24080865889966274" STUDY_ID="STD-Vitriol-2009" TOTAL_1="36" TOTAL_2="35" WEIGHT="16.07844028263785"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.997667932450242" CI_END="0.051216763336417725" CI_START="-0.4472023779698427" DF="1" EFFECT_SIZE="-0.19799280731671248" ESTIMABLE="YES" I2="74.98541607513954" ID="CMP-001.02.02" MODIFIED="2013-06-28 06:53:58 +0100" MODIFIED_BY="Chris Champion" NO="2" P_CHI2="0.04556334319351363" P_Z="0.11943288692728307" STUDIES="2" TAU2="0.0" TOTAL_1="127" TOTAL_2="124" WEIGHT="57.67065223547568" Z="1.5571583808828362">
<NAME>somatoform disorders</NAME>
<CONT_DATA CI_END="-0.1601113833514013" CI_START="-1.4545005879512796" EFFECT_SIZE="-0.8073059856513404" ESTIMABLE="YES" MEAN_1="0.31" MEAN_2="0.62" ORDER="176" SD_1="0.23" SD_2="0.48" SE="0.3302073953424285" STUDY_ID="STD-Monsen-2000" TOTAL_1="20" TOTAL_2="20" WEIGHT="8.5509530918345"/>
<CONT_DATA CI_END="0.1781102799507821" CI_START="-0.36195255913991886" EFFECT_SIZE="-0.09192113959456838" ESTIMABLE="YES" MEAN_1="-40.1" MEAN_2="-38.9" MODIFIED="2013-06-28 06:53:58 +0100" MODIFIED_BY="[Empty name]" ORDER="119" SD_1="13.3" SD_2="12.7" SE="0.13777366404450483" STUDY_ID="STD-Sattel-2012" TOTAL_1="107" TOTAL_2="104" WEIGHT="49.11969914364118"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.097020283222201" CI_END="0.05567656116013242" CI_START="-0.6830776738191277" DF="1" EFFECT_SIZE="-0.3137005563294976" ESTIMABLE="YES" I2="8.843982623295718" ID="CMP-001.02.03" MODIFIED="2013-06-23 14:07:04 +0100" MODIFIED_BY="Chris Champion" NO="3" P_CHI2="0.2949214454256275" P_Z="0.09600521021968288" STUDIES="2" TAU2="0.0" TOTAL_1="56" TOTAL_2="59" WEIGHT="26.250907481886472" Z="1.6645367653378123">
<NAME>mixed disorders</NAME>
<CONT_DATA CI_END="0.4286625213575942" CI_START="-0.6419613296663657" EFFECT_SIZE="-0.1066494041543857" ESTIMABLE="YES" MEAN_1="3.32" MEAN_2="3.45" MODIFIED="2013-06-23 14:07:04 +0100" MODIFIED_BY="[Empty name]" ORDER="129" SD_1="1.4" SD_2="1.0" SE="0.2731233480484601" STUDY_ID="STD-Maina-2010" TOTAL_1="25" TOTAL_2="29" WEIGHT="12.498861623644428"/>
<CONT_DATA CI_END="0.008454952982839159" CI_START="-1.0122224225794612" EFFECT_SIZE="-0.501883734798311" ESTIMABLE="YES" MEAN_1="0.77" MEAN_2="1.05" ORDER="177" SD_1="0.51" SD_2="0.59" SE="0.2603816660952123" STUDY_ID="STD-Marmar-1988" TOTAL_1="31" TOTAL_2="30" WEIGHT="13.752045858242042"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="114.325046785903" CI_END="0.12481197169325853" CI_START="-3.1361372841170554" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-1.5056626562118984" ESTIMABLE="YES" I2="97.37590310755077" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2014-04-04 20:51:12 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="-6.661338147750939E-16" P_Q="0.5969560492598192" P_Z="0.07030667780972913" Q="1.0318238392538286" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="2.6795654048986375" TOTALS="YES" TOTAL_1="171" TOTAL_2="173" UNITS="" WEIGHT="100.0" Z="1.8099297766036098">
<NAME>Reduction in general psychiatric symptoms: long-term</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.1056349656306662E-31" CI_END="-0.255616349992561" CI_START="-1.5644439182328485" DF="0" EFFECT_SIZE="-0.9100301341127047" ESTIMABLE="YES" I2="100.0" ID="CMP-001.03.01" NO="1" P_CHI2="0.0" P_Z="0.006419778136217804" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="24.795024268195004" Z="2.7255328829986882">
<NAME>anxiety disorders</NAME>
<CONT_DATA CI_END="-0.2556163499925609" CI_START="-1.5644439182328482" EFFECT_SIZE="-0.9100301341127046" ESTIMABLE="YES" MEAN_1="0.3" MEAN_2="0.8" ORDER="178" SD_1="0.3" SD_2="0.7" SE="0.3338907190550827" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="24.795024268195004"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="113.74446870231147" CI_END="2.105681263191879" CI_START="-6.693351420231117" DF="1" EFFECT_SIZE="-2.2938350785196193" ESTIMABLE="YES" I2="99.12083636997139" ID="CMP-001.03.02" MODIFIED="2013-06-11 11:54:21 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="2.220446049250313E-16" P_Z="0.30683164753825043" STUDIES="2" TAU2="9.989056073803571" TOTAL_1="120" TOTAL_2="123" WEIGHT="50.02413489570761" Z="1.0218928152961682">
<NAME>somatoform disorders</NAME>
<CONT_DATA CI_END="0.26412950948335234" CI_START="-0.3894195555249915" EFFECT_SIZE="-0.06264502302081956" ESTIMABLE="YES" MEAN_1="0.76" MEAN_2="0.8" ORDER="179" SD_1="0.66" SD_2="0.61" SE="0.16672476386389123" STUDY_ID="STD-Creed-2003" TOTAL_1="71" TOTAL_2="73" WEIGHT="25.561450272637856"/>
<CONT_DATA CI_END="-3.7945379705830096" CI_START="-5.309685264948577" EFFECT_SIZE="-4.552111617765793" ESTIMABLE="YES" MEAN_1="7.9" MEAN_2="11.74" ORDER="181" SD_1="0.73" SD_2="0.93" SE="0.38652426940414614" STUDY_ID="STD-Svedlund-1983" TOTAL_1="49" TOTAL_2="50" WEIGHT="24.462684623069755"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.08364232417393502" CI_START="-1.1112246736206273" DF="0" EFFECT_SIZE="-0.5974334988972811" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.03" MODIFIED="2013-06-11 11:54:21 +0100" MODIFIED_BY="Chris Champion" NO="3" P_CHI2="1.0" P_Z="0.022664976598671623" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="30" WEIGHT="25.180840836097378" Z="2.2790351384040903">
<NAME>mixed disorders</NAME>
<CONT_DATA CI_END="-0.08364232417393502" CI_START="-1.1112246736206273" EFFECT_SIZE="-0.5974334988972811" ESTIMABLE="YES" MEAN_1="0.65" MEAN_2="0.98" ORDER="182" SD_1="0.42" SD_2="0.65" SE="0.26214317139297727" STUDY_ID="STD-Marmar-1988" TOTAL_1="31" TOTAL_2="30" WEIGHT="25.180840836097378"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="122.14468113664265" CI_END="0.041102872132333546" CI_START="-1.2926093977348496" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.625753262801258" ESTIMABLE="YES" I2="94.26909142922963" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2013-11-19 13:03:52 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="2.220446049250313E-16" P_Q="0.7609318634844977" P_Z="0.06589193631949421" Q="0.5464229679372127" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.8519813405749124" TOTALS="YES" TOTAL_1="379" TOTAL_2="365" UNITS="" WEIGHT="100.0" Z="1.8391580943032473">
<NAME>Reduction in somatic symptoms: short-term</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.2520670745428009" CI_START="-0.9225890610417138" DF="0" EFFECT_SIZE="-0.3352609932494564" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.01" NO="1" P_CHI2="1.0" P_Z="0.26322779298778787" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="20" WEIGHT="12.291901964018654" Z="1.118794602580584">
<NAME>anxiety disorders</NAME>
<CONT_DATA CI_END="0.2520670745428009" CI_START="-0.9225890610417138" EFFECT_SIZE="-0.3352609932494564" ESTIMABLE="YES" MEAN_1="29.7" MEAN_2="33.8" ORDER="183" SD_1="12.4" SD_2="11.5" SE="0.2996626838171651" STUDY_ID="STD-Brom-1989" TOTAL_1="26" TOTAL_2="20" WEIGHT="12.291901964018654"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="122.00692573177442" CI_END="0.18548102461422233" CI_START="-1.6328427893408097" DF="5" EFFECT_SIZE="-0.7236808823632938" ESTIMABLE="YES" I2="95.90187198799498" ID="CMP-001.04.02" MODIFIED="2013-06-28 07:30:17 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="2.220446049250313E-16" P_Z="0.1187349587349608" STUDIES="6" TAU2="1.21308293606086" TOTAL_1="302" TOTAL_2="297" WEIGHT="74.74718246179918" Z="1.560105471694934">
<NAME>somatoform disorders</NAME>
<CONT_DATA CI_END="0.21701311047792432" CI_START="-0.41754882996334225" EFFECT_SIZE="-0.10026785974270896" ESTIMABLE="YES" MEAN_1="51.95" MEAN_2="54.46" ORDER="184" SD_1="26.88" SD_2="22.91" SE="0.16188102063267748" STUDY_ID="STD-Creed-2003" TOTAL_1="74" TOTAL_2="79" WEIGHT="13.181997113846048"/>
<CONT_DATA CI_END="0.2322988626253517" CI_START="-0.7259662908445716" EFFECT_SIZE="-0.24683371410960997" ESTIMABLE="YES" MEAN_1="10.9" MEAN_2="12.4" ORDER="185" SD_1="6.4" SD_2="5.5" SE="0.2444598883011618" STUDY_ID="STD-Hamilton-2000" TOTAL_1="37" TOTAL_2="31" WEIGHT="12.69685527187402"/>
<CONT_DATA CI_END="1.1013933678898105" CI_START="-0.4211344218161192" EFFECT_SIZE="0.34012947303684565" ESTIMABLE="YES" MEAN_1="28.59" MEAN_2="21.44" ORDER="186" SD_1="23.18" SD_2="16.84" SE="0.38840708342485747" STUDY_ID="STD-Linnet-2001" TOTAL_1="14" TOTAL_2="13" WEIGHT="11.543456322645001"/>
<CONT_DATA CI_END="-0.16205542527082284" CI_START="-1.45672169892661" EFFECT_SIZE="-0.8093885620987165" ESTIMABLE="YES" MEAN_1="1.95" MEAN_2="3.5" ORDER="187" SD_1="1.5" SD_2="2.19" SE="0.3302780775228396" STUDY_ID="STD-Monsen-2000" TOTAL_1="20" TOTAL_2="20" WEIGHT="12.045237884961175"/>
<CONT_DATA CI_END="0.4045827048748936" CI_START="-0.1358101648358911" EFFECT_SIZE="0.13438627001950126" ESTIMABLE="YES" MEAN_1="-31.3" MEAN_2="-32.6" MODIFIED="2013-06-28 07:30:17 +0100" MODIFIED_BY="[Empty name]" ORDER="120" SD_1="8.1" SD_2="11.0" SE="0.13785785707628678" STUDY_ID="STD-Sattel-2012" TOTAL_1="107" TOTAL_2="104" WEIGHT="13.290976221724614"/>
<CONT_DATA CI_END="-3.100159440367971" CI_START="-4.421466946605549" EFFECT_SIZE="-3.76081319348676" ESTIMABLE="YES" MEAN_1="9.72" MEAN_2="12.68" MODIFIED="2011-10-26 09:35:35 +0100" MODIFIED_BY="[Empty name]" ORDER="189" SD_1="0.74" SD_2="0.82" SE="0.33707443520898434" STUDY_ID="STD-Svedlund-1983" TOTAL_1="50" TOTAL_2="50" WEIGHT="11.988659646748326"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="7.482029994885444E-32" CI_END="0.021658062787485055" CI_START="-0.7738573500487488" DF="0" EFFECT_SIZE="-0.37609964363063186" ESTIMABLE="YES" I2="100.0" ID="CMP-001.04.03" MODIFIED="2013-06-11 11:54:23 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0638475113941491" STUDIES="1" TAU2="0.0" TOTAL_1="51" TOTAL_2="48" WEIGHT="12.960915574182161" Z="1.853243178498006">
<NAME>mixed disorders</NAME>
<CONT_DATA CI_END="0.021658062787485055" CI_START="-0.7738573500487488" EFFECT_SIZE="-0.37609964363063186" ESTIMABLE="YES" MEAN_1="-51.9" MEAN_2="-42.1" MODIFIED="2012-02-09 20:45:48 +0000" MODIFIED_BY="[Empty name]" ORDER="124" SD_1="26.66" SD_2="24.97" SE="0.20294133441000903" STUDY_ID="STD-Guthrie-1999" TOTAL_1="51" TOTAL_2="48" WEIGHT="12.960915574182161"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="69.18041836765443" CI_END="-0.02234924961093321" CI_START="-2.7528394510686143" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-1.3875943503397736" ESTIMABLE="YES" I2="95.66351278181536" I2_Q="97.80908708393693" ID="CMP-001.05" MODIFIED="2013-07-04 01:19:57 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="6.106226635438361E-15" P_Q="1.4189316388524276E-11" P_Z="0.046365696801319134" Q="45.64307383777406" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="1.8357894904194474" TOTALS="YES" TOTAL_1="180" TOTAL_2="179" UNITS="" WEIGHT="100.0" Z="1.9920488638745708">
<NAME>Reduction in somatic symptoms: medium-term</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.504155238527235" CI_END="-0.10570527388707684" CI_START="-1.0447964644617134" DF="2" EFFECT_SIZE="-0.575250869174395" ESTIMABLE="YES" I2="55.59655708816203" ID="CMP-001.05.01" MODIFIED="2013-06-28 07:29:54 +0100" MODIFIED_BY="Chris Champion" NO="1" P_CHI2="0.10518059475358765" P_Z="0.01634158281273851" STUDIES="3" TAU2="0.09709040282323946" TOTAL_1="138" TOTAL_2="145" WEIGHT="75.48220828076964" Z="2.4011959583334384">
<NAME>somatoform disorders</NAME>
<CONT_DATA CI_END="-0.16852832117422478" CI_START="-1.707882106796306" EFFECT_SIZE="-0.9382052139852654" ESTIMABLE="YES" MEAN_1="6.11" MEAN_2="11.0" ORDER="190" SD_1="5.6" SD_2="4.8" SE="0.3926995081961473" STUDY_ID="STD-Baldoni-1995" TOTAL_1="11" TOTAL_2="21" WEIGHT="24.382120455185472"/>
<CONT_DATA CI_END="-0.17972494394251926" CI_START="-1.47694164953308" EFFECT_SIZE="-0.8283332967377997" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="3.26" ORDER="191" SD_1="1.3" SD_2="1.66" SE="0.33092870986988554" STUDY_ID="STD-Monsen-2000" TOTAL_1="20" TOTAL_2="20" WEIGHT="24.942371734338263"/>
<CONT_DATA CI_END="0.006063270624969586" CI_START="-0.5361180420401913" EFFECT_SIZE="-0.26502738570761086" ESTIMABLE="YES" MEAN_1="-34.3" MEAN_2="-31.8" MODIFIED="2013-06-28 07:29:54 +0100" MODIFIED_BY="[Empty name]" ORDER="121" SD_1="9.3" SD_2="9.5" SE="0.1383141009074192" STUDY_ID="STD-Sattel-2012" TOTAL_1="107" TOTAL_2="104" WEIGHT="26.157716091245906"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-2.859406968213686" CI_START="-4.342782803775142" DF="0" EFFECT_SIZE="-3.601094885994414" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.02" MODIFIED="2013-06-11 11:54:25 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="1.7970746916137006E-21" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="34" WEIGHT="24.517791719230356" Z="9.516153778774443">
<NAME>mixed disorders</NAME>
<CONT_DATA CI_END="-2.859406968213686" CI_START="-4.342782803775142" EFFECT_SIZE="-3.601094885994414" ESTIMABLE="YES" MEAN_1="-48.1" MEAN_2="40.5" MODIFIED="2012-02-09 20:46:51 +0000" MODIFIED_BY="[Empty name]" ORDER="125" SD_1="22.6" SD_2="26.37" SE="0.3784191564901538" STUDY_ID="STD-Guthrie-1999" TOTAL_1="42" TOTAL_2="34" WEIGHT="24.517791719230356"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="150.23623893933672" CI_END="1.0679173243259723" CI_START="-5.490636456701759" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="-2.2113595661878938" ESTIMABLE="YES" I2="98.66876326635973" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2013-07-04 22:10:41 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="-2.220446049250313E-16" P_Q="1.0" P_Z="0.1862716403903446" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="8.25397407683531" TOTALS="YES" TOTAL_1="132" TOTAL_2="148" UNITS="" WEIGHT="100.0" Z="1.3216892782473206">
<NAME>Reduction in somatic symptoms: long-term</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="150.23623893933672" CI_END="1.0679173243259723" CI_START="-5.490636456701759" DF="2" EFFECT_SIZE="-2.2113595661878938" ESTIMABLE="YES" I2="98.66876326635973" ID="CMP-001.06.01" MODIFIED="2013-06-11 11:54:27 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="-2.220446049250313E-16" P_Z="0.1862716403903446" STUDIES="3" TAU2="8.25397407683531" TOTAL_1="132" TOTAL_2="148" WEIGHT="100.0" Z="1.3216892782473206">
<NAME>somatoform disorders</NAME>
<CONT_DATA CI_END="0.5510630443964417" CI_START="-0.9109444585489479" EFFECT_SIZE="-0.1799407070762531" ESTIMABLE="YES" MEAN_1="9.75" MEAN_2="10.57" ORDER="192" SD_1="3.13" SD_2="4.97" SE="0.3729679510637742" STUDY_ID="STD-Baldoni-1995" TOTAL_1="11" TOTAL_2="21" WEIGHT="33.353289668577666"/>
<CONT_DATA CI_END="0.374745463589554" CI_START="-0.2679998644479649" EFFECT_SIZE="0.05337279957079454" ESTIMABLE="YES" MEAN_1="52.54" MEAN_2="51.04" ORDER="193" SD_1="29.24" SD_2="26.71" SE="0.1639686578700966" STUDY_ID="STD-Creed-2003" TOTAL_1="72" TOTAL_2="77" WEIGHT="33.80528201045041"/>
<CONT_DATA CI_END="-5.587366070847496" CI_START="-7.623912227615024" EFFECT_SIZE="-6.60563914923126" ESTIMABLE="YES" MEAN_1="8.05" MEAN_2="13.57" ORDER="195" SD_1="0.75" SD_2="0.9" SE="0.5195366274154891" STUDY_ID="STD-Svedlund-1983" TOTAL_1="49" TOTAL_2="50" WEIGHT="32.84142832097192"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="148.06828881505933" CI_END="-0.2583906163788437" CI_START="-1.0225217058066645" CI_STUDY="95" CI_TOTAL="95" DF="17" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.640456161092754" ESTIMABLE="YES" I2="88.51881105937991" I2_Q="30.31203259395752" ID="CMP-001.07" MODIFIED="2013-07-04 22:05:47 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="4.440892098500626E-16" P_Q="0.2194353444559839" P_Z="0.001018065910062" Q="5.739871815594337" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="18" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.5827651411588609" TOTALS="YES" TOTAL_1="550" TOTAL_2="552" UNITS="" WEIGHT="99.99999999999999" Z="3.2854860292584736">
<NAME>Reduction in anxiety symptoms: short-term</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="10.327276417655773" CI_END="-0.2652927477837176" CI_START="-1.0149272787336954" DF="5" EFFECT_SIZE="-0.6401100132587065" ESTIMABLE="YES" I2="51.584524343205594" ID="CMP-001.07.01" MODIFIED="2011-05-13 18:14:06 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.06647572090648257" P_Z="8.162897528128932E-4" STUDIES="6" TAU2="0.11126784829076863" TOTAL_1="135" TOTAL_2="120" WEIGHT="32.79435465982859" Z="3.3472112618415086">
<NAME>anxiety disorders</NAME>
<CONT_DATA CI_END="-0.19501232375542688" CI_START="-1.8908176357587434" EFFECT_SIZE="-1.0429149797570851" ESTIMABLE="YES" MEAN_1="2.3" MEAN_2="3.7" ORDER="196" SD_1="1.3" SD_2="1.3" SE="0.4326113452542017" STUDY_ID="STD-Alstrom-1984a" TOTAL_1="16" TOTAL_2="10" WEIGHT="4.935546551406558"/>
<CONT_DATA CI_END="-0.0641975868694491" CI_START="-1.5024279431943428" EFFECT_SIZE="-0.783312765031896" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="3.4" ORDER="197" SD_1="1.5" SD_2="1.7" SE="0.3669022409772504" STUDY_ID="STD-Alstrom-1984b" TOTAL_1="14" TOTAL_2="19" WEIGHT="5.2969863176802265"/>
<CONT_DATA CI_END="-0.009868857114626928" CI_START="-1.2042742650501133" EFFECT_SIZE="-0.6070715610823701" ESTIMABLE="YES" MEAN_1="40.1" MEAN_2="48.2" ORDER="198" SD_1="13.2" SD_2="13.0" SE="0.304700856076133" STUDY_ID="STD-Brom-1989" TOTAL_1="26" TOTAL_2="20" WEIGHT="5.624513214890484"/>
<CONT_DATA CI_END="0.4312597818545037" CI_START="-0.57627138470839" EFFECT_SIZE="-0.07250580142694313" ESTIMABLE="YES" MEAN_1="17.7" MEAN_2="18.6" MODIFIED="2011-05-13 18:08:02 +0100" MODIFIED_BY="[Empty name]" ORDER="89" SD_1="12.3" SD_2="12.2" SE="0.25702797972569164" STUDY_ID="STD-Levy-Berg-2009" TOTAL_1="33" TOTAL_2="28" WEIGHT="5.856654872971704"/>
<CONT_DATA CI_END="0.20737691362483224" CI_START="-0.9244315408891832" EFFECT_SIZE="-0.3585273136321755" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="11.1" MODIFIED="2011-05-13 18:14:06 +0100" MODIFIED_BY="[Empty name]" ORDER="90" SD_1="5.7" SD_2="6.4" SE="0.28873195207707286" STUDY_ID="STD-Milrod-2007" TOTAL_1="26" TOTAL_2="23" WEIGHT="5.704528282372419"/>
<CONT_DATA CI_END="-0.626858518947859" CI_START="-2.0075250794135924" EFFECT_SIZE="-1.3171917991807256" ESTIMABLE="YES" MEAN_1="5.5" MEAN_2="16.0" ORDER="199" SD_1="4.7" SD_2="10.0" SE="0.3522173293377467" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="5.3761254205072015"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.1312296277042771" CI_START="-0.7140054220245251" DF="0" EFFECT_SIZE="-0.291387897160124" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.02" MODIFIED="2012-02-15 15:59:49 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.17657910603292104" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="43" WEIGHT="6.038789506567676" Z="1.3513632312052075">
<NAME>depressive disorders</NAME>
<CONT_DATA CI_END="0.1312296277042771" CI_START="-0.7140054220245251" EFFECT_SIZE="-0.291387897160124" ESTIMABLE="YES" MEAN_1="12.64" MEAN_2="14.98" MODIFIED="2012-02-15 15:59:49 +0000" MODIFIED_BY="[Empty name]" ORDER="134" SD_1="7.85" SD_2="8.07" SE="0.21562514831800694" STUDY_ID="STD-Vitriol-2009" TOTAL_1="44" TOTAL_2="43" WEIGHT="6.038789506567676"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="120.49922343777544" CI_END="0.3678366471674491" CI_START="-2.2520262095145918" DF="4" EFFECT_SIZE="-0.9420947811735713" ESTIMABLE="YES" I2="96.68047653264291" ID="CMP-001.07.03" MODIFIED="2013-06-23 12:09:28 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="5.551115123125783E-16" P_Z="0.15865951864938588" STUDIES="5" TAU2="2.1387627580070863" TOTAL_1="212" TOTAL_2="223" WEIGHT="28.13679314635162" Z="1.4095942743062753">
<NAME>somatoform disorders</NAME>
<CONT_DATA CI_END="1.0683270373197975" CI_START="-0.4280367937575193" EFFECT_SIZE="0.32014512178113913" ESTIMABLE="YES" MEAN_1="39.94" MEAN_2="37.08" ORDER="200" SD_1="8.29" SD_2="9.1" SE="0.38173248153548833" STUDY_ID="STD-Linnet-2001" TOTAL_1="15" TOTAL_2="13" WEIGHT="5.216257888594687"/>
<CONT_DATA CI_END="0.06811211364923075" CI_START="-1.1986400085152904" EFFECT_SIZE="-0.5652639474330298" ESTIMABLE="YES" MEAN_1="0.31" MEAN_2="0.6" ORDER="201" SD_1="0.31" SD_2="0.64" SE="0.32315698965810086" STUDY_ID="STD-Monsen-2000" TOTAL_1="20" TOTAL_2="20" WEIGHT="5.529669919860048"/>
<CONT_DATA CI_END="0.2698862507625915" CI_START="-0.2698862507625915" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="3.5" MEAN_2="3.5" MODIFIED="2013-06-23 12:09:28 +0100" MODIFIED_BY="[Empty name]" ORDER="117" SD_1="2.3" SD_2="2.2" SE="0.13769959697801581" STUDY_ID="STD-Sattel-2012" TOTAL_1="107" TOTAL_2="104" WEIGHT="6.3151047355674335"/>
<CONT_DATA CI_END="-3.4424251282217257" CI_START="-4.853343965846334" EFFECT_SIZE="-4.14788454703403" ESTIMABLE="YES" MEAN_1="4.03" MEAN_2="5.54" ORDER="203" SD_1="0.33" SD_2="0.39" SE="0.3599348887922829" STUDY_ID="STD-Svedlund-1983" TOTAL_1="50" TOTAL_2="50" WEIGHT="5.334644524729174"/>
<CONT_DATA CI_END="0.17734416077713205" CI_START="-0.9252705025190109" EFFECT_SIZE="-0.3739631708709394" ESTIMABLE="YES" MEAN_1="17.1" MEAN_2="20.5" MODIFIED="2011-05-13 18:16:56 +0100" MODIFIED_BY="[Empty name]" ORDER="91" SD_1="8.9" SD_2="9.0" SE="0.2812844195080692" STUDY_ID="STD-S_x00f8_rensen-2010" TOTAL_1="20" TOTAL_2="36" WEIGHT="5.741116077600279"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="11.914722691441055" CI_END="-0.03264741431812507" CI_START="-0.9061436952633928" DF="4" EFFECT_SIZE="-0.4693955547907589" ESTIMABLE="YES" I2="66.42808982139884" ID="CMP-001.07.04" MODIFIED="2013-06-23 13:18:27 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.017996826355832107" P_Z="0.03516324308987039" STUDIES="5" TAU2="0.15548610644215505" TOTAL_1="137" TOTAL_2="150" WEIGHT="27.53270527120084" Z="2.1064734949930055">
<NAME>mixed disorders</NAME>
<CONT_DATA CI_END="0.20521309319631026" CI_START="-0.9366308407985156" EFFECT_SIZE="-0.3657088738011027" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="1.1" MODIFIED="2011-05-13 18:20:31 +0100" MODIFIED_BY="[Empty name]" ORDER="92" SD_1="0.75" SD_2="0.86" SE="0.2912920704159732" STUDY_ID="STD-Bressi-2010" TOTAL_1="24" TOTAL_2="24" WEIGHT="5.691840115400796"/>
<CONT_DATA CI_END="-0.9989565204493833" CI_START="-3.2968197151143737" EFFECT_SIZE="-2.1478881177818785" ESTIMABLE="YES" MEAN_1="12.1" MEAN_2="20.1" ORDER="204" SD_1="3.2" SD_2="3.9" SE="0.5862003620449768" STUDY_ID="STD-Maina-2005" TOTAL_1="10" TOTAL_2="10" WEIGHT="4.101879445664728"/>
<CONT_DATA CI_END="0.5349041503793738" CI_START="-0.5349041503793738" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="18.48" MEAN_2="18.48" MODIFIED="2013-06-23 13:18:27 +0100" MODIFIED_BY="[Empty name]" ORDER="124" SD_1="5.2" SD_2="5.2" SE="0.2729152956884052" STUDY_ID="STD-Maina-2010" TOTAL_1="25" TOTAL_2="29" WEIGHT="5.78163085081791"/>
<CONT_DATA CI_END="0.2875406481030537" CI_START="-0.7195083746904102" EFFECT_SIZE="-0.21598386329367827" ESTIMABLE="YES" MEAN_1="1.15" MEAN_2="1.36" ORDER="205" SD_1="0.95" SD_2="0.97" SE="0.2569049816060239" STUDY_ID="STD-Marmar-1988" TOTAL_1="31" TOTAL_2="30" WEIGHT="5.857225519207009"/>
<CONT_DATA CI_END="-0.12623682670674774" CI_START="-0.9118542443648228" EFFECT_SIZE="-0.5190455355357853" ESTIMABLE="YES" MEAN_1="42.8" MEAN_2="48.8" ORDER="206" SD_1="11.8" SD_2="11.2" SE="0.20041628924177304" STUDY_ID="STD-Piper-1990" TOTAL_1="47" TOTAL_2="57" WEIGHT="6.100129340110394"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.8328301969906193" CI_START="-0.45818756237436126" DF="0" EFFECT_SIZE="0.187321317308129" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.05" MODIFIED="2013-07-04 21:42:12 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.5695154458980267" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="16" WEIGHT="5.497357416051267" Z="0.5687652749891231">
<NAME>personality disorders</NAME>
<CONT_DATA CI_END="0.8328301969906193" CI_START="-0.45818756237436126" EFFECT_SIZE="0.187321317308129" ESTIMABLE="YES" MEAN_1="90.0" MEAN_2="85.3" MODIFIED="2013-07-04 21:42:12 +0100" MODIFIED_BY="[Empty name]" ORDER="93" SD_1="23.0" SD_2="26.6" SE="0.32934731697836384" STUDY_ID="STD-Emmelkamp-2006" TOTAL_1="22" TOTAL_2="16" WEIGHT="5.497357416051267"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="14.287139860393921" CI_END="-0.15501344490149244" CI_START="-0.7710855451160703" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4630494950087814" ESTIMABLE="YES" I2="58.0041907713601" I2_Q="19.749493786106" ID="CMP-001.08" MODIFIED="2013-12-03 19:43:49 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.02658809136836371" P_Q="0.2911458577388949" P_Z="0.0032162152293316836" Q="3.738294175994371" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.09142330300371972" TOTALS="YES" TOTAL_1="251" TOTAL_2="255" UNITS="" WEIGHT="100.00000000000001" Z="2.946279609028125">
<NAME>Reduction in anxiety symptoms: medium-term</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.12066972049209745" CI_START="-2.0233696937232137" DF="0" EFFECT_SIZE="-1.0720197071076556" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.01" NO="1" P_CHI2="1.0" P_Z="0.027204785181928638" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="8" WEIGHT="7.553036900056585" Z="2.2085668221039754">
<NAME>anxiety disorders</NAME>
<CONT_DATA CI_END="-0.12066972049209745" CI_START="-2.0233696937232137" EFFECT_SIZE="-1.0720197071076556" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="3.5" ORDER="207" SD_1="1.2" SD_2="1.1" SE="0.48539156541634715" STUDY_ID="STD-Alstrom-1984a" TOTAL_1="13" TOTAL_2="8" WEIGHT="7.553036900056585"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.557364530573686E-32" CI_END="0.015328515569574652" CI_START="-0.8344263446317723" DF="0" EFFECT_SIZE="-0.4095489145310989" ESTIMABLE="YES" I2="100.0" ID="CMP-001.08.02" MODIFIED="2012-02-15 16:00:33 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.05885788467893115" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="43" WEIGHT="17.84515619010195" Z="1.8892533834951621">
<NAME>depressive disorders</NAME>
<CONT_DATA CI_END="0.015328515569574652" CI_START="-0.8344263446317723" EFFECT_SIZE="-0.4095489145310989" ESTIMABLE="YES" MEAN_1="11.75" MEAN_2="15.0" MODIFIED="2012-02-15 16:00:33 +0000" MODIFIED_BY="[Empty name]" ORDER="135" SD_1="7.89" SD_2="7.84" SE="0.21677818238092764" STUDY_ID="STD-Vitriol-2009" TOTAL_1="44" TOTAL_2="43" WEIGHT="17.84515619010195"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="10.322688803897567" CI_END="0.05328527050705778" CI_START="-1.4198614777958793" DF="2" EFFECT_SIZE="-0.6832881036444108" ESTIMABLE="YES" I2="80.62520300675097" ID="CMP-001.08.03" MODIFIED="2013-12-03 19:43:49 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.00573401715388322" P_Z="0.06903722802896135" STUDIES="3" TAU2="0.3332411117014948" TOTAL_1="138" TOTAL_2="145" WEIGHT="44.095020719827815" Z="1.8181760584958646">
<NAME>somatoform disorders</NAME>
<CONT_DATA CI_END="-0.5766187891168945" CI_START="-2.207295482545848" EFFECT_SIZE="-1.3919571358313712" ESTIMABLE="YES" MEAN_1="3.77" MEAN_2="10.2" MODIFIED="2013-12-03 19:43:49 +0000" MODIFIED_BY="[Empty name]" ORDER="208" SD_1="3.66" SD_2="4.87" SE="0.4159965964404252" STUDY_ID="STD-Baldoni-1995" TOTAL_1="11" TOTAL_2="21" WEIGHT="9.339419174318026"/>
<CONT_DATA CI_END="-0.11473625061137593" CI_START="-1.4028578692983862" EFFECT_SIZE="-0.758797059954881" ESTIMABLE="YES" MEAN_1="0.25" MEAN_2="0.68" ORDER="209" SD_1="0.29" SD_2="0.73" SE="0.32860849200484016" STUDY_ID="STD-Monsen-2000" TOTAL_1="20" TOTAL_2="20" WEIGHT="12.387020309683363"/>
<CONT_DATA CI_END="0.14021022194197202" CI_START="-0.40014253123642646" EFFECT_SIZE="-0.12996615464722722" ESTIMABLE="YES" MEAN_1="3.1" MEAN_2="3.4" MODIFIED="2013-06-23 12:13:09 +0100" MODIFIED_BY="[Empty name]" ORDER="118" SD_1="2.3" SD_2="2.3" SE="0.13784762307895249" STUDY_ID="STD-Sattel-2012" TOTAL_1="107" TOTAL_2="104" WEIGHT="22.368581235826426"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.9263356683643513" CI_END="0.17875762072221202" CI_START="-0.5566410573675371" DF="1" EFFECT_SIZE="-0.18894171832266254" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.04" MODIFIED="2013-06-23 13:20:01 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.33581706058183947" P_Z="0.3138750278387522" STUDIES="2" TAU2="0.0" TOTAL_1="56" TOTAL_2="59" WEIGHT="30.50678619001367" Z="1.0071243643011716">
<NAME>mixed disorders</NAME>
<CONT_DATA CI_END="0.5367321549128038" CI_START="-0.5330763855066979" EFFECT_SIZE="0.0018278847030529682" ESTIMABLE="YES" MEAN_1="17.8" MEAN_2="17.79" MODIFIED="2013-06-23 13:20:01 +0100" MODIFIED_BY="[Empty name]" ORDER="125" SD_1="6.1" SD_2="4.7" SE="0.27291535682747614" STUDY_ID="STD-Maina-2010" TOTAL_1="25" TOTAL_2="29" WEIGHT="14.888281391005284"/>
<CONT_DATA CI_END="0.14644156847913758" CI_START="-0.8661302502590051" EFFECT_SIZE="-0.3598443408899338" ESTIMABLE="YES" MEAN_1="0.87" MEAN_2="1.2" ORDER="210" SD_1="0.86" SD_2="0.95" SE="0.2583138840114359" STUDY_ID="STD-Marmar-1988" TOTAL_1="31" TOTAL_2="30" WEIGHT="15.618504799008388"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="73.60653464580338" CI_END="0.038888318331482985" CI_START="-2.2439411446900785" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="-1.1025264131792978" ESTIMABLE="YES" I2="94.5656998807944" I2_Q="0.0" ID="CMP-001.09" MODIFIED="2013-11-14 11:55:13 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="3.3306690738754696E-15" P_Q="0.5382274850304911" P_Z="0.05833294380830267" Q="1.238949101736816" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="1.5979832881174094" TOTALS="YES" TOTAL_1="144" TOTAL_2="149" UNITS="" WEIGHT="100.0" Z="1.8931874648011242">
<NAME>Reduction in anxiety symptoms: long-term</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.702753068938134" CI_END="0.22633808278388806" CI_START="-1.1180411209109868" DF="1" EFFECT_SIZE="-0.4458515190635494" ESTIMABLE="YES" I2="63.00068950091386" ID="CMP-001.09.01" MODIFIED="2011-05-13 18:52:20 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1001751976805928" P_Z="0.1935976868720485" STUDIES="2" TAU2="0.14944338397985815" TOTAL_1="53" TOTAL_2="48" WEIGHT="40.24381189262007" Z="1.3000095767850974">
<NAME>anxiety disorders</NAME>
<CONT_DATA CI_END="0.37136684074543347" CI_START="-0.6369913508459074" EFFECT_SIZE="-0.132812255050237" ESTIMABLE="YES" MEAN_1="16.8" MEAN_2="18.6" MODIFIED="2011-05-13 18:52:20 +0100" MODIFIED_BY="[Empty name]" ORDER="94" SD_1="14.3" SD_2="12.2" SE="0.25723895937505525" STUDY_ID="STD-Levy-Berg-2009" TOTAL_1="33" TOTAL_2="28" WEIGHT="20.37966055740351"/>
<CONT_DATA CI_END="-0.1734409948848814" CI_START="-1.4697440386843046" EFFECT_SIZE="-0.821592516784593" ESTIMABLE="YES" MEAN_1="7.7" MEAN_2="15.6" ORDER="211" SD_1="5.8" SD_2="12.0" SE="0.33069562859942736" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="19.86415133521656"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="31.28483727179286" CI_END="0.6890489810803633" CI_START="-4.76939890778389" DF="1" EFFECT_SIZE="-2.040174963351763" ESTIMABLE="YES" I2="96.80356336421917" ID="CMP-001.09.02" MODIFIED="2013-06-11 11:54:32 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="2.2281964939807608E-8" P_Z="0.14288529596034882" STUDIES="2" TAU2="3.754199103611097" TOTAL_1="60" TOTAL_2="71" WEIGHT="39.39772605400918" Z="1.4651305762165259">
<NAME>somatoform disorders</NAME>
<CONT_DATA CI_END="0.10862904270955254" CI_START="-1.3882631510233217" EFFECT_SIZE="-0.6398170541568845" ESTIMABLE="YES" MEAN_1="6.62" MEAN_2="10.09" ORDER="212" SD_1="5.26" SD_2="5.3" SE="0.3818672704039892" STUDY_ID="STD-Baldoni-1995" TOTAL_1="11" TOTAL_2="21" WEIGHT="19.448791565647237"/>
<CONT_DATA CI_END="-2.798555441123081" CI_START="-4.051114284812424" EFFECT_SIZE="-3.4248348629677525" ESTIMABLE="YES" MEAN_1="4.11" MEAN_2="5.53" ORDER="214" SD_1="0.38" SD_2="0.44" SE="0.3195361888201435" STUDY_ID="STD-Svedlund-1983" TOTAL_1="49" TOTAL_2="50" WEIGHT="19.948934488361942"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.0030661975003497544" CI_START="-1.0245418491374072" DF="0" EFFECT_SIZE="-0.5138040233188784" ESTIMABLE="YES" I2="0.0" ID="CMP-001.09.03" MODIFIED="2013-11-14 11:55:13 +0000" MODIFIED_BY="Chris Champion" NO="3" P_CHI2="1.0" P_Z="0.04864037273393226" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="30" WEIGHT="20.358462053370737" Z="1.9717305629416852">
<NAME>mixed disorders</NAME>
<CONT_DATA CI_END="-0.0030661975003497544" CI_START="-1.0245418491374072" EFFECT_SIZE="-0.5138040233188784" ESTIMABLE="YES" MEAN_1="0.67" MEAN_2="1.08" ORDER="215" SD_1="0.59" SD_2="0.95" SE="0.26058531169305327" STUDY_ID="STD-Marmar-1988" TOTAL_1="31" TOTAL_2="30" WEIGHT="20.358462053370737"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="89.46452675634181" CI_END="-0.39100225700803093" CI_START="-0.6070133097070672" CI_STUDY="95" CI_TOTAL="95" DF="17" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4990077833575491" ESTIMABLE="YES" I2="80.99805518862264" I2_Q="0.0" ID="CMP-001.10" MODIFIED="2013-11-28 13:00:32 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="7.639111565538315E-12" P_Q="0.6575656420724996" P_Z="1.3602151858762624E-19" Q="1.6080514510336983" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="18" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="695" TOTAL_2="720" UNITS="" WEIGHT="100.00000000000001" Z="9.055437406239033">
<NAME>Reduction in depressive symptoms: short-term</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.7863280191326562" CI_END="-0.14374271484062506" CI_START="-0.9961280631735082" DF="1" EFFECT_SIZE="-0.5699353890070666" ESTIMABLE="YES" I2="0.0" ID="CMP-001.10.01" MODIFIED="2011-05-13 18:56:29 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3752128123653954" P_Z="0.008767115351876574" STUDIES="2" TAU2="0.0" TOTAL_1="46" TOTAL_2="43" WEIGHT="6.422143341721086" Z="2.621004310206496">
<NAME>anxiety disorders</NAME>
<CONT_DATA CI_END="0.16643976456684068" CI_START="-0.9677759704137143" EFFECT_SIZE="-0.40066810292343685" ESTIMABLE="YES" MEAN_1="9.0" MEAN_2="11.5" MODIFIED="2011-05-13 18:56:29 +0100" MODIFIED_BY="[Empty name]" ORDER="95" SD_1="5.6" SD_2="6.7" SE="0.28934606552138303" STUDY_ID="STD-Milrod-2007" TOTAL_1="26" TOTAL_2="23" WEIGHT="3.6271090324540887"/>
<CONT_DATA CI_END="-0.14356353916921416" CI_START="-1.4356227064349634" EFFECT_SIZE="-0.7895931228020887" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="7.4" ORDER="216" SD_1="2.7" SD_2="6.1" SE="0.32961298714092374" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="2.7950343092669976"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="9.982947842170779" CI_END="-0.2827135759287831" CI_START="-0.6671572983695524" DF="4" EFFECT_SIZE="-0.47493543714916775" ESTIMABLE="YES" I2="59.931674859575295" ID="CMP-001.10.02" MODIFIED="2013-07-16 11:07:10 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.04071598391083364" P_Z="1.2814181836586076E-6" STUDIES="5" TAU2="0.0" TOTAL_1="213" TOTAL_2="222" WEIGHT="31.570859051436216" Z="4.842614392995173">
<NAME>depressive disorders</NAME>
<CONT_DATA CI_END="0.346151144326912" CI_START="-0.5672820654386903" EFFECT_SIZE="-0.11056546055588917" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="9.7" MODIFIED="2011-06-10 16:08:51 +0100" MODIFIED_BY="[Empty name]" ORDER="102" SD_1="7.0" SD_2="7.3" SE="0.23302295781214527" STUDY_ID="STD-Burnand-2002" TOTAL_1="35" TOTAL_2="39" WEIGHT="5.592401612993533"/>
<CONT_DATA CI_END="-0.8954176813028665" CI_START="-3.1350583943659984" EFFECT_SIZE="-2.0152380378344326" ESTIMABLE="YES" MEAN_1="14.9" MEAN_2="25.81" MODIFIED="2013-07-16 11:07:10 +0100" MODIFIED_BY="[Empty name]" ORDER="1288" SD_1="5.18" SD_2="5.19" SE="0.5713474152405688" STUDY_ID="STD-Carrington-1979" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.9302404912552495"/>
<CONT_DATA CI_END="-0.1160604234407775" CI_START="-0.9358904355100367" EFFECT_SIZE="-0.5259754294754071" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="11.3" ORDER="217" SD_1="4.2" SD_2="4.8" SE="0.20914415227421873" STUDY_ID="STD-Cooper-2003" TOTAL_1="45" TOTAL_2="50" WEIGHT="6.942315092570891"/>
<CONT_DATA CI_END="-0.1421395941092909" CI_START="-0.7566083437747553" EFFECT_SIZE="-0.4493739689420231" ESTIMABLE="YES" MEAN_1="12.13" MEAN_2="15.62" MODIFIED="2012-02-15 13:31:34 +0000" MODIFIED_BY="[Empty name]" ORDER="218" SD_1="7.55" SD_2="7.91" SE="0.15675511246949317" STUDY_ID="STD-de-Jonghe-2001" TOTAL_1="84" TOTAL_2="83" WEIGHT="12.358118220585188"/>
<CONT_DATA CI_END="-0.12297803141976799" CI_START="-1.023980057670149" EFFECT_SIZE="-0.5734790445449585" ESTIMABLE="YES" MEAN_1="22.09" MEAN_2="27.47" MODIFIED="2011-05-13 19:03:00 +0100" MODIFIED_BY="[Empty name]" ORDER="96" SD_1="8.86" SD_2="9.69" SE="0.22985167925466232" STUDY_ID="STD-Vitriol-2009" TOTAL_1="39" TOTAL_2="40" WEIGHT="5.747783634031352"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="73.43751690763693" CI_END="-0.3946795366349124" CI_START="-0.7679948003240281" DF="4" EFFECT_SIZE="-0.5813371684794703" ESTIMABLE="YES" I2="94.55319274338913" ID="CMP-001.10.03" MODIFIED="2013-06-23 12:24:57 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="4.6629367034256575E-15" P_Z="1.033016151528879E-9" STUDIES="5" TAU2="0.0" TOTAL_1="247" TOTAL_2="256" WEIGHT="33.481156609641374" Z="6.104223555365306">
<NAME>somatoform disorders</NAME>
<CONT_DATA CI_END="-0.18150500715632018" CI_START="-0.9956611365655175" EFFECT_SIZE="-0.5885830718609188" ESTIMABLE="YES" MEAN_1="8.18" MEAN_2="13.6" ORDER="219" SD_1="8.08" SD_2="10.14" SE="0.20769670663113124" STUDY_ID="STD-Guthrie-1993" TOTAL_1="50" TOTAL_2="47" WEIGHT="7.039414738521956"/>
<CONT_DATA CI_END="-0.03860392115744726" CI_START="-1.3170703555878869" EFFECT_SIZE="-0.677837138372667" ESTIMABLE="YES" MEAN_1="0.49" MEAN_2="0.83" ORDER="220" SD_1="0.45" SD_2="0.53" SE="0.32614538953644545" STUDY_ID="STD-Monsen-2000" TOTAL_1="20" TOTAL_2="20" WEIGHT="2.8547842112610957"/>
<CONT_DATA CI_END="0.13949006879850268" CI_START="-0.40086915818702706" EFFECT_SIZE="-0.1306895446942622" ESTIMABLE="YES" MEAN_1="10.3" MEAN_2="11.1" MODIFIED="2013-06-23 12:24:57 +0100" MODIFIED_BY="[Empty name]" ORDER="122" SD_1="6.0" SD_2="6.2" SE="0.13784927459071042" STUDY_ID="STD-Sattel-2012" TOTAL_1="107" TOTAL_2="104" WEIGHT="15.980369000264417"/>
<CONT_DATA CI_END="-2.2406328001280027" CI_START="-3.3544451729319524" EFFECT_SIZE="-2.7975389865299776" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="3.55" ORDER="222" SD_1="0.32" SD_2="0.48" SE="0.28414103054687717" STUDY_ID="STD-Svedlund-1983" TOTAL_1="50" TOTAL_2="50" WEIGHT="3.7612125009490818"/>
<CONT_DATA CI_END="0.3492694904618111" CI_START="-0.7522864546512823" EFFECT_SIZE="-0.20150848209473562" ESTIMABLE="YES" MEAN_1="14.1" MEAN_2="15.4" MODIFIED="2011-05-13 19:10:01 +0100" MODIFIED_BY="[Empty name]" ORDER="98" SD_1="5.7" SD_2="6.7" SE="0.2810143333760278" STUDY_ID="STD-S_x00f8_rensen-2010" TOTAL_1="20" TOTAL_2="35" WEIGHT="3.8453761586448203"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.6496825363677643" CI_END="-0.21082920477055092" CI_START="-0.6152716661943202" DF="5" EFFECT_SIZE="-0.41305043548243553" ESTIMABLE="YES" I2="0.0" ID="CMP-001.10.04" MODIFIED="2013-06-23 13:21:15 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.6008696528308646" P_Z="6.244969671413449E-5" STUDIES="6" TAU2="0.0" TOTAL_1="189" TOTAL_2="199" WEIGHT="28.52584099720134" Z="4.003357978260888">
<NAME>mixed disorders</NAME>
<CONT_DATA CI_END="-0.054902546791619544" CI_START="-1.2172433003499141" EFFECT_SIZE="-0.6360729235707668" ESTIMABLE="YES" MEAN_1="0.87" MEAN_2="1.39" MODIFIED="2011-05-13 19:11:24 +0100" MODIFIED_BY="[Empty name]" ORDER="99" SD_1="0.64" SD_2="0.94" SE="0.29652094699869236" STUDY_ID="STD-Bressi-2010" TOTAL_1="24" TOTAL_2="24" WEIGHT="3.4537032279255895"/>
<CONT_DATA CI_END="0.1751147775190266" CI_START="-0.6076931961174423" EFFECT_SIZE="-0.21628920929920786" ESTIMABLE="YES" MEAN_1="2.3" MEAN_2="2.44" ORDER="223" SD_1="0.37" SD_2="0.84" SE="0.19969958116862307" STUDY_ID="STD-Guthrie-1999" TOTAL_1="52" TOTAL_2="49" WEIGHT="7.614501303626994"/>
<CONT_DATA CI_END="-0.13424239264268711" CI_START="-2.042013211246556" EFFECT_SIZE="-1.0881278019446217" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="12.0" ORDER="224" SD_1="3.3" SD_2="2.0" SE="0.48668517218992846" STUDY_ID="STD-Maina-2005" TOTAL_1="10" TOTAL_2="10" WEIGHT="1.282034002333775"/>
<CONT_DATA CI_END="0.18221560958115623" CI_START="-0.8967083632043451" EFFECT_SIZE="-0.35724637681159443" ESTIMABLE="YES" MEAN_1="13.52" MEAN_2="15.55" MODIFIED="2013-06-23 13:21:15 +0100" MODIFIED_BY="[Empty name]" ORDER="126" SD_1="5.6" SD_2="5.6" SE="0.27524076495688593" STUDY_ID="STD-Maina-2010" TOTAL_1="25" TOTAL_2="29" WEIGHT="4.008392686326686"/>
<CONT_DATA CI_END="0.1637399915209134" CI_START="-0.8480048293489568" EFFECT_SIZE="-0.34213241891402174" ESTIMABLE="YES" MEAN_1="6.77" MEAN_2="8.77" ORDER="225" SD_1="5.82" SD_2="5.72" SE="0.25810291129081564" STUDY_ID="STD-Marmar-1988" TOTAL_1="31" TOTAL_2="30" WEIGHT="4.55837412778463"/>
<CONT_DATA CI_END="-0.07531561252923996" CI_START="-0.8584149772770318" EFFECT_SIZE="-0.4668652949031359" ESTIMABLE="YES" MEAN_1="7.6" MEAN_2="12.3" ORDER="226" SD_1="9.2" SD_2="10.6" SE="0.19977391700173566" STUDY_ID="STD-Piper-1990" TOTAL_1="47" TOTAL_2="57" WEIGHT="7.608835649203662"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="12.933735283727776" CI_END="-0.0888030526085446" CI_START="-0.6000870313769778" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3444450419927612" ESTIMABLE="YES" I2="53.60968917039198" I2_Q="0.0" ID="CMP-001.11" MODIFIED="2013-07-04 22:06:52 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.04410041234728679" P_Q="0.7036255242315099" P_Z="0.008271004100327614" Q="0.7030182554588794" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.05993859609977046" TOTALS="YES" TOTAL_1="295" TOTAL_2="306" UNITS="" WEIGHT="99.99999999999999" Z="2.640802000427866">
<NAME>Reduction in depressive symptoms: medium-term</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.6338956770916884" CI_END="0.0684997404546267" CI_START="-0.5992249873126365" DF="2" EFFECT_SIZE="-0.2653626234290049" ESTIMABLE="YES" I2="44.96264676478941" ID="CMP-001.11.01" MODIFIED="2013-06-11 11:54:35 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.16252110558700794" P_Z="0.11927328362049458" STUDIES="3" TAU2="0.03915017397437919" TOTAL_1="126" TOTAL_2="131" WEIGHT="47.285760654156135" Z="1.5578311335062514">
<NAME>depressive disorders</NAME>
<CONT_DATA CI_END="0.4662282557668515" CI_START="-0.35701515968318914" EFFECT_SIZE="0.0546065480418312" ESTIMABLE="YES" MEAN_1="9.5" MEAN_2="9.2" ORDER="227" SD_1="5.5" SD_2="5.4" SE="0.21001493444361213" STUDY_ID="STD-Cooper-2003" TOTAL_1="43" TOTAL_2="48" WEIGHT="16.35112084191773"/>
<CONT_DATA CI_END="0.03345845698743882" CI_START="-0.7781772652287342" EFFECT_SIZE="-0.3723594041206477" ESTIMABLE="YES" MEAN_1="18.8" MEAN_2="23.7" ORDER="228" SD_1="13.5" SD_2="12.6" SE="0.2070537337977259" STUDY_ID="STD-Guthrie-2001" TOTAL_1="47" TOTAL_2="48" WEIGHT="16.547541981059062"/>
<CONT_DATA CI_END="-0.039501438351165374" CI_START="-0.9860624201332249" EFFECT_SIZE="-0.5127819292421951" ESTIMABLE="YES" MEAN_1="19.39" MEAN_2="25.02" MODIFIED="2011-05-13 19:13:01 +0100" MODIFIED_BY="[Empty name]" ORDER="100" SD_1="10.58" SD_2="11.14" SE="0.24147407535250945" STUDY_ID="STD-Vitriol-2009" TOTAL_1="36" TOTAL_2="35" WEIGHT="14.387097831179343"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="9.281699003422492" CI_END="0.10214334177877948" CI_START="-1.2816324214404942" DF="2" EFFECT_SIZE="-0.5897445398308574" ESTIMABLE="YES" I2="78.45222087828394" ID="CMP-001.11.02" MODIFIED="2013-06-28 06:41:46 +0100" MODIFIED_BY="Chris Champion" NO="2" P_CHI2="0.009649520666417777" P_Z="0.09479780921733745" STUDIES="3" TAU2="0.2858346891340036" TOTAL_1="138" TOTAL_2="145" WEIGHT="39.238796245160145" Z="1.670614688984789">
<NAME>somatoform disorders</NAME>
<CONT_DATA CI_END="-0.5872778542764602" CI_START="-2.220786514030575" EFFECT_SIZE="-1.4040321841535175" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="9.7" ORDER="229" SD_1="4.94" SD_2="3.36" SE="0.4167190501047525" STUDY_ID="STD-Baldoni-1995" TOTAL_1="11" TOTAL_2="21" WEIGHT="7.282956167995042"/>
<CONT_DATA CI_END="0.12039610224804775" CI_START="-1.1413917098629882" EFFECT_SIZE="-0.5104978038074702" ESTIMABLE="YES" MEAN_1="0.43" MEAN_2="0.71" ORDER="230" SD_1="0.34" SD_2="0.68" SE="0.3218905607612837" STUDY_ID="STD-Monsen-2000" TOTAL_1="20" TOTAL_2="20" WEIGHT="10.401883673427664"/>
<CONT_DATA CI_END="0.15852768619279622" CI_START="-0.38167250703438205" EFFECT_SIZE="-0.11157241042079291" ESTIMABLE="YES" MEAN_1="10.5" MEAN_2="11.2" MODIFIED="2013-06-28 06:41:46 +0100" MODIFIED_BY="[Empty name]" ORDER="123" SD_1="6.0" SD_2="6.5" SE="0.13780870400890233" STUDY_ID="STD-Sattel-2012" TOTAL_1="107" TOTAL_2="104" WEIGHT="21.55395640373744"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.21841708759612533" CI_START="-0.7909897719950179" DF="0" EFFECT_SIZE="-0.28628634219944626" ESTIMABLE="YES" I2="0.0" ID="CMP-001.11.03" MODIFIED="2013-06-11 11:54:35 +0100" MODIFIED_BY="Chris Champion" NO="3" P_CHI2="1.0" P_Z="0.2662398087666751" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="30" WEIGHT="13.475443100683703" Z="1.1117636355352296">
<NAME>mixed disorders</NAME>
<CONT_DATA CI_END="0.21841708759612533" CI_START="-0.7909897719950179" EFFECT_SIZE="-0.28628634219944626" ESTIMABLE="YES" MEAN_1="6.58" MEAN_2="8.13" ORDER="231" SD_1="4.43" SD_2="6.15" SE="0.25750648163772794" STUDY_ID="STD-Marmar-1988" TOTAL_1="31" TOTAL_2="30" WEIGHT="13.475443100683703"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="91.91722363662495" CI_END="0.21433366387522268" CI_START="-2.2226657997614385" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="-1.004166067943108" ESTIMABLE="YES" I2="95.64825846370954" I2_Q="38.268530503185744" ID="CMP-001.12" MODIFIED="2013-11-14 11:55:36 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="1.1102230246251565E-16" P_Q="0.1823592622825524" P_Z="0.10626586960051074" Q="4.859757955632045" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="1.8392069985264818" TOTALS="YES" TOTAL_1="152" TOTAL_2="169" UNITS="" WEIGHT="100.0" Z="1.6152070257157236">
<NAME>Reduction in depressive symptoms: long-term</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.013567907747769059" CI_START="-1.289095361048957" DF="0" EFFECT_SIZE="-0.6513316343983631" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.01" NO="1" P_CHI2="1.0" P_Z="0.045321242966740345" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="19.870790518588024" Z="2.001660633972985">
<NAME>anxiety disorders</NAME>
<CONT_DATA CI_END="-0.013567907747769059" CI_START="-1.289095361048957" EFFECT_SIZE="-0.6513316343983631" ESTIMABLE="YES" MEAN_1="2.9" MEAN_2="7.3" ORDER="232" SD_1="3.2" SD_2="8.8" SE="0.3253956356755496" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="19.870790518588024"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.45659742221666333" CI_START="-0.37709362913895816" DF="0" EFFECT_SIZE="0.03975189653885256" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.02" MODIFIED="2013-06-28 07:23:57 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.851731784840234" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="48" WEIGHT="20.510318800443915" Z="0.18690925231025177">
<NAME>depressive disorders</NAME>
<CONT_DATA CI_END="0.45659742221666333" CI_START="-0.37709362913895816" EFFECT_SIZE="0.03975189653885256" ESTIMABLE="YES" MEAN_1="9.1" MEAN_2="8.9" ORDER="233" SD_1="5.6" SD_2="4.4" SE="0.2126801966596504" STUDY_ID="STD-Cooper-2003" TOTAL_1="41" TOTAL_2="48" WEIGHT="20.510318800443915"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="38.77865519926581" CI_END="1.006577913475164" CI_START="-5.118437650571776" DF="1" EFFECT_SIZE="-2.055929868548306" ESTIMABLE="YES" I2="97.42126178728618" ID="CMP-001.12.03" MODIFIED="2013-11-14 11:55:36 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="4.747107151814589E-10" P_Z="0.18825205897628874" STUDIES="2" TAU2="4.757153191044889" TOTAL_1="60" TOTAL_2="71" WEIGHT="39.3392085301945" Z="1.315767594370791">
<NAME>somatoform disorders</NAME>
<CONT_DATA CI_END="0.2525787107948078" CI_START="-1.2285708764679693" EFFECT_SIZE="-0.48799608283658075" ESTIMABLE="YES" MEAN_1="7.12" MEAN_2="9.85" ORDER="234" SD_1="4.12" SD_2="6.01" SE="0.3778512255699329" STUDY_ID="STD-Baldoni-1995" TOTAL_1="11" TOTAL_2="21" WEIGHT="19.500948906600417"/>
<CONT_DATA CI_END="-2.965781691387838" CI_START="-4.260378414234892" EFFECT_SIZE="-3.613080052811365" ESTIMABLE="YES" MEAN_1="2.12" MEAN_2="3.47" ORDER="236" SD_1="0.35" SD_2="0.39" SE="0.3302603346435618" STUDY_ID="STD-Svedlund-1983" TOTAL_1="49" TOTAL_2="50" WEIGHT="19.838259623594084"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.15615176235685668" CI_START="-0.8559506586819294" DF="0" EFFECT_SIZE="-0.3498994481625364" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.04" NO="4" P_CHI2="1.0" P_Z="0.17536031767904947" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="30" WEIGHT="20.279682150773567" Z="1.3551796781696068">
<NAME>mixed disorders</NAME>
<CONT_DATA CI_END="0.15615176235685668" CI_START="-0.8559506586819294" EFFECT_SIZE="-0.3498994481625364" ESTIMABLE="YES" MEAN_1="5.35" MEAN_2="7.4" ORDER="237" SD_1="4.88" SD_2="6.59" SE="0.2581941375000053" STUDY_ID="STD-Marmar-1988" TOTAL_1="31" TOTAL_2="30" WEIGHT="20.279682150773567"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="12.858676573906735" CI_END="-0.36188867938363745" CI_START="-0.6609112158543428" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5113999476189901" ESTIMABLE="YES" I2="30.008349239741303" I2_Q="36.9792652399424" ID="CMP-001.13" MODIFIED="2013-11-28 13:00:48 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.1691061311586316" P_Q="0.1746817843030961" P_Z="2.0277227519330357E-11" Q="6.34711736578354" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="367" TOTAL_2="353" UNITS="" WEIGHT="100.0" Z="6.704012954067672">
<NAME>Social adjustment: short-term</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.174093386644304" CI_END="-0.30934633815970564" CI_START="-0.9963912242845092" DF="2" EFFECT_SIZE="-0.6528687812221075" ESTIMABLE="YES" I2="52.08540358969141" ID="CMP-001.13.01" MODIFIED="2012-01-12 19:33:21 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.12405301088846266" P_Z="1.9536436825522046E-4" STUDIES="3" TAU2="0.0" TOTAL_1="75" TOTAL_2="66" WEIGHT="18.94251410952142" Z="3.7249365322936057">
<NAME>anxiety disorders</NAME>
<CONT_DATA CI_END="0.2997871377677423" CI_START="-0.7992608464210389" EFFECT_SIZE="-0.24973685432664833" ESTIMABLE="YES" MEAN_1="15.0" MEAN_2="16.8" MODIFIED="2012-01-12 19:31:44 +0000" MODIFIED_BY="[Empty name]" ORDER="121" SD_1="6.2" SD_2="8.1" SE="0.2803745356695152" STUDY_ID="STD-Brom-1989" TOTAL_1="29" TOTAL_2="23" WEIGHT="7.402433832702235"/>
<CONT_DATA CI_END="-0.15867141175704635" CI_START="-1.3216331349092365" EFFECT_SIZE="-0.7401522733331414" ESTIMABLE="YES" MEAN_1="7.3" MEAN_2="12.7" MODIFIED="2011-05-13 19:17:29 +0100" MODIFIED_BY="[Empty name]" ORDER="101" SD_1="7.8" SD_2="6.4" SE="0.2966793605202656" STUDY_ID="STD-Milrod-2007" TOTAL_1="26" TOTAL_2="23" WEIGHT="6.611149838270714"/>
<CONT_DATA CI_END="-0.46779503960904045" CI_START="-1.8146709226170554" EFFECT_SIZE="-1.141232981113048" ESTIMABLE="YES" MEAN_1="1.1" MEAN_2="3.6" MODIFIED="2012-01-12 19:33:21 +0000" MODIFIED_BY="[Empty name]" ORDER="122" SD_1="0.9" SD_2="2.9" SE="0.34359710015898254" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="4.92893043854847"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.022736586408673307" CI_END="-0.12650566385805678" CI_START="-0.6309909367740132" DF="1" EFFECT_SIZE="-0.378748300316035" ESTIMABLE="YES" I2="0.0" ID="CMP-001.13.02" MODIFIED="2012-05-02 12:43:59 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.880144102655271" P_Z="0.0032511940139606675" STUDIES="2" TAU2="0.0" TOTAL_1="122" TOTAL_2="124" WEIGHT="35.132645760631014" Z="2.9429324013145424">
<NAME>depressive disorders</NAME>
<CONT_DATA CI_END="-0.08580831887038892" CI_START="-0.6984270495255389" EFFECT_SIZE="-0.39211768419796394" ESTIMABLE="YES" MEAN_1="147.33" MEAN_2="157.54" MODIFIED="2012-05-02 12:43:29 +0100" MODIFIED_BY="[Empty name]" ORDER="124" SD_1="26.03" SD_2="25.81" SE="0.15628316017217878" STUDY_ID="STD-de-Jonghe-2001" TOTAL_1="83" TOTAL_2="84" WEIGHT="23.824692277580304"/>
<CONT_DATA CI_END="0.0940323695812208" CI_START="-0.7951931429736006" EFFECT_SIZE="-0.3505803866961899" ESTIMABLE="YES" MEAN_1="14.52" MEAN_2="17.14" MODIFIED="2011-05-13 19:19:14 +0100" MODIFIED_BY="[Empty name]" ORDER="102" SD_1="6.79" SD_2="7.95" SE="0.22684741137309633" STUDY_ID="STD-Vitriol-2009" TOTAL_1="39" TOTAL_2="40" WEIGHT="11.307953483050708"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.18215531260331752" CI_START="-0.983274074464227" DF="0" EFFECT_SIZE="-0.5827146935337723" ESTIMABLE="YES" I2="0.0" ID="CMP-001.13.03" MODIFIED="2012-08-15 22:21:15 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.004354604781953296" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="13.9320183076046" Z="2.8512621772470252">
<NAME>somatoform disorders</NAME>
<CONT_DATA CI_END="-0.18215531260331752" CI_START="-0.983274074464227" EFFECT_SIZE="-0.5827146935337723" ESTIMABLE="YES" MEAN_1="15.0" MEAN_2="16.5" ORDER="239" SD_1="2.7" SD_2="2.4" SE="0.2043707864481266" STUDY_ID="STD-Svedlund-1983" TOTAL_1="50" TOTAL_2="50" WEIGHT="13.9320183076046"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.1700843040169843" CI_START="-0.6208122165310195" DF="0" EFFECT_SIZE="-0.22536395625701758" ESTIMABLE="YES" I2="0.0" ID="CMP-001.13.04" MODIFIED="2012-02-15 15:45:24 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.2640056628639158" STUDIES="1" TAU2="0.0" TOTAL_1="51" TOTAL_2="48" WEIGHT="14.294484969317526" Z="1.1169735261223854">
<NAME>mixed disorders</NAME>
<CONT_DATA CI_END="0.1700843040169843" CI_START="-0.6208122165310195" EFFECT_SIZE="-0.22536395625701758" ESTIMABLE="YES" MEAN_1="-43.4" MEAN_2="-37.0" MODIFIED="2012-02-09 19:16:49 +0000" MODIFIED_BY="[Empty name]" ORDER="120" SD_1="25.95" SD_2="30.37" SE="0.20176302390923878" STUDY_ID="STD-Guthrie-1999" TOTAL_1="51" TOTAL_2="48" WEIGHT="14.294484969317526"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.3147292350702164" CI_END="-0.442803600531885" CI_START="-1.1535876816680766" DF="2" EFFECT_SIZE="-0.7981956410999808" ESTIMABLE="YES" I2="13.596805635051705" ID="CMP-001.13.05" MODIFIED="2012-03-15 17:54:53 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.31431346989884645" P_Z="1.0725902266540886E-5" STUDIES="2" TAU2="0.0" TOTAL_1="69" TOTAL_2="65" WEIGHT="17.698336852925458" Z="4.401997035927044">
<NAME>personality disorders</NAME>
<CONT_DATA CI_END="-0.3314322986581163" CI_START="-1.982326861818286" EFFECT_SIZE="-1.1568795802382013" ESTIMABLE="YES" MEAN_1="-78.1" MEAN_2="-64.6" MODIFIED="2012-02-09 19:27:41 +0000" MODIFIED_BY="[Empty name]" ORDER="124" SD_1="10.1" SD_2="12.5" SE="0.42115431104403334" STUDY_ID="STD-Abbass-2008" TOTAL_1="14" TOTAL_2="13" WEIGHT="3.2807200107268986"/>
<CONT_DATA CI_END="0.08101285161182098" CI_START="-1.0337400050303964" EFFECT_SIZE="-0.4763635767092877" ESTIMABLE="YES" MEAN_1="1.85" MEAN_2="2.05" ORDER="240" SD_1="0.33" SD_2="0.48" SE="0.2843809543020294" STUDY_ID="STD-Winston-1994" TOTAL_1="25" TOTAL_2="26" WEIGHT="7.195328964309768"/>
<CONT_DATA CI_END="-0.3995592371336204" CI_START="-1.5122296080418525" EFFECT_SIZE="-0.9558944225877365" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="2.05" MODIFIED="2012-02-15 14:43:31 +0000" MODIFIED_BY="[Empty name]" ORDER="129" SD_1="0.21" SD_2="0.48" SE="0.283849698179363" STUDY_ID="STD-Winston-1994" TOTAL_1="30" TOTAL_2="26" WEIGHT="7.222287877888791"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.061064113575571365" CI_END="-0.29314100388627184" CI_START="-0.8612331013575281" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5771870526219" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.14" MODIFIED="2014-04-04 20:51:28 +0100" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.9699293389654103" P_Q="0.9699293389654103" P_Z="6.814114804521408E-5" Q="0.061064113575571365" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="100" TOTAL_2="99" UNITS="" WEIGHT="100.0" Z="3.9826846404565157">
<NAME>Social adjustment: long-term</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0070426113623881514" CI_START="-1.2661531342100454" DF="0" EFFECT_SIZE="-0.6295552614238286" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.01" MODIFIED="2012-01-12 19:34:00 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.05258893437365784" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="19.908894193059552" Z="1.9382811212797983">
<NAME>anxiety disorders</NAME>
<CONT_DATA CI_END="0.0070426113623881514" CI_START="-1.2661531342100454" EFFECT_SIZE="-0.6295552614238286" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="2.8" MODIFIED="2012-01-12 19:34:00 +0000" MODIFIED_BY="[Empty name]" ORDER="123" SD_1="2.0" SD_2="2.9" SE="0.32480080134513667" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="19.908894193059552"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.1828714835738342" CI_START="-0.9882390669069069" DF="0" EFFECT_SIZE="-0.5855552752403705" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.02" MODIFIED="2013-06-11 11:54:40 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.004371293362337148" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="50" WEIGHT="49.75642928441685" Z="2.8500458031321796">
<NAME>somatoform disorders</NAME>
<CONT_DATA CI_END="-0.1828714835738342" CI_START="-0.9882390669069069" EFFECT_SIZE="-0.5855552752403705" ESTIMABLE="YES" MEAN_1="14.7" MEAN_2="16.4" ORDER="242" SD_1="3.3" SD_2="2.4" SE="0.20545468939371064" STUDY_ID="STD-Svedlund-1983" TOTAL_1="49" TOTAL_2="50" WEIGHT="49.75642928441685"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.013365352531395258" CI_START="-1.0448174513819588" DF="0" EFFECT_SIZE="-0.529091401956677" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.03" MODIFIED="2013-06-11 11:54:40 +0100" MODIFIED_BY="Chris Champion" NO="3" P_CHI2="1.0" P_Z="0.044351062787742104" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="29" WEIGHT="30.334676522523598" Z="2.01075763677346">
<NAME>mixed disorders</NAME>
<CONT_DATA CI_END="-0.013365352531395258" CI_START="-1.0448174513819588" EFFECT_SIZE="-0.529091401956677" ESTIMABLE="YES" MEAN_1="108.26" MEAN_2="119.56" ORDER="243" SD_1="21.08" SD_2="21.08" SE="0.2631303705033679" STUDY_ID="STD-Marmar-1988" TOTAL_1="31" TOTAL_2="29" WEIGHT="30.334676522523598"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.047465149982743" CI_END="-0.17459149662672985" CI_START="-0.6676190929280148" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4211052947773723" ESTIMABLE="YES" I2="29.05250478589109" I2_Q="24.27056141504018" ID="CMP-001.15" MODIFIED="2014-05-06 20:44:50 +0100" MODIFIED_BY="Anne Lawson" NO="15" P_CHI2="0.21713422364144974" P_Q="0.25957042238217176" P_Z="8.136959432822366E-4" Q="5.28196177700757" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="133" TOTAL_2="132" UNITS="" WEIGHT="100.0" Z="3.348093362945987">
<NAME>Interpersonal problems: short-term</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.7655033729751723" CI_END="0.4882661508224876" CI_START="-0.5606380341348008" DF="1" EFFECT_SIZE="-0.036185941656156614" ESTIMABLE="YES" I2="43.35893007585533" ID="CMP-001.15.01" MODIFIED="2012-01-12 19:18:13 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.18393967426374114" P_Z="0.8924277883426806" STUDIES="2" TAU2="0.0" TOTAL_1="30" TOTAL_2="29" WEIGHT="22.09382049592209" Z="0.1352328332937725">
<NAME>anxiety disorders</NAME>
<CONT_DATA CI_END="1.1688879632494351" CI_START="-0.4264013124651948" EFFECT_SIZE="0.3712433253921202" ESTIMABLE="YES" MEAN_1="11.8" MEAN_2="9.2" MODIFIED="2012-01-12 19:16:11 +0000" MODIFIED_BY="[Empty name]" ORDER="117" SD_1="5.5" SD_2="8.5" SE="0.40696902807859436" STUDY_ID="STD-Alstrom-1984a" TOTAL_1="16" TOTAL_2="10" WEIGHT="9.55132375297003"/>
<CONT_DATA CI_END="0.34961386818458223" CI_START="-1.0425143297801787" EFFECT_SIZE="-0.3464502307977982" ESTIMABLE="YES" MEAN_1="8.3" MEAN_2="10.5" MODIFIED="2012-01-12 19:18:13 +0000" MODIFIED_BY="[Empty name]" ORDER="119" SD_1="5.9" SD_2="6.4" SE="0.3551412701829448" STUDY_ID="STD-Alstrom-1984b" TOTAL_1="14" TOTAL_2="19" WEIGHT="12.542496742952059"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.08271616924530129" CI_START="-0.806983119610607" DF="0" EFFECT_SIZE="-0.3621334751826529" ESTIMABLE="YES" I2="0.0" ID="CMP-001.15.02" MODIFIED="2012-01-12 20:15:06 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.11059496439449973" STUDIES="1" TAU2="0.0" TOTAL_1="39" TOTAL_2="40" WEIGHT="30.70831385670897" Z="1.5955246403917944">
<NAME>depressive disorders</NAME>
<CONT_DATA CI_END="0.08271616924530129" CI_START="-0.806983119610607" EFFECT_SIZE="-0.3621334751826529" ESTIMABLE="YES" MEAN_1="19.09" MEAN_2="22.6" MODIFIED="2012-01-12 19:09:18 +0000" MODIFIED_BY="[Empty name]" ORDER="112" SD_1="7.73" SD_2="11.12" SE="0.2269682748952896" STUDY_ID="STD-Vitriol-2009" TOTAL_1="39" TOTAL_2="40" WEIGHT="30.70831385670897"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3139642077330896" CI_START="-0.9338543980707323" DF="0" EFFECT_SIZE="-0.30994509516882135" ESTIMABLE="YES" I2="0.0" ID="CMP-001.15.03" MODIFIED="2012-01-12 19:11:01 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.33022086561471686" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="15.611317040819989" Z="0.9736691228840928">
<NAME>somatoform disorders</NAME>
<CONT_DATA CI_END="0.3139642077330896" CI_START="-0.9338543980707323" EFFECT_SIZE="-0.30994509516882135" ESTIMABLE="YES" MEAN_1="0.84" MEAN_2="0.97" MODIFIED="2012-01-12 19:11:01 +0000" MODIFIED_BY="[Empty name]" ORDER="114" SD_1="0.44" SD_2="0.38" SE="0.318326922241035" STUDY_ID="STD-Monsen-2000" TOTAL_1="20" TOTAL_2="20" WEIGHT="15.611317040819989"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.324389130354917" CI_START="-1.3848042005725687" DF="0" EFFECT_SIZE="-0.8545966654637429" ESTIMABLE="YES" I2="0.0" ID="CMP-001.15.04" MODIFIED="2012-01-12 20:15:22 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.0015825711516917844" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="21.616763706518356" Z="3.15910011590682">
<NAME>mixed disorders</NAME>
<CONT_DATA CI_END="-0.324389130354917" CI_START="-1.3848042005725687" EFFECT_SIZE="-0.8545966654637429" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="1.22" MODIFIED="2012-01-12 20:15:22 +0000" MODIFIED_BY="[Empty name]" ORDER="125" SD_1="0.41" SD_2="0.55" SE="0.27051901937537387" STUDY_ID="STD-Bressi-2010" TOTAL_1="30" TOTAL_2="30" WEIGHT="21.616763706518356"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="7.768192227498143E-32" CI_END="0.090813875596375" CI_START="-1.4706370324076339" DF="0" EFFECT_SIZE="-0.6899115784056294" ESTIMABLE="YES" I2="100.0" ID="CMP-001.15.05" MODIFIED="2012-01-12 19:06:55 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.08327690124045832" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="13" WEIGHT="9.969784900030604" Z="1.7319812480313264">
<NAME>personality disorders</NAME>
<CONT_DATA CI_END="0.0908138755963751" CI_START="-1.4706370324076339" EFFECT_SIZE="-0.6899115784056293" ESTIMABLE="YES" MEAN_1="0.67" MEAN_2="1.11" MODIFIED="2012-01-12 19:06:55 +0000" MODIFIED_BY="[Empty name]" ORDER="110" SD_1="0.66" SD_2="0.57" SE="0.3983366327954326" STUDY_ID="STD-Abbass-2008" TOTAL_1="14" TOTAL_2="13" WEIGHT="9.969784900030604"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.1014819793099223" CI_END="-0.052742706457140354" CI_START="-0.9242225233375512" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4884826148973458" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.16" MODIFIED="2014-05-06 20:45:04 +0100" MODIFIED_BY="Anne Lawson" NO="16" P_CHI2="0.9505248371038421" P_Q="0.9675434225000703" P_Z="0.02800606642002336" Q="0.0016556370312383062" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="46" TOTAL_2="39" UNITS="" WEIGHT="100.00000000000001" Z="2.197201389470911">
<NAME>Interpersonal problems: long-term</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.09982634227868399" CI_END="0.11598980677554277" CI_START="-1.076069732827158" DF="1" EFFECT_SIZE="-0.4800399630258076" ESTIMABLE="YES" I2="0.0" ID="CMP-001.16.01" MODIFIED="2012-01-12 19:17:35 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7520381551130617" P_Z="0.11443998659554505" STUDIES="2" TAU2="0.0" TOTAL_1="26" TOTAL_2="20" WEIGHT="53.446438657792044" Z="1.5785470564399828">
<NAME>anxiety disorders</NAME>
<CONT_DATA CI_END="0.3133341923248907" CI_START="-1.491969102145439" EFFECT_SIZE="-0.5893174549102742" ESTIMABLE="YES" MEAN_1="9.0" MEAN_2="13.0" MODIFIED="2012-01-12 19:16:42 +0000" MODIFIED_BY="[Empty name]" ORDER="116" SD_1="5.2" SD_2="8.3" SE="0.4605450173345867" STUDY_ID="STD-Alstrom-1984a" TOTAL_1="13" TOTAL_2="8" WEIGHT="23.303133199129192"/>
<CONT_DATA CI_END="0.3980953498749275" CI_START="-1.189215176143017" EFFECT_SIZE="-0.39555991313404476" ESTIMABLE="YES" MEAN_1="5.9" MEAN_2="8.7" MODIFIED="2012-01-12 19:17:35 +0000" MODIFIED_BY="[Empty name]" ORDER="118" SD_1="6.4" SD_2="7.3" SE="0.4049335953462531" STUDY_ID="STD-Alstrom-1984b" TOTAL_1="13" TOTAL_2="12" WEIGHT="30.143305458662848"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.14045698980868698" CI_START="-1.1368076183720934" DF="0" EFFECT_SIZE="-0.4981753142817032" ESTIMABLE="YES" I2="0.0" ID="CMP-001.16.02" MODIFIED="2013-06-11 11:54:43 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.12628894730692558" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="19" WEIGHT="46.55356134220797" Z="1.5289011653893148">
<NAME>somatoform disorders</NAME>
<CONT_DATA CI_END="0.14045698980868698" CI_START="-1.1368076183720934" EFFECT_SIZE="-0.4981753142817032" ESTIMABLE="YES" MEAN_1="0.71" MEAN_2="0.98" MODIFIED="2012-01-12 19:15:03 +0000" MODIFIED_BY="[Empty name]" ORDER="115" SD_1="0.55" SD_2="0.51" SE="0.32583879557371476" STUDY_ID="STD-Monsen-2000" TOTAL_1="20" TOTAL_2="19" WEIGHT="46.55356134220797"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2014-05-15 12:55:39 +0100" MODIFIED_BY="Anne Lawson">
<FIGURE FILENAME="H05 Prisma.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2014-05-06 20:46:07 +0100" MODIFIED_BY="Anne Lawson" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>PRISMA flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtAAAAPACAAAAAA5nRFvAAA5yUlEQVR42u2dP2j0WLqnDzcwBU7q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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2014-05-15 12:55:39 +0100" MODIFIED_BY="Anne Lawson" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADnCAMAAAD7EqYIAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2014-05-15 12:55:39 +0100" MODIFIED_BY="Anne Lawson" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAATMAAAT4CAIAAAD7LbLZAAA/sElEQVR42u3dvY4dx3r18QEMGA4m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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2014-05-08 12:58:25 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2014-05-08 12:58:25 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2014-05-08 11:14:09 +0100" MODIFIED_BY="[Empty name]">Other electronic searches: CENTRAL</TITLE>
<APPENDIX_BODY MODIFIED="2014-05-08 12:58:25 +0100" MODIFIED_BY="[Empty name]">
<P>#1 ANXIETY<BR/>#2 DEPRESSION<BR/>#3 (PANIC next DISORDER)<BR/>#4 (DEPRESSIVE next DISORDER)<BR/>#5 (DEPRESSIVE next SYMPTOMS)<BR/>#6 (ANXIOUS next SYMPTOMS)<BR/># 7 (SOMATIZATION next SYMPTOMS)<BR/># 8 (SOMATIZATION next SYMPTOMS)<BR/>#9 (SOMATIZATION next DISORDER)<BR/>#10 (SOMATIZATION next DISORDER)<BR/>#11 (SOMATOFORM next SYMPTOMS)<BR/>#12 (SOMATOFORM next SYMPTOMS)<BR/>#13 (((((#1 or #2) or #3) or #4) or #5) or #6) or #7) or #8) or #9) or #10) or #11) or #12)<BR/>#14 (BRIEF next PSYCHODYNAMIC)<BR/>#15 (BRIEF next DYNAMIC)<BR/>#16 (TIME-LIMITED next PSYCHODYNAMIC)<BR/>#17 (TIME-LIMITED next DYNAMIC)<BR/>#18 (BRIEF next PSYCHOANALYTIC)<BR/>#19 (BRIEF next ANALYTIC)<BR/>#20 (TIME-LIMITED next PSYCHOANALYTIC)<BR/>#21 (TIME-LIMITED next ANALYTIC)<BR/>#22 (((((((#14 or #15) or #16) or #17) or #18) or #19) or #20) or #21)#19 (#13 and #22)<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS><EXTENSION ID="AFF_z1301251413262757031162189942043_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS"><ALIAS ALIAS_ID="z1301251413262757031162189942043"><ADDRESS><DEPARTMENT>Department of Medical Psychology</DEPARTMENT><ORGANISATION>University Medical Center Hamburg-Eppendorf</ORGANISATION><ADDRESS_1>Martinistr. 52, W26</ADDRESS_1><CITY>Hamburg</CITY><ZIP>20246</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+43 680 4424495</PHONE_1></ADDRESS></ALIAS></EXTENSION></EXTENSIONS>
</COCHRANE_REVIEW>